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ABSTRACT 
The adult stage of the parasitic nematode Brugia malayi can live in the host 
lymphatics for many years and must have an extremely effective immuno-suppressive 
mechanism that prevents rejection. We have discovered that this parasite can induce 
alternatively activated IL-4 dependent macrophages that can block proliferation of 
other cells via a receptor-mediated mechanism. The proliferative block is reversible 
and is not a result of apoptosis. Furthermore, these suppressive cells can reduce the 
proliferation of a wide range of human cancer cell lines. These data demonstrates that 
B. malayi can lead to the activation of a novel mechanism of proliferative suppression, 
via IL-4 dependent macrophages. These macrophages may have important roles in 
altering host immune responses during parasitic infection and may even have the 
potential to reduce tumour cell growth. 
Another feature of B. malayi infection is a bias towards a type 2 immune 
response. To investigate the role that the B.malayi recruited antigen presenting cells 
have on naïve T cells, the suppressive macrophages recruited by B. malayi was used to 
stimulate naïve T cells from ICR transgenic mice. Although the proliferation of the 
naïve T cells was inhibited by parasite-induced macrophages during primary 
stimulation, they proliferated normally upon secondary stimulation and were not 
rendered anergic. However, naïve T cells primed by suppressive macrophages 
differentiated into IL4 producing Th2 cells upon secondary stimulation instead of 
IFN-y producing Thi cells, as has been previously described. Th2 differentiation was 
associated with the inhibition of (or failure to stimulate) IFN-y producing T cells 
during primary stimulation. Interestingly, blocking antibodies against TGF-J3 (but not 
IL-b) restored the differentiation of IFN-'y producing Thi cells. These data indicate 
that T cells exposed to parasite induced alternatively activated macrophages are driven 
towards Th2 differentiation. This may be an important factor in the Th2 bias that 
accompanies helminth infection. 
In order to identify genes that are highly expressed in suppressive 
macrophages, which could be involved in proliferative suppression and Th2 induction, 
a eDNA library was constructed from these alternatively activated macrophages and 
an expressed sequence tag (EST) strategy was used to characterise the abundantly 
expressed genes in these cells. The gene YM1/ECF-L, also recently characterised as a 
novel eosinophil chemotactic factor (ECF-L), was massively upregulated in this 
library, representing 8.5% of the EST clones. The recruitment of eosinophils is another 
key feature of nematode infection and indeed many other type 2 immune responses 
such as allergic responses. Interestingly, we found that in vivo administration of the 
Brugia malayi homologue of the cytokine MIF (BmMIF-l) also induced YM1/ECF-.L 
up-regulation. A single amino acid mutation that abolishes enzyme activity of 
BniMIF-1 (called BmMJF'-lG) also abolishes induction of YM1/ECF-L in F4/80 
macrophages. BmMIF-1 injected mice had much higher levels of eosinophilia than 
BmIvllF-1G injected mice, suggesting that eosinophil recruitment is linked to the 
enzyme activity of BmIVIIF- 1. Thus, parasite derived MIF could activate macrophages 
to produce YM1/ECF-L, which in turn recruits eosinophils to the local site of 
inflammation. 
In order to identify IL-4 dependent genes in alternatively activated 
macrophages and also potentially discover novel genes involved in the mechanism of 
proliferative suppression, we took a number of molecular approaches. Firstly, we 
constructed a eDNA library from non-suppressive macrophages that are recruited in 
parasite implanted IL-4 deficient mice and again used an expressed sequence tag 
(EST) strategy to characterise the abundantly expressed genes in these cells. 
Comparison of the IL-4' macrophage EST dataset with the suppressive macrophage 
EST dataset revealed a number of potentially differentially expressed genes. Secondly, 
we have made a subtractive library by using 'driver' RNA from non-suppressive IL-4 
deficient PEC to subtract away 'tester' RNA from suppressive macrophages, yielding 
a population of 20 000 recombinants enriched in putative suppression generating 
transcripts. A preliminary assay of 176 randomly selected clones from this library has 
revealed that between 10-20% of the recombinants are differentially expressed 
between the 2 macrophage populations. 
Thus, we have found that alternatively activated macrophages could play a 
crucial role in: 1) immune suppression, 2) inducing Th2 differentiation of naïve T cells 
and 3) recruiting eosinophils to the site of inflammation. We have also made the first 
steps towards defining the molecular basis of IL-4 dependent genes in alternatively 
activated macrophages, which could lead to the identification of a novel mechanism 
that inhibits proliferation. 
GLOSSARY 
AAM 	Alternatively activated macrophages 
APC Antigen presenting cell 
BALF Bronchoalveolar lavage fluid 
CAMO Classically activated macrophages 
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CTL Cytotoxic T lymphocytes 
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EST Expressed sequence tags 
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One of the most interesting areas of investigative immunology revolves around 
the mechanisms involved in maintaining peripheral tolerance. It is becoming 
increasingly clear that the link between the innate immune system and the adaptive 
immune system plays a crucial role in peripheral tolerance. During the evolutionary 
arms race between hosts and parasites, it is likely that parasites have evolved strategies 
that exploit these mechanisms to prevent rejection by the host immune response. Thus, 
by studying the interaction between parasites and host responses, we might gain 
important insights into the process of maintaining peripheral tolerance. 
The filarial parasites are remarkable organisms because they can live in the 
very heart of the immune system (i.e. the lymphatic system) without being rejected for 
many years. As a foreign organism living within the host, they are behaving in some 
ways like a successful xeno-transplant. The many mechanisms that filarial parasites 
must utilise in order to prevent rejection remain unclear. Our laboratory has been 
particularly interested in the effects that these parasites have on the antigen presenting 
cells of the immune system. 
This introduction will begin by reviewing the mechanisms involved in 
regulating and maintaining peripheral tolerance. I will then describe the biology and 
immunological responses to filarial parasites and discuss how the parasites could be 
exploiting the mechanisms involved in peripheral tolerance. Finally, I will describe the 
work that has been done previously in the lab with respect to the antigen presenting 
cells that are recruited by these parasites. 
Peripheral tolerance 
T cell activation 
To understand T cell tolerance, one must first understand T cell activation, 
since the decision between activation, death or not responding is the basis of most 
immune mechanisms. T cell activation requires a number of different signals, all of 
which can also serve as checkpoints in determining whether activation is appropriate. 
First of all, T cells need to receive signal one through recognition of a specific 
antigen in order to undergo clonal expansion and generate extended progeny that are 
specific to this antigen (Bumet, 1959). Zinkernagel and Doherty showed that the major 
histocompatitibility complex (MHC) plays a crucial role in delivering signal one to T 
cells (Zinkemagel and Doherty, 1974), whereas Townsend completed the signal one 
story by showing that it was peptides presented on MIHC molecules that delivered the 
specific signals to I cells (Townsend et al., 1986). 
By then, it was already clear that T cells required a second signal for 
activation, which was particularly true for "naïve" T cells that have never before 
encountered antigen. In the mid- 1970s, Lafferty and Cunningham had already 
proposed that signal one from the antigen specific receptor was not enough to activate 
T cells, and a second signal from an antigen presenting cell was necessary for full 
activation (Lafferty and Cunningham, 1975). This second signal is also known as co- 
stimulation. In the 1980s, Schwartz and Jenkins expanded and modified this idea by 
arguing that in the absence of a second signal, T cells receiving signal one would 
become "anergic" or non-responsive (Jenkins and Schwartz, 1987). Although there is 
no disagreement about the fact that signal two clearly enhances activation of T cells, 
arguments that signal one in the absence of signal 2 leads to deletion (Matzinger, 
1994) or tolerance through anergy (Schwartz, 1996) is more controversial 
(Zinkernagel, 2000). 
From these models it was suggested that antigen presenting cells (APC) 
themselves have to become activated in order to deliver signal 2, the absence of which 
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could result in tolerance. This implied an instructive role played by the antigen 
presenting cell, which has the predicted power to determine whether I cells are 
activated or tolerised. Indeed the recent advances in immunology have shifted away 
from understanding T cell activation from the T cell point of view towards an 
emphasis on the antigen presenting cell. 
Medzhitov and Janeway (Medzhitov and Janeway, 1997) have proposed that 
antigen presenting cells are activated by having pattern recognition receptors (PRR), 
which bind and recognise pathogen associated molecular patterns (PAMPS). In 
contrast, Matzinger has proposed that antigen presenting cells recognise "danger", 
which is an endogenous signal from stressed or damaged host cells, instead of 
"foreign" exogenous factors (Gallucci et al., 1999; Matzinger, 1998). Although this 
debate continues, both models acknowledge the crucial role played by antigen 
presenting cells and the innate immune response in instructing T cell (and indeed the 
adaptive immune response). This clear role for APCs in T cell activation should 
translate to an equally important role in maintaining or inducing T cell tolerance, 
although this role for APCs remains a relatively unexplored area of immunology. 
Thus, T cell activation (or tolerance) can be regulated via 1) signal one from 
TCR-peptide-MHC engagament, 2) signal 2 via costimulation and 3) activation of 
APCs. 
Signal one: TCR engagement of peptide-MHC complex 
Unlike antibodies, which recognise an unlimited range of molecular structures, 
the T cell receptor (TCR) recognises antigens as a peptide presented on a major 
histocompatibility complex (M}-IC) class I or II molecule. Interestingly, there is a new 
awareness of how cross reactive T cell receptors are in their recognition of peptides in 
the context of MHC. This is due to a number of observations including the emerging 
awareness of 'altered peptide ligands' (APL). These are peptides that differ slightly in 
sequence from the original peptide recognised by a TCR, and causes either partial 
activation (weak or partial agonists) or down regulation of the T cell (antagonist) when 
engaged by the TCR (reviewed by Kersh and Allen 1996 (Kersh and Allen, 1996)). 
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The resolution of the crystal structure of a TCR-peptide-MHC complex has also 
shown that there is a considerable amount of space in the region between the TCR and 
the peptide-MEIC complex (i.e. They do not fit together as tightly as previously 
thought) (Garboczi et al., 1996; Garcia et al., 1996). Slight variations in peptide 
sequence (e.g. in APLs) are more likely to lead to a difference in the kinetics of 
molecular interactions, rather than the lack of structural specificity. 
Signal two: Costimulation 
Costimulation (or signal 2) plays a crucial role in enabling the sensitivity and 
specificity of T cell activation by enhancing appropriate T cell activation and 
preventing non-specific T cell activation. CD28 was the molecule that was originally 
recognised as being a prime positive mediator of costimulation (Hara et al., 1985). The 
subsequent discovery of CTLA-4 (Linsley et al., 1991), which shares 75% nucleotide 
sequence homology with CD28, has eventually led to the concept of an opposing role 
for these 2 costimulatory molecules (Allison and Krummel, 1995). It is now generally 
accepted that costimulation via CTLA-4 inhibits T cell activation (Thompson and 
Allison, 1997), while costimulation via CD28 enhances T cell activation (Lenschow et 
al., 1996). The family of ligands expressed on the surface of APC that bind CD28 and 
CTLA-4 on T cells are called B7 (Lenschow et al., 1996). The first 2 members of this 
family (137-1 & 137-2) will bind to either CD28 or CTLA-4, although CTLA-4 has a 
much higher affinity for both 137-1 & 137-2 than CD28 (van der Merwe et al., 1997). 
CD28 is constitutively expressed on T cells and can be down regulated by T cell 
activation (Linsley et al., 1991), while CTLA-4 is only detectable after T cell 
activation (Krummel and Allison, 1995) and is mostly sequestered inside the cell 
(Zhang and Allison, 1997). The distinct expression pattern and function of CD28 and 
CTLA-4 suggests that the kinetic interplay between these 2 costimulatory molecules 
and their ligands is extremely complex. 
The recent discovery of more costimulatory molecules (ie. ICOS and B7H) has 
added extra layers of complexity to the costimulation story (Abbas and Sharpe, 1999). 
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It is important to note that B7-H does not bind CTLA-4 and CD28, but binds to ICOS 
instead (Ling et al., 2000; Mages et al., 2000; Yoshinaga et al., 1999). In contrast to 
CD28, ICOS delivers a positive signal to activated T cells, instead of resting or naïve 
T cells. In particular, ICOS has been implicated in the differentiation of Th2 cells 
(Kopf et al., 2000), as well as potentially stimulating T regulatory cells, since ICOS 
signalling induces IL- 10 production (Dong et al., 1999). 
The combination of TCR and positive costimulatory molecule engagement 
initiates multiple signal transduction cascades that lead to the expression of genes 
necessary for T cell responses. However, it is still uncertain whether positive 
costimulation lransduces independent signals that are necessary for T cell activation, 
or whether costimulation simply amplifies signals delivered via TCR engagement. 
This is partly due to difficulties in identifying a genuine independent signal. Apart 
from the ability of CD28 to induce bcl-xl (Boise et al., 1995), there have not been 
many other examples of changes in gene expression, which is induced by 
costimulation and not simply an amplified response to TCR engagement. it is possible 
that such genes do not exist and that costimulation is simply a process that influences 
TCR induced gene expression. Apart from the difficulties in identifying independent 
costimulatory signals, the signal amplification theory of costimulation has been 
boosted by recent studies showing that costimulation leads to cytoskeletal changes 
(Wulfmg and Davis, 1998), reorganization of lipid membrane microdomains (Viola et 
al., 1999) and contributes towards the formation of the immunological synapse 
(Grakoui et al., 1999). This could lead to T cell activation at a much lower level of 
TCR triggering, by enhancing and stabilising early phosphorylation events (Grakoui et 
al., 1999; Lanzavecchia et al., 1999). 
Cytokines: Th1/Th2 paradigm 
Lanzavecchia has proposed that the maturation of a naive T cell into a fully 
activated effector T cell requires a combination of 3 signals (Lanzavecchia, 1999). 
Apart from signal one and two (as discussed above), he refers to the presence of 
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polarizing cytokines as signal 3 and argues that it promotes the differentiation of T 
effector cells. Although the cytokine environment of an immune response is usually 
attributed to the Th subsets of CD4 T cells, their differentiation is also subject to the 
cytokine microenvironment that they are in, which means that the systems works via a 
positive feedback loop mechanism. Ever since Mosmann et.al . first delineated T-cell 
clones into Thi and Th2 subsets (Mosmann et al., 1986), these T helper subsets have 
provided us with an important framework to understand the regulation of the immune 
response. The basic concept is that; Thi cells are involved in cell mediated 
inflammatory functions and secrete cytokines such as WN-y and TNF-a, whereas Th2 
cells encourages antibody production, enhances eosinophil response, and is 
characterised by the cytokines IL-4, IL-5, IL-6 and IL-13. However, the concept of 
these Th subsets has since become so influential that it is frequently oversimplified 
and has become almost a 'dangerous dogma' (Allen and Maizels, 1997). 
Although the cytokine environment is widely considered to be the most 
important factor influencing the differentiation of naïve T cells (Abbas et al., 1996; 
O'garra, 1998), with interleukin-12 (IL-12) as the major Thi polarizing factor and IL-4 
as the major Th2 driving cytokine, many other factors can influence the differentiation 
of naïve T cells (e.g. altered peptide ligands, antigen dose and costimulatory molecules 
(Constant and Bottomly, 1997)). It has also been proposed that the type of APC and its 
previous environmental exposure could also play an important role in influencing T 
cell differentiation (Goerdt and Orfanos, 1999; Kalinski et al., 1999; Rissoan et al., 
1999). This is probably due to the different cytokines (e.g IL-12) that are produced by 
APC that have been activated under different conditions (Kalinski et al., 1998). 
Antigen presenting cells 
An important source of cytokines is the antigen presenting cells (APC) that are 
delivering signals one and two to the T cells. The term APC is generally used to 
describe cells that express MHC class II, which restricts the term to B cells, 
macrophages and dendritic cells (Professional APC). Although most cells express 
M}IC class I and can be destroyed by activated cytotoxic T lymphocytes (CTL), only 
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APC that express MHC class II can stimulate/activate CD4 T cells. Although most 
cells that express class I can be surveyed and recognised by CTL, it is thought that 
only professional APC(probably dendritic cells) can activate naïve CD8 T cells to 
differentiate/mature into activated CTL (Lanzavecchia, 1998; Ridge et al., 1998). 
From studies with naïve T cells from TCR lransgenic mice, B cells, macrophages and 
dendritic cells could all prime and activate naïve T cells in vitro (Swain, 1994), 
although physiologically, it is probably dendritic cells that play this role in vivo. 
B cells need to present antigen to CD4 cells in order to receive their 
equivalent of "signal 2" (Bretscher and Cohn, 1970), which allows them to undergo 
expansion and somatic hypermutation. Macrophages also need to restimulate activated 
. CD4+  T cells m order to receive their own activation signals to either clear intracellular 
parasites via oxygen radicals (MacMicking et al., 1997) or perhaps to play an 
immuno-regulatory role by entering an alternative activation pathway (Goerdt and 
Orfanos, 1999). It remains a controversy whether naïve T cells are solely activated by 
dendritic cells in vivo, or whether B cells and macrophages can also perform this role 
in a real infection. Nonetheless, dendritic cells are probably the most important APC in 
the role of kick starting the immune response, but the role for macrophages in priming 
the immune response is still unclear. 
T cell tolerance 
T cell tolerance is essentially a two stage process known as 'central tolerance' 
and 'peripheral tolerance'. A few decades ago, tolerance was thought to involve 
mainly the process of clonal deletion or survival. This is the basis of our understanding 
of "central tolerance", which is the process of positive and negative selection in the 
thymus (Bevan et al., 1994; Goldrath and Bevan, 1999). Positive selection is the 
process that restricts the TCR repertoire to peptides that can bind MHC complexes. T 
cells that bear TCR with no binding affmity to self MHC complexes are deleted by 
apoptosis, presumably T cells that can't recognise MHC-peptide complexes at all are a 
waste of space. However, T cells which have TCR that reacts with very high affinity 
to self MHC complexes in the thymus also undergo apoptosis in a process known as 
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negative selection. This would in theory delete all auto-reactive T cells that encounter 
self antigens in the thymus. 
Whereas central tolerance depends on signal one, peripheral tolerance depends 
on all the T cell activation signals discussed above. Although thymic selection (i.e. 
central tolerance) is crucial for successful tolerance, many self antigens would be 
expressed in peripheral tissues that never get into the thymus and become involved in 
the process of selection and deletion. It is now clear that an extremely complex 
multilayered set of checkpoints are involved in maintaining the fine balance between 
an effective immune response and an auto-immune reaction in the periphery. This 
change in perception and emphasis is largely due to advances in technology, especially 
in our ability to generate T cell receptor (TCR) iransgenic mice (Stockinger, 1999). 
These mice clearly demonstrated that T cells exist with TCR that recognise self 
antigens, but have not been deleted in the process of thymic selection, as negative 
selection is not efficient in deleting T cells which react to peripheral tissue specific 
antigens. The auto-reactive T cells that have escaped negative selection remain 
unresponsive, but can be stimulated to proliferate in response to auto-antigens. Why 
are these auto-reactive T cells not activated when their TCR recognises MHC with self 
peptides? The melange of mechanisms that has emerged to explain these observations 
is lumped together as the process of "peripheral tolerance". 
Peripheral tolerance 
As discussed earlier, the understanding of peripheral tolerance requires not 
only an understanding of the specificity of T cells, but also an understanding of the 
activation and interaction of T cells with antigen presenting cells (APC). I believe that 
the decision for a T cell to respond to an antigen depends more on the kinetics of TCR-
peptide-MIHC engagement, accompanied by the correct molecular context of its APC, 
then it does on the specificity of theTCR to the peptide-MHC. The presence of 
appropriate accessory signalling molecules and adhesion molecules that modify 
cytoskeletal organisation and stabilises TCR engagement and signalling is probably as 
important as TCR specificity itself. Hence, peripheral tolerance could be more 
important than central tolerance in the prevention of auto-immunity. Although this 
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interpretation of immunological data is consistent with some aspects of Matzinger's 
"danger hypothesis", the fact that central tolerance occurs at all is clear evidence that 
there is a self-non-self element to the process of tolerance. Furthermore, it is also 
consistent with Medzhitov and Janeways interpretation of innate/acquired immunity. 
Peripheral tolerance involves a number of mechanisms, all of which probably 
act in concert to prevent auto-immunity. These mechanisms are: 1) physical barriers to 
lymphocyte migration, 2) immune ignorance, 3) peripheral deletion/apoptosis, 4) 
anergy and 5) suppression. Apart from the first mechanism, all the other mechanisms 
involve the molecular context of T cell activation. Immune privileged sites such as the 
testes, the anterior chamber of the eye and the brain, which can accept allogeneic or 
xenogeneic tissue grafts, have improved our understanding of the tolerance 
mechanisms that underly their protection. 
Physical barriers 
The simplest mechanism for the prevention of T cell responses to self antigens 
in the periphery, is that in vivo, potentially autoreactive T cells never encounter their 
cognate antigen in a physiological relevant situation. This may be the situation in 
immune privileged sites such as the brain and the anterior chamber of the eye, which 
lack immune surveillance (Vaux, 1995). For example, 'it is possible that T cells which 
can react specifically to antigens expressed only in the brain are present, but are never 
activated because they never cross the blood/brain barrier. This passive mechanism of 
peripheral tolerance is perhaps less well studied that it should be. 
Ignorance 
The term immunologically ignorant was first used by Ohashi et.al . (1991). In a 
classic study, lransgenic mice were generated to express a viral glycoprotein (LCMV-
GP) in 3 islet cells of the pancreas, and crossed with mice transgenic for TCR specific 
to LCMV-GP (Ohashi et al., 1991). Some of the T cells from these double transgenics 
were neither deleted nor were they anergized, because they could be functionally 
activated in vitro. Ohashi et.al . called these 'ignorant' T cells. Interestingly, if these 
mice were infected with LCMV, this state of tolerance is reversed and the mice 
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develop diabetes. Since then, many other examples of ignorance have emerged from 
similar double lransgenic animals, of T cells which can be functionally activated in 
vitro (i.e. not anergised), not deleted, but also non-responsive in-vivo. 
Another example of ignorance is the observation that immunisation with a self-
peptide from cytochrome c (81-104) could elicit a strong autoimmune response 
(Mamula, 1993). However, the autoreactive T cells which recognise this self-peptide 
do not react to the entire cytochrome c protein when stimulated in-vitro. This example 
of an ignorant T cell is probably a result of the lack of processing and presentation of 
this cryptic epitope in vivo. 
The term 'ignorance' has essentially been used to describe any situation in 
which there are tolerant auto-reactive T cells which are neither deleted nor anergised. 
These observations have generated interest because the emergence of autoimmune 
disease could be a result of the activation of these 'ignorant' T cells (Elson et al., 
1995). 
Deletion 
The best examples of T cell deletion in the periphery are the active process of 
Fas-ligand induced apoptosis in immune privileged sites of the testis (Bellgrau et al., 
1995) and the eye (Griffith et al., 1995). Bellgrau et. al (1995) showed that grafts of 
mouse testes taken from mice that lack Fas ligand (gld mice), are rejected whereas 
normal mouse testes which express high levels of Fas-ligand in the testes survive. 
Although this strongly suggests that Fas-ligand on the testis induces apoptosis in 
activated T cells which responds to the graft, it was not formally demonstrated. It 
should also be noted that these experiments could not be replicated by a separate group 
and remain controversial (Allison et al., 1997; Vaux, 1995). 	- 
Griffith et.al  (1995) showed that Fas mediated apoptosis was indeed 
responsible for the death of inflammatory cells infiltrating the eye after the injection of 
antigen into the eye. This appears to explain the previous observations that injection of 
antigens into the eye can lead to tolerance to delayed type hypersensitivity response. 
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However, expression of Fas-ligand alone is not sufficient to prevent rejection since the 
transfer of pancreata from lransgenic mice expressing Fas-ligand in their f3-islet cells 
could not prevent host rejection (Allison et al., 1997). 
There are surprisingly few reports of peripheral deletion of other auto-reactive 
T cells. The best example is work by Rocha and von Boehmer (1991). They showed 
that the adoptive transfer of T cells from TCR transgenic mice specific for the male 
antigen HY into male mice resulted in an expansion of these T cells in the first 5 days, 
which surprisingly did not cause any auto-reactive pathology. The majority of these T 
cells disappeared from the peripheral lymphoid organs between 5-9 days, leaving 
behind a smaller 'ignorant' population with down regulated receptors (Rocha and von 
Boebmer, 1991). This observation appears similar to the expansion and deletion of T 
cells after response to a foreign antigen. 
Anergy 
Anergy is a condition for lymphocytes whereby they cannot be fully activated 
to perform their normal functions although they have received all the appropriate 
signals (Schwartz, 1996; Schwartz, 1997). The anergic T cell lacks the ability to 
produce or respond to signals for proliferation. There are many routes to anergy and 
these include: 1) TCR engagement without co-stimulation, 2) TCR engagement by 
altered peptide ligands (APL), 3) the cytokine environment in which TCR engagement 
occurs, 4) an excess of antigen. 
The earliest models for anergy revolved around the absence of co-stimulation 
during TCR engagement. This model was attractive because it provided a mode of 
peripheral tolerance whereby an APC could induce T cell unresponsiveness by 
providing signal one without signal two. However, when more ways of anergising 
cells emerged, this model became inadequate. Jenkins (1992) then argued that anergy 
occurs when a T cell receptor is engaged but the T cell is prevented from proliferating 
(Jenkins, 1992), for example when T cell activation occurs in the presence of anti-1L2 
and anti-1L2-receptor antibodies. Inhibition by IL-10 during human CD4 T cell 
activation has also been reported to result in anergy (Schwartz, 1996). Interestingly, 
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there have been no reports of anergy as a result of T cell suppression by TGF-3. 
Although this model can account for some mechanisms which lead to anergy, it is not 
consistent with induction of anergy by APLs. 
As a result of recent signal lransduction data, Schwartz has proposed a more 
mechanistic model for anergy (1996, 1997). He argues that anergy occurs due to a 
block in IL-2 gene transcription by; 1) a failure to activate p2l  or 2) a repressor 
molecule such as Nil-2-a. A block to p2l probably leads to the decreased 
phosphorylation and activity of ERK and iNK which has been reported in anergic 
cells (Desilva et al., 1996). This leads to a failure in activating AP-1, a transcription 
factor that induces IL-2 gene transcription (Schwartz 1996). 
It is interesting that although CTLA-4 provides an inhibitory signal towards T 
cell activation, there are no reports that it induces anergy. Especially since, early 
reports of signal transduction pathways suggest that CTLA-4 signalling might intersect 
with the p2l signalling pathway (Chambers and Allison, 1997). 
T suppressor/regulatory cells 
Recently, the experimental evidence supporting the existence of CD4 
regulatory T cells has been mounting (Sakaguchi, 2000). This idea is being received 
with much greater enthusiasm due to the cloning of CD4 T cells that suppress the 
proliferation of other T cells (Chen et al., 1994; Oroux et al., 1997). Naive T cells 
cultured in the presence of IL-10 differentiate into a Th subset which secretes high 
levels of IL- 10, low levels of IL-2 and no IL-4, and has been termed Trl cells (Groux 
et al., 1997). Trl cells proliferate very slowly, and can suppress antigen specific T cell 
proliferation via IL-10 and TGF-P dependent pathways. Hence the properties and 
function of T regulatory cells probably overlaps with phenomenon that had -previously 
been attributed to anergic T cells (Chai et al., 1999; Frasca et al., 1997; Lombardi et 
al., 1994; Taams et al., 1998). Adoptive transfer of Trl cells can prevent the 
development of inflammatory bowel disease in vivo. 
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In a different system, Chen et.al  (Chen et al., 1994) described the generation of 
CD4 T cells that secreted TGF-, IL-4 and IL-b, in response to orally administered 
antigen. These cells could also suppress the development of experimental autoimmune 
encephalomyelitis (EAE) in vivo. However, there has been no evidence that exposure 
of naive T cells to either of these sets of regulatory T cells would lead to anergy. 
Indeed, these regulatory I cells might explain the phenomenon of 'ignorance' instead 
of anergy. 
There is also data emerging from the transplantation field of 'infectious 
suppression' and 'linked suppression', from the adoptive transfer of CD4 cells 
(Cobbold and Waldmann, 1998). Treatment with antibodies to CD4 and CD8 at the 
time of organ grafts leads to acceptance and tolerance to the graft (Qin et al., 1993). 
CD4 cells from mice which have been tolerised in this way can then be adoptively 
transferred to a naive animal. Interestingly, the naive animal will then be able to accept 
the same organ graft even though it has not been treated with antibodies. In fact, if 
CD4 cells are taken from a naive animal and transferred into a tolerized animal, these 
CD4 cells from the naive animal are then converted into suppressor cells, which can 
prevent the rejection of the organ graft when transferred into a different naive animal 
(Cobbold and Waldmann, 1998). 
More recently, a clearer phenotype of these cells have emerged. It is now 
thought that suppressive T cells express CD4, CD25 and are CD45RBI0w (Shevach, 
2000). It has been suggested that engagement of CTLA-4 could play an important role 
in the differentiation of these suppressor cells or be involved in their biological 
function (Read et al., 2000; Takahashi et al., 2000) (eg. by triggering release of TGF- 
(Chen et al., 1998b)). Indeed, it is possible that the lympho-proliferative disease - 
associated with CTLA-4 mice could be due to the lack of T regulatory cells, as well 
as the inability to dowmnodulate activated T cells. On the other hand, there is also 
been evidence that the CD28/B7 interaction is necessary for the development or 
differentiation of CD4/CD25 suppressor cells (Salomon et al., 2000). The number of 
these CD4tICD25 cells are reduced in NOD CD28 4 mice as well as in NOD 
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B7. 1/137.2 mice, and can be decreased by treatment with CTLA-4-Ig (Salomon et al., 
2000). Shevach and Sakaguchi have recently provided a more detailed review of these 
suppressive or regulatory T cells (Sakaguchi, 2000; Shevach, 2000). 
Alternatively activated or suppressive antigen presenting cells 
Although the importance of suppressor T cells in the immune response is 
becoming more established, immuno-suppresive cells are not restricted to T cells, and 
there has always been considerable evidence for the presence of suppressive antigen 
presenting cells, especially macrophages. There are examples of antigen specific 
(Kirschmann et al., 1994) as well as antigen independent suppression against tumours 
(Taramelli et al., 1981). There have also been early suggestions of macrophages 
inducing the activity of regulatory T cells, before the scepticism of suppressor T cells 
set in (Ptak et al., 1978). Suppressor macrophages have been described to play a role 
in protecting the immune privileged embryo (Chang et al., 1993) and the alveoli of the 
lungs (Poulter et al., 1994). In vitro studies have shown that macrophages that 
phagocytose or interact with apoptotic cells will secrete TGF-3, which could suppress 
production of pro-inflammatory cytokines (Fadok et al., 1998). More recently, there 
have also been reports that suppressive T cells might act via the antigen presenting cell 
(Taams et al., 1998), which might act as a bridges that brings suppressive T cells 
together with naïve T cells. 
More significantly, there is a growing view that IFN-y activated macrophages 
have different suppressive capabilities from IL-4 activated macrophages (Goerdt and 
Orfanos, 1999). Whereas WN-y activated macrophages, or classically activated 
macrophages suppress proliferation vie nitric oxide (NO) mediated mechanisms 
(MacMicking et al., 1997), IL-4 activated macrophages could suppress via novel 
mechanisms (Schebesch et at., 1997). For example, human macrophages activated in 
vitro by IL-4 and glucocorticoids suppress proliferation independently of IL- 10, NO or 
prostaglandins (Schebesch et at., 1997). 
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In terms of parasitic infections, Trypanosoma brucei can induce suppressive 
macrophages in mice that act via NO (Mabbott et al., 1995; Schleifer and Mansfield, 
1993b; Sternberg and Mabbott, 1996a), whereas Th2 driving nematode infections 
could induce suppressive macrophages that are activated by IL-4. Macrophages that 
suppress a pro-inflammatory response via IL-10 have been described in response to 
schistosome eggs (Stadecker, 1999). 
By discussing the various mechanisms of peripheral tolerance, it becomes clear 
that it is difficult to distinguish between 'tolerance' (i.e. the lack of an immune 
response) and an anti-inflammatory response, which in turn suppresses proliferation of 
I cells and cytokines and prevents rejection. It seems to me likely that this distinction 
can never be clearly made experimentally and thus general theories about 'tolerance' 
are useful in guiding our thinking, but dangerous in affecting the interpretation of 
complex empirical data common to biology. 
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Lymphatic filariasis 
Lymphatic filariasis is a serious, debilitating and widespread tropical disease. 
The WHO estimates the 120 million people are infected with the parasitic filarial 
nematodes that cause this disease. Wuchereria bancrofli causes 90% of the infections 
and the remainder is mostly caused by Brugia malayi. It is estimated that 44 million 
people suffer from pathology caused by lymphatic filariasis (e.g. lymphoedema, 
genital pathology (especially hydrocoeles) and elephantiasis), with a further 76 million 
people having hidden, asymptomatic infections. Due to the global nature of this 
disease, it is the second leading cause of permanent and long-term disability world 
wide. Recently (1998), a collaboration between pharmaceutical companies and the 
WHO has raised hopes that this disease could potentially be eradicated. SmithKline 
Beecham has agreed to provide albendazole free-of-charge for as long as necessary to 
ensure success of the elimination programme, while Merck & Co will expand it's 
onchocerciasis ivermectin donation program to cover the treatment of lymphatic 
filariasis. Notable successes in countries like China and Japan suggests that a well 
organised effort can radically reduce the consequences of this tropical disease. 
However, drug resistance as well as logistical difficulties in continuing treatment for a 
minimum of 4-6 years in order to successfully interrupt transmission makes global 
eradication a formidable task. 
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Lilecycle 
The related lymphatic fllariae have similar lifecycles that depends on larval 
development in the intermediate hosts (i.e. mosquitoe) as well as development in 
humans, which are considered the definitive hosts. Like all nematodes, filarial worms 
develop through a moulting process, which distinguishes the 5 developmental stages 
(Ll-L5) that occur during their life cycle (Figure 1). We have been particularly 
interested in the adult (or L5) stage of this parasite, because this is the stage that 
resides in the lumen of the lymphatics for long periods of time. The female adults are 
considerably longer than the males averaging about 4.8cm in length in comparison to 
an average of about 2.2cm for male adults. After mating, the female adults can live for 
5-10 years in the host lymphatics, during which time they are constantly producing 
thousands of microfilariae (Mf), which circulate in the bloodstream. The microfilariae 
are ingested by mosquitoes, where they migrate into the thoracic flight muscles and 
moult twice (from Ll-L3 stage) in a period of about 10 days. The infective L3 larvae 
migrate throughout the body cavities of the mosquito, including the head, and can then 
be transmitted to a mammalian host when the mosquito feeds. After entering the 
mammalian host through the lesion created by the feeding mosquito the larvae migrate 
rapidly to the afferent lymphatics where they moult 2 more times (L3-L5) and remain 
for the rest of their lives. 
L3 develop in 
mosquito 
7 Mosquito Vector 
Mt ingested in 	 Mosquito takes blood meal; 
	
mosquito blood meal 
L3 enter bite wound 
Mt enter bloodstream 
	 L3 migrate to lymphatics, where 
they mature to adulthood 
Mammalian Host 
Adult parasites mate and 
produce Mt 
Figure 1: The life cycle of Brugia malayi. 
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Animal models 
It is interesting to note that most filarial worms have a narrow host specificity, 
which could be an important clue to their remarkable abilities of immune evasion. 
However, this has been a major hindrance towards a better understanding of this 
infection since suitable laboratory animal models have not been readily available. 
Whereas W. bancrofli cannot be maintained in any non primate laboratory animals, at 
least B. malayi can develop to maturity in jirds, rats, hamsters, ferrets, dogs and cats. 
The Brugia-Jird model via intraperitoneal infection results in the best recovery of 
sexually mature adult parasite, and is routinely used in the maintenance of this 
parasitic life cycle. 
Unfortunately, inbred strains of laboratory mice are resistant to the full 
developmental lifecycle of B. malayi, which deprives us of many immunological tools 
that could significantly improve our understanding of the immune responses that are 
necessary for resistance and protection against this parasite. However, the individual 
stages of B.malayi can survive in mice for various periods of time, and the analysis of 
genetically deficient mice have been useful in developing our understanding for the 
cytokine responses that are associated with these Th2 inducing nematode parasites 
(Lawrence, 1996). At present, the most promising rodent model is the recent discovery 
that the rodent filarial parasite Litomosoides sigmodontis can undergo full 
development in inbred strains of laboratory mice (Maréchal et al., 1997; Maréchal et 
al., 1996). In our laboratory, we are beginning to switch over from the Brugia-mouse 
model to the Litomosoides-mouse model in order to ask questions about natural and 
acquired immunity, as well as to verify whether our findings with the Brugia-mouse 
model are relevant to a natural host-parasite interaction. 
Unfortunately, none of the animal modeis can reproduce the extremely wide 
spectrum of clinical presentation in an endemic region, which is one of the most 
interesting and important aspects of filariasis (Ottesen, 1992). It has been reported that 
infection of SCID or athymic nude mice with Brugian parasites can result in an 
elephantiasis-like disease with dilated lymphatics, but without inflammation (Nelson 
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et al., 1991; Vincent et al., 1984). However, the Brugia pahangi-infected cat model (a 
natural host-parasite pair) is probably the best mimic of the natural course of disease 
development. 
Human lymphatic filariasis 
In order to study the disease in an endemic area, researchers have divided the 
population into 3 categories; 1) endemic normals, 2) asymptomatic microfilaraemics, 
and 3) individuals with clinical manifestations. This classification system has been 
useful in defining the immune parameters that could be associated with various disease 
states, but as always, is an oversimplification of the situation. 
Endemic normals 
The term endemic normals is used to describe individuals who are constantly 
exposed to the filarial parasites, but have no clinical manifestations or signs of 
infection. They seem to be truly immune to the parasites and have high levels of anti- 
filaria antibodies as well as active cellular responses (Maizels et al., 1995). However, 
because detection of microfilarac in the blood is a relative insensitive indicator of 
current infection, some of these individuals might harbour undetected infections. 
Asymptomatic microfilaraemic 
Asymptomatic microfilaraemic individuals represent a large proportion of the 
people infected with filarial parasites, who although have circulating Mf, do not show 
obvious signs of clinical disease. It is estimated that 76 million people fall into this 
category of the minimum of 120 million infected people. Contrary to earlier models of 
a clear dichotomy between asymptomatic microfilaraemics and the clinically affected 
patients, modern lymphoscintigraphic analysis has revealed that asymptomatic 
microfllaraemics often suffer from significant damage to the lymphatic vessels 
(Freedman et al., 1994), although this seems to be sustained without clinical 
manifestations. 
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Clinical filariasis 
Individuals with clinical manifestations had previously been grouped into a 
category termed "chronic pathology" and thought to be amicrofilaraemic. More recent 
studies have demonstrated that 10-40% of individuals with chronic diseases remain 
microfilaraemic. Furthermore, the wide spectrum of clinical manifestations (not all of 
which are a result of chronic infection), has led to the term "clinical fliariasis" being 
proposed as an alternative term of classification (Freedman, 1998). An important 
question revolves around the reasons for the development of clinical manifestations, 
since almost all infected individuals (including asymptomatic microfilaraemics) suffer 
from some form of lymphatic damage. 
Clinical pathogenesis can be separated into the acute and chronic stages 
(Kumaraswami, 2000). The acute stage is characterised by recurrent fever attack 
associated with inflammation of lymph nodes and lymphatic vessels. More recent 
evidence suggests that secondary infections could play an important role in triggering 
the episodes of fever and inflammation. These attacks have serious impacts on the 
ability of patients to work productively. The chronic stages of disease manifestation 
are usually associated with obstruction of lymphatics, which result in elephantiasis of 
the limbs or hydrocoeles (male genital disease). There is some epidemiological 
evidence which suggests that many individuals in an endemic area will progress from 
asymptomatic microfilaraemics, to suffering from acute filarial disease and eventually 
develop signs of chronic pathology (Bundy et al., 1991). However, this hypothesis is 
controversial and conversion is certainly not inevitable since some infected individuals 
will never develop clinical filariasis (Ottesen, 1992). 
A distinct group of infected individual suffer from an extreme manifestation 
immmunological hyperesponsiveness known as tropical pulmonary eosinophilia 
(Ottesen and Nutman, 1992). They are almost always amicrofilaraemic, but remnants 
of microfilaria surrounded by eosinophils are often found in tissue biopsies. These 
patients suffer from symptoms similar to asthma, including severe obstructive lung 
function abnormalities, probably as a result of eosinophil infiltration into the lungs. 
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However, treatment with antifilarial drugs is usually accompanied by rapid and 
dramatic clinical improvement, which is surprising considering the fact that these 
patients are usually amicrofilariaemic. 
Immunology of filarial infection 
The immunological features of filarial infection share remarkable similarities 
with other helminth (defined as multicellular macroparasites that do not undergo 
asexual expansion in their hosts) infections. They have 1) high levels of type 2 
responses, 2) immune suppression or downmodulation, 3) ineffective immune 
responses 4) resulting in chronic infections due to long lived parasites 
Th1/Th2 paradigm 
Since Mosmann et. al. distinguished Thi from Th2 clones (Mosmann et al., 
1986), the Th1/Th2 paradigm has been a major guiding principle in most of the 
immunological studies in infectious diseases. The work on filarial immunology is no 
exception in relying heavily upon the concepts behind this paradigm. Like other 
nematodes, many studies have suggested that infected individuals show a bias towards 
a Th2 response. However, a more significant concept in filarial immunology was the 
perspective that differential Th1/Th2 responses is associated with different levels of 
clinical disease (Ottesen, 1992). 
Consistent with the concept that a Th2 response is associated with reduced 
pathology, the predominant serum antibody that is specific for parasites in 
asymptomatic Mf+ patients is IgG4, which is often also accompanied by high levels of 
IgE. These antibody isotypes are known to be promoted by the Th2 cytokine IL-4. In 
contrast, patients that are suffering from the chronic stage of the disease often have 
higher IgG 1-3 antibodies, which are not significantly enhanced in Mf+ individuals 
(Kurniawan et al., 1993). 
In terms of T cell responses, many studies have consistently shown that both 
asymptomatic individuals as well as those in the chronic stages of disease have 
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comparable levels of IL-4 production. However, asymptomatic individuals have 
suppressed/reduced IFN-y production, whereas clinically affected patients often have 
elevated IFN-y production. Although these data suggests that the Thi response is 
associated with clinical pathology, it should be noted that IgE antibodies are also 
elevated in elephantiasis patients as well as individuals suffering from TPE. 
Thus, clinical disease can be associated with both a hyperresponsive Thi or 
Th2 response. Because there is not a suitable animal model for human disease, as well 
as the fact that human in vitro studies can only be relied upon to provide associations 
and correlation, whether pathology is 1) immune mediated or 2) associated with the 
switch from a Th2 to a Thl response, remains difficult to answer. 
Immunological tolerance to filarial infections 
Because one of the most consistent findings of human studies is the antigen 
specific hyporesponsiveness of T cells in asymptomatic Mf+ individuals, it has long 
been suggested that filarial nematodes induce a state of tolerance in the host to the 
parasite burden (Maizels and Lawrence, 1991). However, more recent evidence 
indicates that the term tolerance oversimplifies a complex interaction between the host 
and the parasite (Maizels et al., 1999a). For example, it seems that T cell 
unresponsiveness is restricted to Thi responses, proliferation and IL-5 production, 
whereas IL-4 production and antibody responses remain intact (Maizels et al., 1999a). 
Thus, as was discussed in the previous section, it is often difficult to distinguish 
between a state of peripheral tolerance and anti-inflammatory responses that prevent 
rejection. 
Parasites can prevent host rejection by either evading the immune system (a 
strategy directed towards itself), or by actively down modulating the immune response 
(a strategy directed towards the host). With regard to helminth parasites, there are 
numerous examples of the first strategy (Maizels et al., 1993) but considerably less 
knowledge about the latter mechanism. However, there is a clear recognition that this 
is likely to be a key strategy for parasites that do not replicate in the host and do not 
undergo antigenic variation. Further understanding of strategies directed towards the 
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host provides the opportunity for us to learn potentially novel means by which to 
regulate the mammalian immune response. Although, it is unlikely that any single 
mechanism is responsible for this balance of responsiveness/unresponsiveness, by 
dissecting a piece of the puzzle at a time, we hope to understand this complex host-
parasite interaction. 
Which of the mechanisms of peripheral tolerance discussed in the earlier 
section on peripheral tolerance could be involved in parasite specific hypo-
responsiveness? 
Since filarial nematodes live in the lymphatic system of the host, there are no 
physical barriers involved in preventing T cells from being exposed to parasite 
antigen. There have been no reports of immune  ignorant T cells in filarial patients in 
the literature. The existence of inactivated T cells that are parasite specific, but are 
neither anergised nor deleted remains an interesting prospect. Although there have 
been no reports of genes homologous to Fas-ligand found in parasites, it is possible 
that structural homologies, or molecular mimicry of Fas-ligand could lead to the 
deletion of parasite activated T cells. This remains an intriguing possibility for a 
mechanism of peripheral tolerance to parasites. Our current knowledge of peripheral 
tolerance to parasites is restricted to reports of parasite induced anergy and 
suppression. 
T cell anergy in lymphatic filariasis 
As mentioned before, a consistent finding of human studies is the observation 
that T cells isolated from parasite infected individuals do not proliferate in response to 
stimulation in vitro. This lack of proliferation is accompanied by the lack of IFN-y, 
and IL-5 secretion (Maizels et al., 1999a). However, antigen specific IL-4 production 
remains high even in the absence of proliferation. These observations have led to he 
suggestion that parasite induce tolerance by inducing anergy in parasite specific T 
cells (Nutman et al., 1987). However, there is still no direct evidence of a parasite 
mechanism for inducing anergy, especially since there are several possible 
mechanisms that can lead to anergy. It is important to note that hyporesponsiveness 
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observed in infected individuals is antigen specific and Thi response to mycobacterial 
antigens remains the same (Sartono et al., 1996). 
There are reports that high antigen doses can lead to anergy in human I cell 
clones (O'Hehir et al., 1991). Since it is common for individuals to have chronic high 
level infections in filiriasis, high antigen load causing anergy is an attractive 
explanation (Maizels et al., 1999a). Another model is the suggestion that parasites 
could prevent the expression of co-stimulatory molecules on APC (Maizels et al., 
1999a). This would cause T cells that have parasite specific TCR to become anergic 
when TCR engagement occurs in the absence of costimulation. Finally, the prevention 
of T proliferation by active suppression in the presence of antigen might also lead to 
anergy. 
Suppression in lymphatic filariasis 
T cell responses can either be 1) actively suppressed by the parasite itself or 2) 
actively suppressed by a cell type which is induced/recruited by the presence of the 
parasite. Piessens et.al . have reported both forms of suppression (Wadee et al., 1987: 
Piessens, 1980). A high molecular weight fraction from microfilarial extracts of 
Brugia appears to suppress lymphocyte proliferation in response to conA (Wadee et 
al., 1987). Maizels et.al  has also postulated that B.malayi might express homologues of 
the cytokine TGF-j that can down regulate T cell responses (Gomez-Escobar et al., 
1998). Piessens et.al . also reported an adherent cell type isolated from blood of 
patients, which suppresses antigen specific responses (1980). 
So far, there have been few descriptions of suppressor T cells being involved 
in immune-suppression by filarial parasites. However, a recent study by Doetze et.al . 
found that hypo-responsive T cells in individuals infected with Onchocerca volvulus is 
associated with the cytokines IL-10 and TGF- (Doetze et al., 2000). More 
significantly, they were able to clone 27 0. volvulus specific T cell clones from an 
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infected individual, and found that 3 of these T cell clones produced EL- 10 only, 11 of 
these clones produced TGF-P and 4 clones produced both IL- 10 and TGF-3. 
APC in a murine model for filarial infection 
Our group has been interested in the possibility that filarial parasites interfere 
with the function of antigen presenting cells and hence down modulate the immune 
response and potentially induce the antigen specific tolerance that is observed in Mf 
patients. Initial studies involved in vitro co-culture studies whereby live parasites were 
cultured with APC and T cells. There was no a direct effect of co-culturing live 
parasites in vitro, on the proliferation of I cells or the function of APCs and so this 
approach was abandoned. 
We subsequently decided to take an in vivo approach and developed a mouse 
model to investigate the interaction of filarial parasites with APC in vivo. Adult B. 
malayi parasites that are implanted in the peritoneal cavity of mice can survive for 
many weeks, although the full lifecycle of the parasite cannot be reproduced in mice. 
A result of this implantation is the generation of a population of antigen presenting 
cells (APCs) that can induce antigen specific cytokine production, but block cellular 
proliferation of a Th2 cell clone DlO.G4 (Allen et al., 1996). The suppression of 
proliferation is an active process that cannot be reversed by mixing an excess of 
irradiated splenocytes with the DiOs and suppressor cells. The generation of these 
suppressor cells only occurs when live but not dead parasites were used, and is 
dependent on IL4 but not IL-10 (Allen et al., 1996; MacDonald et al., 1998). 
Furthermore, suppressor cells also block proliferation of a wide range of cell types 
including B cell hybridomas and a colon carcinoma (Allen et al., 1996). Depletion of 
T cells suggests that suppressive T cells are not involved. This raises the possibility 
that we are studying a novel suppressor cell type acting through a novel mechanism 
and represents the starting basis for this thesis. 
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Chapter 2 
MATERIALS AND METHOD 
Immunological techniques 
Parasite isolation and infection model 
B. malayi adult parasites were obtained from infected jirds purchased from 
TRS laboratories (Athens, GA) or maintained in house courtesy of Bill Gregory, 
Janice Murray and Yvonne Harcus. Adult worms were removed from the peritoneal 
cavity and washed in RPMI. For all experiments, mice used were 6-8 week old males. 
Mice were surgically implanted intra-peritoneally (i.p.) with 6 live adult B. inalayi 
females and 3-6 weeks later mice were euthanized by cardiac puncture and PEC were 
harvested by thorough washing of the peritoneal cavity with 15 ml of RPM1I wash. 
Mouse strains 
Apart from experiments comparing C57BL/6 wild type mice (WT) with 
genetically deficient mice, 6-8 week old CBAICa males were used. Experimental mice 
were generally purchased from Harlan-UK (Bicester, UK), or obtained from source 
(Ann Walker House, Edinburgh University). C57BL/6 IL-4 deficient (1L4) breeding 
pairs were purchased from B&K Universal Ltd. (North Humberside, UK) with 
permission of the Institute of Genetics, University of Cologne. C57BL/6 IL-5 deficient 
(IL-5 1 ) mice were the kind gift of Prof. Manfred Kopf (Basel, Switzerland). Naïve 
CD4 lymphocytes were obtained from splenocytes of mice expressing lransgenic 
TCR for PCC peptide 88-104/I-E' (B10.A X BlO Fl). 
Cultures and cell lines 
All in vitro cultures were carried out in RPMI 1640 medium supplemented 
with 2 mM glutamine, 0.25 units/ml penicillin, 100 j.tg/ml of streptomycin, 5 jtM 
2-mercaptoethanol and 10% FCS (RPMJ complete). The Th2 cell clone, D10.G4 was 
maintained by incubation of cells with 100 .tg/ml conalbumin in the presence of 
syngeneic irradiated splenocytes for 2-3 days, after which cells were diluted 1:10 in 
complete medium with 10% (v/v) conditioned medium from a 48 h culture of 
concanaviin A (Con A)-stimulated mouse lymphocytes. The D10.G4 cells were used 
5-7 days after this rest period. The murine T cell lymphoma EL4 and the B cell 
hybridoma HB32 were maintained by growth in complete RPMT. The tumour cell 
lines used were acclimatized to RPMI media for at least 2 weeks prior to exposure to 
PEC. HB32 and EL-4 cells were maintained by growth in complete medium. The 
tumour cell lines were provided courtesy of Scott Bader and Jim Ross. 
Cell sorting by magnetic beads 
CD4 lymphocytes (>95% pure) were isolated with directly conjugated L3T4 
beads and either MS or VS columns in conjunction with MiniMacs or VarioMacs 
magnet (Miltenyi Biotec). Before magnetic bead cell purification, PEC were passed 
through a 70j.tm cell strainer and purified by centrifugation over Histopaque (Sigma) 
in order to remove any microfilariae. PEC were then sorted with MS or VS columns 
according to the manufacturers instructions (Miltenyi Biotec). F4/80 cells were 
purified with biotin conjugated 174/80 (rat IgG2b;Caltag) and Streptavidin Microbeads 
(Miltenyi Biotec). 
Antigen presenting cell suppression assays 
For investigation into the effect of suppressive PEC on apoptosis, recovery and 
the cell cycle, lml of PEC from parasite implanted or control mice, adjusted to 
1x106/ml, were adhered on. 24 well plates for 2-3 hours at 37°C. Non-adherent cells 
and microfilariae were then removed by washing with complete medium and the 
adherent PEC were co-cultured with Dl 0.G4, EL4 or HB32 cells to a final volume of 
2mllwell. D10.G4 (imi at lx 10 6/ml) were added to each well, with conalbumin at a 
final concentration of 50p.g/ml. EL4 and HB32 cells were added in lml of complete 
RPMI (at 5 x 105/ml). In all these experiments, suppression was also confirmed by 
[311] thymidine incorporation assays in 96 well plates. 100 p1 PEC at 1x10 6/ml were 
adhered to flat-4ottom 96 well plates as described above and co-cultured with 
different cell lines, at the same concentration as above, to a final volume of 
200p.11well. After incubation for 48 hr at 37°C, 1 p.Ci [ 311] thymidine in 10 p.1 
MATERIALS AND METHODS 	 30 
complete medium was then added to each well, and plates were incubated for 16-18 hr 
at 37°C prior to harvesting and counting using a Microplate Scintillation Counter 
(Wallac). The same protocol was used to measure the suppression of human cancer 
cell lines, which were adjusted to lx i0 5 cells/ml before adding lOOjil to the adherent 
PEC in 96 well flat bottom plates. To determine if suppressed cells recovered ability to 
proliferate after removal from suppressive PEC: EL4, HB32 and D10.G4 cells (with 
50j.tg/ml conalbumin) were co-cultured in 24 well plates with PEC for 48 hours at the 
same concentration as described above. The non-adherent HB32, EL4 and D10.G4 
cells were then aspirated from the adherent PEC and further purified using nylon wool 
columns to remove all the adherent PEC. The suppressed HB32 and EL4 cells were 
then cultured in 96 well plates at the same starting concentration (5x104 cells per well), 
and their proliferation was assayed by [3H] thymidine incorporation 48 hours later. 
lx104  nylon-wool purified D10.G4 cells (per well) were restimulated with 5x10 4 
syngeneic irradiated splenocytes and 50jig/ml conalbumin in each well, and 
proliferation was also assayed 48 hours later. 
T cell stimulation assays 
For primary stimulation studies, 1x10 5 PEC from control or parasite-implanted 
mice were plated out on flat-3ottom 96 well plates for 2-3 hours at 37'C. The non-
adherent cells and microfilariae were then removed by washing with complete 
medium. The adherent PEC were used to stimulate lx 10 5 purified naïve CD4 T cells, 
with 109g/ml PCC protein. Supernatants were harvested after 48 hours for cytokine 
assays (see below) and proliferation was measured by [ 3H] thymidine incorporation. 
For two stage assays, lx 106  PEC were adhered to 24 well plates, washed and used to 
stimulate lx 106  naïve T cells (at lOjig/mi PCC protein). After 48 hours co-culture, 
non adherent T cells were aspirated from adherent PEC and allowed to expand/rest for 
72 hours in complete media before being repurified for CD4 cells as above. In 
secondary cultures, 1x10 5 repurified T cells were stimulated with 5x10 5 irradiated 
splenocytes and 109g/ml PCC protein. After 48 hours, proliferation and cytokine 
production were assayed as described for primary stimulation. Neutralizing antibodies 
against TGF-f (25j.tg/ml, clone 11.16, Celtrix Corporation, Santa Clara, CA) and 
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IL-10 (5j.tg/ml, clone JES5-2A5, Pharmingen, San Diego, CA) were added to the 
primary stimulation cultures at the recommended concentrations. 
Cytokine assays 
IL-2 and IL-4 production were measured with the IL-2/IL-4 responsive NK 
cell line, as described previously (Allen et al., 1996). Briefly, IX104  NK cells were 
added to 1 0.tl of cell culture supernatant in the presence of saturating anti-IL-2 (S4B6) 
or anti-IL-4 (111) antibody to distinguish between the two cytokines responsible for 
proliferation. Proliferation data was converted to concentrations with standard curves 
of recombinant IL-4 and IL-2 (Sigma). IFN-y and IL-10 was measured by capture 
ELISA, with reference to standard curves of known amounts of rIFN-y (Sigma) and 
rIL-10 (Genzyme). IFN-y was measured using R46A2 (ATCC) as capture Ab and 
biotinylated rat anti-mouse IFN-y monoclonal XMG1.2 (Pharmingen). IL-10 was 
measured using JES5-2A5 (Pharmingen) as capture Ab and biotinylated rat anti-
mouse IL-10 clone SXC- 1 (Pharmingen). Avidin-alkaline phosphatase (Sigma) was 
used for detection. 
CFSE and intracellular cytokine staining 
A modification of Lyons and Parish's technique for USE staining was used 
(Bird et al., 1998; Lyons and Parish, 1994). Briefly, 1 x 10 7 cells/ml were incubated 
with 10iM USE (Molecular Probes) in PBS for 8 minutes at room temperature. 
Staining was stopped with an equal volume of FCS, and the cells were washed 3 times 
with complete RPMI Stained naïve T cells were primed by PEC (as described above) 
for 72 hours before being harvested and stained for intracellular cytokines using the 
CytofixlCytoperm PlusTm kit (Pharmingen) according to the manufacturer's 
instructions. Briefly, GolgiStop was added to the culture at 1:1500 dilution together 
with SOng/mi PMA and SOOng/ml lonomycin and incubated for 4 hours at 37°C. Non-
adherent cells were harvested and fixed in Cytofix/Cytoperm solution before being 
stained with anti-IL-4 (1 1B11, Pharmingen), anti-IFN-'y XMG1.2, Pharmingen_ or 
control Ig-PE conjugates (Phanningen) in Perm/Wash solution. After staining, cells 
were analyzed by flow cytometry using a Becton-Dickinson FACSCAN and Cell 
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Quest Software. All data plots shown represent activated lymphocytes, gated by 
forward and side light scatter. 
Cell cycle analysis 
To investigate changes in the cell cycle as a result of suppression, EL4 and 
DlO.G4 cells were stained with propidium iodide according to the protocol of 
Darynkiewicz (Darynkiewicz, 1993). Briefly, after 24 or 48 hours culture with PEC, 
suppressed cells were fixed with 0.5% formaldehyde in HBSS, permeabilised with 
0.1% Triton X-100 and 1% BSA in 1HBSS, and resuspended in HBSS solution 
containing 5.tgIm1 or propidium iodide and 100 units of Rnase A. The cells were then 
analyzed by a FACScan (Becton Dickinson). FACS data was analyzed using the cell 
cycle analysis software Modfit (Verity Software House), which calculates the 
percentage of cells in the different phases of the cell cycle using a Gaussian model for 
GO/Gi and G2/M cells, and estimates S-phase cells as a trapezoid component. 
Suppressed cells were also double stained, by incubating with FITC conjugated Ki-67 
(Boehringer Mannheim) prior to incubation with propidium iodide containing HBSS 
solution (Darynkiewicz, 1993). Cell division of suppressed EL4 cells was investigated 
with the proliferation dyes PKH26 (Sigma) and carboxyfluorescein diacetate 
succinimidyl ester (CFSE) (Molecular Probes) with identical results. PKH26 staining 
was carried out according to manufacturer instructions (SIGMA). PKH26 and USE 
labeled cells were then co-cultured with control and implanted PEC as described 
above. A TUNEL kit from Boehringer Mannheim was used to assay the level of 
apoptosis after 48 hours co-culture with PEC according to the manufacturer's 
instructions. 
Cytology and immunohistochemistry 
Cytocentrifuge preparations of the adherent PEC (1 x 10 5 cells/slide) were air-
dried and fixed in methanol before staining with Diff-Quik (Dade Diagnostics, 
Unterschleissheim, Germany). The proportion of macrophages, lymphocytes, mast 
cells, and eosinophils was determined by morphological examination of at least 300 
cells in randomly selected fields using an Olympus BH2 microscope. 
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Molecular Biology Techniques 
Construction of cDNA libraries 
F4/80 macrophages from the PEC of B. malayi implanted IL-5 and IL-4 
deficient mice were purified as described above. 30j.tg  of total RNA, which was 
extracted using RNAStat60 (Biogenesis), was used to synthesize cDNA and 
unidirectionally cloned into the pCMV-Script plasmid vector, using the cDNA library 
construction kit from Stratagene (CA). Briefly, first strand cDNA was synthesised 
with a poly(dT) primer containing a XhoI restriction site protected by GAGA 
sequences and an 18 base poly(dT) sequence. Methylated dCTP was used in the first 
strand reaction to protect the cDNA from restriction enzymes in subsequent cloning. 
The second strand was synthesised with RNase H and DNA polymerase I, and blunt 
ended with cloned Pfu DNA polymerase before being ligated with EcoR I adapters. 
The subsequent Xho I digest releases the EcoR I adapter from the 3' end of the cDNA 
to enable unidirectional cloning. The cDNA was then size separated on a cDNA size 
separation column (Gibco). In order to reduce inherent bias for smaller fragments, the 
different sized fractions were ligated and transformed separately to produce 10 
different sub-libraries. About half of each sub-library was stored as primary 
recombinants by freezing down immediately in 15% glycerol at —80°C, while the other 
half was amplified by plating out on large petri dishes and incubated at room 
temperature for 48 hours. The unamplified IL-54- library contained 5 X 105 primary 
recombinants, whereas the unamplified IL-44- library contained 1 X 10 5 primary 
recombinants. 
Construction of subtractive cDNA library 
Total RNA was extracted from F4/80 purified macrophages from PEC of 
either WT implanted mice or IL4 mice. lp.g of total RNA was converted into 1st 
strand cDNA using the Clontech SMART system (according to manufacturers 
instructions). After synthesis of first strand cDNA from WT macrophage, 2 rounds of 
subtractive hybridisation were undertaken with 20 times the amount of EL-4 -1-  
macrophage RNA (20jig) as was used in the 1st  strand synthesis reaction of WT 
macrophage RNA using the Invitrogen 'Subtractor kit'. After 2 rounds of subtractive 
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hybridisation and phenol-choloroform extraction, the remaining single stranded cDNA 
was PCR amplified for 25 cycles. The PCR products were then size separated on a 
sepharose cDNA size selection column (Gibco) and the fractions were cloned 
separately in order to reduce cloning bias of small DNA fragments. The subtracted and 
then Taq amplified cDNA products with 3'-A overhangs were cloned into the 
eukaryotic expression vector (pcDNA3.1/V5fHis-TOPO), which has a single 3' 
thymidine (T) overhang, and Topoisomerase I, for TA cloning (In vitrogen). The 
ligated plasmids were transformed into XL-10 gold ultracompetent cells (Stratagene). 
Using this combination of kits, we generated a combined subtractive cDNA library 
with between 10-20,000 primary recombinants. Since cDNA were cloned 
bidirectionally into plasmid vectors, a special sequencing primer, called SMART seq 
primer 5'-AAC GCA GAG TAC GCG GG (AGCT)-3', was designed to sequence 
unidirectionally from the 5' end of the transcripts. 
Express Sequence Tag analysis of eDNA libraries 
Single clones from the unamplified library were randomly picked and the 
cDNA inserts were amplified using vector primers T3 
(AATFAACCCTCAICTAAAGGG) and 17 (CGGGATATCACTCAGCATAATG). 
Aliquots of the amplified PCR products were checked by agarose gel and clones 
containing inserts greater than 200 bp were selected for sequencing. PCR products 
were prepared for sequencing using shrimp alkaline phosphatase and exonuclease I 
(Amersham Pharmacia Biotech Ltd, Sweden). Inserts were sequenced using the 5' 
vector primer SAC (GGGAACAAAAGCTGGAG) and ABI Big DYE terminators 
(Perkin Elmer Corporation, CT). Sequencing reactions were analysed using an ABI 
377 automated sequencer. The sequences were edited manually and poor 3' sequence 
removed. The edited sequences were sent to NCBI for Blastn, blastx and blastn against 
dbest analysis. The search results were downloaded in html format and assembled into 
a web table that can be viewed using an internet browser (i.e. Internet Explorer or 
Netscape), which links the blast search results to other NCBI based information. 
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RT-PCR 
For reverse transcription (RT)-PCP, first strand cDNA was made with oligo-
dT primers from total RNA using GeneAmp RT-PCR kits according to manufacturer's 
instructions (Perkin Elmer Corporation, CT). Gene specific primers were used to PCR 
amplify from the first strand cDNA. The conditions used for PCR were; an initial 
denaturation at 94°C for 3 mm, then 35 cycles of 20 sec 94°C, 30 sec 55 °C, 90 sec at 
72 °C, resulting in a 1506 bp amplicon for Yml/ECF-L and 348 bp for f-actin. Gel 
images were captured and analysed with GelDoc2000 (BioRad) software. 
RT-PCR primers 
Ym1IECF-L-For: 5'-TGG GGG ATC CGT ACC AGC TGA TGT GCT ACT-3' 
Yml/ECF-L-Rev: 5'-GTA AAG GAT CCT CAA TAA GGG CCC TTG CA-3' 
3-actin-For: 5'-TGG AAT CCI GTG GCA TCC ATG AAA C-3' 
0-actin-Rev: 5'-TAA AAC GCA GCT CAG TAA CAG TCC G-3' 
PNG-1-For: 5'-GGT CCC AGT GCA TAT GGA TGA GAC CAT AGA-3' 
PNG-1-Rev: 5'-CAC CTC YITC ACT CGA GGG ACA GTT GGC AGC-3' 
IL-i j-For: 5'-GCA AGT GTC TGA AGC AGC TAT GG-3' 
IL-1-Rev: 5'-GGG TGT GCC GTC iTT CAT TAC AC-3' 
TNF-a-For: 5'-GGA AAT AGC TCC CAG AAA AGC AAG-3' 
TNF-a-Rev: 5'-TAG CAA ATC GGC TGA CGG TOT G-3' 
Arginase I-For: 5'-CAG AAG AAT GGA AGA GTC AG-3' 
Arginase I-Rev: 5'-CAG ATA TGC AGG GAG TCA CC-3' 
Arginase II-For: 5'-TGA iTG GCA AAA GGC AGA GG-3' 
MATERIALS AND METHODS 	 36 
Arginase Il-Rev: 5'-CTA GGA GTA GGA AGU TGQ TC-3' 
DNA blots 
Single clones from the subtractive library were randomly picked and the 
cDNA inserts were amplified with T7-For (5'-TAA TAC GAC TCA CTA TAG 0(3-
3') and pcDNA3.1-Rev (5'-TAG AAG GCA CAG TCG AGG-3'). Aliquots of the 
amplified PCR products were checked by agarose gel and clones containing inserts 
greater than 500 bp were selected for differential expression analysis. Aliquots of the 
PCR products were immobilised onto nitrocellulose membranes using a Bio-Dot 
microfiltration apparatus (BioRad) according to manufacturers instructions Briefly, 
nitrocellulose membrane was pre-wet in 6X SSC, before being clamped in place into 
the microfiltration unit. The PCR products were denatured at a final concentration of 
0.4M NaOH, 10mM EDTA and incubation at 100°C for 10 minutes. After 
neutralisation with an equal volume of 2M ammonium acetate, the samples were 
loaded onto the microfiltration apparatus and pulled through to the nitrocellulose 
membrane by a gentle vacum. The membrane was washed in 2X SSC and air dried, 
before being baked for 2 hours at 80°C. 
Probing the DNA arrays 
Total RNA was extracted from F4/80 purified macrophages from PEC of 
either WT implanted mice or 1L4' mice. Total RNA was treated with DNAse to 
remove contaminating genomic DNA with DNA-free (Ambion) according to 
manufacturers instructions. 5jig of total RNA was converted into radioactivelly 
labelled cDNA probes in an RT. reaction with oligo-dT primers with 35iCi of [a- 32P] 
dATP. The DNA blots described above were pre-hybridized with pre-warmed Rabid-
hyb buffer (Amersham Pharmacia) for 15 minutes before addition of the radioactive 
probes. After overnight hybridixation, blots were washed 1X in 2X SSC, 1%SDS and 
4X with 0. lx SSC, 0.5%SDS, or until background counts were low, hybridized blots 
were visualized using a phosphorimager (Molecular Dynamics) as well as with x-ray 
film (Kodak). 
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Statistical Analysis 
The Students t-test or the non-parametric Mann-Whitney test (for smaller 
samples) was used to determine if the differences between groups of animals were 
statistically significant. In order to determine if the representation of clones between 
the two different EST datasets were significantly different, the Fishers exact test was 
used. All statistical analysis were performed using Prism Version 2.0 (Graphpad, San 
Diego) 
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Chapter 3 
WHAT IS THE SUPPRESSOR CELL? 
(Some of the experiments described in this chapter have been published in part in the 
European Journal of Immunology and were done with help from Andrew S. 
MacDonald and Amy 0. Robb) 
Summary 
Previous work has shown that Brugia malayi induced suppressive cells in the 
peritoneal cavity of mice after surgical implantation. Here, we describe the 
identification of these suppressive cells as IL-4 dependent F4/80 macrophages. The 
adherent population of peritoneal exudate cells (PEC) is highly enriched for 
macrophages, but still contains eosinophils and lymphocytes. Purification of CD  lc 
cells from the PEC population demonstrated that dendritic cells were not the 
suppressive cells. Purification of Mac-i (CD 11 b) cells from IL4 deficient as well as 
IL-5 deficient mice strongly suggested that the suppressive cells were IL-4 dependent 
macrophages (M(D) and not eosinophils. Purification of F4/80 cells from suppressive 
PEC confirmed that MD were the suppressive cell type. Using purified M as antigen 
presenting cells to stimulate a Th2 clone (DiO.G4) showed that these Mc1  retained 
antigen processing and presentation capabilities and could stimulate antigen specific 
cytokine production while suppressing proliferation. Pro-inflammatory factors such as 
IFN-'y, LPS and anti-CD4O antibodies, did not reverse the suppressive phenotype of 
these cells. 
Introduction 
There is a fine balance between an effective immune response that can 
eliminate infectious organisms and a pathological autoimmune response that induces 
the process of self-destruction. A prominent feature of an activated immune response 
is the massive proliferation of immune cells necessary for the effective clearance of 
parasites. Understanding mechanisms that regulate proliferation is therefore a key 
issue in understanding immune-modulation. This could provide novel approaches to 
either boosting a more effective immune response against pathogens, or down-
modulating an overblown autoimmune response. 
Filarial parasites are adept at preventing rejection by the host immune response 
(Maizels et al., 1993; Maizels et al., 1999b), perhaps due to their ability to induce 
hypo-responsive T cells (Piessens et al., 1980; Yazdanbakhsh et al., 1993). It was 
previously found that Brugia malayi, when implanted into the peritoneal cavity of 
mice, generates host cells that inhibit proliferation of immune cells, while retaining the 
capacity to stimulate antigen specific cytokine production by Th2 cells (Allen et al., 
1996; MacDonald et al., 1998). A key objective of my studies was to first establish the 
identity of the suppressor cell, in order to further characterise at a cellular, molecular 
or biochemical level, which molecules are involved in the mechanism of proliferative 
inhibition. 
Previous work had provided some clues towards the identification of the 
suppressive cell type (MacDonald, 1998; MacDonald et al., 1998). Whereas 
implantation of live adult stage parasites and high doses (400) of L3 stage larvae 
induces recruitment of suppressive cells, dead adult parasites and microfilariae do not 
induce suppression (MacDonald et al., 1998). Because the suppressive cells can be 
induced by the daily injection of excretory secreted (ES) products from the adult 
parasites (Allen and MacDonald, 1998), instead of implantation, but cannot be 
generated by the implantation of dead parasites (MacDonald, 1998), it is clear that live 
adult parasites secrete factors that can generate the suppressive cells. Interestingly, 
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even a single adult parasite, irregardless of sex, was sufficient to drive recruitment of 
suppressive cells (MacDonald, 1998). 
A time course experiment had showed that suppressive cells are generated 1 
week after parasite implantation and remained almost indefinitely for many months 
(MacDonald, 1998). The emergence of suppressive cells is paralleled by the 
emergence of eosinophils into the peritoneal cavity (MacDonald, 1998). Significantly, 
the recruitment or induction of these adherent suppressive cells is dependent on host 
production of the Th2 cytokine IL-4, as they are not found in mice genetically 
deficient in IL-4 (MacDonald et al., 1998). This finding is consistent with the 
induction of type 2 responses by B. malayi, a characteristic feature of infection with 
nematode parasites (Maizels et al., 1993). Since infected IL-4 deficient mice also had 
reduced numbers of eosinophils (MacDonald, 1998), this suggested that eosinophils 
might be the suppressor cell. Experiments involving purified macrophages (M(D) 
based on sorting F4/80 cells by flow cytometry suggested that the suppressive cells 
were not M (MacDonald et al., 1998), further encouraging the hypothesis that 
eosinophils were the suppressive cell. However, when parasites were implanted into 
IL-5 deficient mice, that fall to recruit any cosinophils into the peritoneal cavity, the 
adherent peritoneal cells from implanted mice remained highly suppressive 
(MacDonald, 1998). The complete absence of eosinophils in parasite implanted 1L5 
mice unequivocally showed that eosinophils were not the suppressive cells 
(MacDonald, 1998). These confusing results led us to re-evaluate the identity of the 
suppressive cell. 
In this chapter, we establish that F4/80 macrophages are in fact the 
suppressive population, and exclude a suppressive role for dendritic cells. The 
requirement for the type-2 cytokine IL-4 places these macrophages in the recently 
defined category of 'alternatively activated' macrophages (AAMI)), which have been 
suggested to play an important role as anti-inflammatory cells (Goerdt and Orfanos, 
1999). 
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Results 
The cellular composition of adherent peritoneal cells recruited by Brugia 
malayi 
Previous work had described an almost 10 fold increase in total cell numbers 
(3.1 ± 0.8 x 107  ) recovered from the peritoneal cavity of parasite-implanted mice, in 
comparison to control mice (3.8 ±1.1 x 106)  (MacDonald, 1998). The peritoneal 
exudate cells (PEC) recruited by B. malayi consist of a mixed population consisting 
mainly of macrophages (74.3 ± 3.5%), eosinophils (11.7 ± 0.5%) and lymphocytes (8.6 
± 4.7%) (MacDonald et al., 1998) (Figure 1B). In comparison to control mice, parasite- 
implanted mice had a marked reduction in masts cells and an increase in both 
macrophages and eosinophils (MacDonald et al., 1998). In this study, we first 
established that the adherent component of the PEC populations show a similar profile 
(Figure 1A). The adherent cells are slightly enriched for macrophages (78.2 ± 2.8%) 
and slightly depleted of eosinophils (6.1 ± 0.43%) in comparison to total cells, while 
lymphocyte numbers remained similar (10.3 ± 1.8%). 
The suppressive cell is not a CD11c dendritic cell 
Although there are extremely few CD11c dendritic cells in the peritoneal 
cavity, both in control mice as well as parasite implanted mice (Figure 2A), we 
decided to ensure that a small population of CD  1c dendritic cells did not mediate 
suppression. We used indirect magnetic sorting to purify CD! 1c cells from PEC of 
parasite implanted mice (Figure 2A), and found that CD1 1c cells were not 
suppressive when co-cultured with the T cell lymphoma EL4 (Figure 2C), or the B cell 
hybridoma HB32 for 48 hours (Figure 213). The CD! ic- fraction that had been almost 
entirely depleted of CD1 1c dendritic cells (Figure 2A) blocked proliferation as 
effectively as the total PEC population (Figure 2B & C). This data provided strong 
evidence that the suppressive cells are not CD!! c dendritic cells. 
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Figure 1. Adherent peritoneal cell populations in control and parasite implanted 
mice. Adherent cells were removed non-enzymatically from tissue culture wells 
with a cell scraper, after the non-adherent cells had been washed away with 
medium. The cell composition of adherent PEC was determined by microscopy of 
cyto-centrifuge preparations stained with Diff Quik (A). Data shown are mean 
percentage of mast cells, eosinophils, lymphocytes, macrophages and unidentified 
monocytes, from 3 cyto-centrifuge preparations per sample. 500 cells were 
counted from randomly selected fields per cyto-centrifuge preparation. (B) An 
example of PEC recruited by B. malayi. L; lymphocyte, E; eosinophil, M; 
macrophage. 
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Figure 2: Suppressive cells are not CD1 lc+ dendritic cells. (A) CD1 lc+ 
dendritic cells were purified from PEC of parasite implanted mice (as shown) as 
well as control mice (not shown) using FITC conjugated a-CD1 ic antibodies 
and anti-FITC conjugated magnetic beads. Total as well as purified cells were 
stained with FITC conjugated a-CD 1 I  (FL 1) and PE conjugated aIEk  (FL2) 
and analysed by FACS (B) 1x10 5 cells from the CD  lc+ and CD11c- fractions 
from control (El or implanted mice () were co-cultured with 5x10 4 HB32 and 
EL4 cells and after 48 hours, proliferation was measured by [3 H]TdR 
incorporation. Data shown are mean ± SD of quadruplicate wells. 
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Figure 3: Macl+ cells from IL-5 -I- mice suppress proliferation. Macl+ cells were 
purified from parasite implanted IL-4 -I-, IL-5 -I- and WI mice using FITC 
conjugated a-Maci antibodies and a-FITC conjugated magnetic beads. 1x10 5 
Mac I+ cells were co-cultured with 5x10 4 EL4 or HB32 cells and proliferation was 
measured with [3H]TdR after 48 hours. Data shown are mean ± SD of 
quadruplicate wells. 





















Figure 4: A typical example of F4180 
purification of macrophages from PEC of parasite 
implanted mice. (A) Histogram showing the number of F4/80+ cells in the PEC of 
parasite implanted mice before magnetic bead purification. PEC were stained with 
F4/80-Tricolor. (B) Histogram showing the negative fraction of PEC after magnetic 
bead purification with F4/80-biotin and streptavidin conjugated microbeads. It was 
urity e difficult to obtain negative fractions of greater pven after two rounds of passage 
through purification columns. (C) Histogram showing the 
F4180 positive fraction of 
PEC after magnetic bead purification. There are fewer cells in this sample because only 
5000 data points were collected. Purity of F4/80+ cells are usually within the range of 
90-95% F4180+. (D) C
ytocentriftuge preparations of F4180+ 
purified cells stained with 
DiffQUik. 
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Control 	 Implant 	Implant (FACS) 
Figure 5: Suppressive cells are F4/80+ macrophages (M(D) (A) F4/80+ MCD were 
purified from PEC of parasite implanted mice using F4/80-biotin and streptavidin 
conjugated microbeads. W0 5 cells from resident peritoneal cells of control mice, and 
the F4/80+ and F4/80- fractions of parasite implanted mice were co-cultured with 5x10 4 
HB32 and EL4 cells and after 48 hours, proliferation was measured by [3 H]TdR 
incorporation. (B) F4/80+ and F4/80- fractions from control mice and parasite implanted 
mice were separated using magnetic beads. F4/80+ cells were also purified from parasite 
implanted PEC using a FACS cell sorter. W0 5 cells from these populations were co-
cultured with 5x10 4  HB32 and EL4 cells and after 48 hours, proliferation was measured 
by [3H]TdR incorporation. Data shown are mean ± SD of quadruplicate wells. 
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We found that F4/80 macrophages purified from B. inalayi implanted mice 
suppress proliferation of EL4 and HB32 after 48 hours of co-culture (Figure 6B), in 
comparison to F4/80- cells and also resident peritoneal cells from control mice (Figure 
To confirm that these results were not an artifact of magnetic bead separation,, we 
used flow cytometly to sort for F4/80 cells, which produced identical results (Figure 
Additionally, co-culture with different concentrations of EL4 and HB32 cells 
with purified F4/80 cells gave identical results as adherent PEC (Figure 6A). This 
demonstrated that proliferative suppression is directly mediated by F4/80 
macrophages. 
Furthermore, we found that F4/80 purified macrophages from implanted mice 
can stimulate antigen specific cytokine production by DlO.G4 cells, while inhibiting 
proliferation (figure 6B) repeating our original observations using unsorted adherent 
peritoneal exudate cells. The lack of proliferation of DlO.G4 cells is not a result of 
defective antigen processing and presentation capabilities of the macrophages, but is 
instead due to an active mechanism. This confirmed that parasite-exposed 
macrophages alone can directly mediate proliferative suppression while presenting 
antigen and stimulating cytokine production. 
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Figure 6: P4/80+ macrophages suppress proliferation but stimulate cytokine 
production. (A) EL4 and HB32 cells were cultured at different cell concentrations 
with fixed numbers (lxi 5  cells per well) of control PEC (,), implant PEC ( ) 
and F4/80 purified cells from implant PEC (U). After 48 hours, proliferation was 
measured by [3H] TdR incorporation. (B) D10 cells were co-cultured with control 
and implant PEC, as well as F480 cells purified from these PEC populations. 
After 48 hours of co-culture with (0) or without antigen (U), IL-4 production was 
assayed by NK bioassay, and proliferation was measured by 
[ 3 H]TdR 
incorporation. Data shown are mean ± SD of quadruplicate wells. 

















The suppressive property of F4/80 AAM is not reversed by classical 
activation factors 
Since the F4/80 macrophages are dependent on the Th2 cytokine IL4 for their 
suppressive phenotype, this suggests that they belong to the recently defined category 
of 'alternatively activated' macrophages (AAM) (Goerdt and Orfanos, 1999). We 
therefore asked if treatment with inflammatory factors that are known to activate 
macrophages, as well as mature dendritic cells, would be able to reverse the 
suppressive phenotype of these cells. Overnight pre-incubation of adherent PEC from 
parasite implanted mice with LPS, IFN-y and anti-CD40 antibodies, did not reverse 
the ability of these cells to block proliferation of HB32 cells (Figure 7). Overnight 
treatment of resident peritoneal cells from control mice with IFN-y resulted in the 
suppression of co-cultured HB32 cells (Figure 7), most probably as a result of 
inducing nitric oxide production (although this was not measured). This data suggests 
that the activation status of these suppressive anti-inflammatory macrophages cannot 
be simply reversed by pro-inflammatory factors. 
"Classical" activation factors 
do not reverse suppression 
Figure 7: Classical activation factors do not reverse suppressive property of 
AAM'D. Adherent PEC from control or parasite implanted mice were cultured 
overnight with LPS, IFN-g and anti-CD40, before being co-cultured with HB32 
cells. Proliferation of HB32 cells was measured after 48 hours by [3H] Tdr 
incorporation. Data shown are mean ± SD of triplicate wells. 
WHAT IS THE SUPPRESSOR CELL? 	 50 
Discussion 
We had previously found that filarial nematodes induce the recruitment and/or 
activation of a suppressor cell type in the peritoneal cavity of mice, which profoundly 
inhibits the proliferation of immune cells. The recruitment of these anti-proliferative 
cells is induced by the excretory/secretory (ES) products of the worms (Allen and 
MacDonald, 1998), and is dependent on IL-4 production by the host (MacDonald et 
al., 1998). In this study, we have identified this suppressive cell type as an IL-4 
dependent F4/80 macrophage. These data suggest that filarial nematodes can induce 
the activation of a macrophage population that inhibits proliferation of cells in the 
local vicinity, while retaining their ability to process/present antigen and stimulate 
antigen specific cytokine production. 
Protozoan parasites (Trypanosoma brucei and Toxoplasma gondii) induce 
IFN-y dependent macrophages that suppress splenocyte proliferation via nitric oxide 
(Channon and Kasper, 1996; Mabbott et al., 1995; Schleifer and Mansfield, 1993a; 
Sternberg and McGuigan, 1992). Unlike these classically-activated macrophages, 
suppressive macrophages that do notrely on IFN-'y for activation have been described 
as 'alternatively activated' (reviewed recently by Goerdt and Orfanos (Goerdt and 
Orfanos, 1999)). Alternative activation is associated with type 2 immune response 
mediators such as IL-4, glucocorticoids, IL-13 and TGF-. Thus, it is appropriate to 
categorize the macrophages that are recruited by the Th2 driving nematode Brugia 
malayi as 'alternatively activated'. Furthermore, by performing a small EST project 
from a cDNA libraiy constructed from these nematode induced suppressive 
macrophages, we have found that they highly express many genes that are associated 
with alternative activation and are induced by Th2 cytokines, including type I hepatic 
arginase and the chemokine C 1 (described in the EST study in chapter 7). 
More interestingly, we have previously found that these macrophages do not 
exert their suppressive effects via well-known mediators such as PGE2, IL-10 and 
TGF- (Allen et al., 1996; MacDonald et al., 1998). Whether suppressive 
macrophages are recruited by the parasite during a natural filarial infection to 
TU 
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modulate the immune response, or they perform some role in preventing 
immunopathology, remains to be established. The possibility that these cells act to 
induce regulatory I cells in response to infection is another exciting prospect that we 
are currently testing. Recently, we have found that these suppressive macrophages can 
drive Th2 differentiation when used as APC to prime naive T cells from TCR 
transgenic mice (described in chapter 6). The parasite-induced macrophages prevent 
Thi differentiation by the inhibition of early IFN-y production via TGF-J. 
Interestingly, while TGF-0 is involved in Th2 differentiation,, it is not involved in the 
proliferative suppression. The biased induction of Th2 cells by these alternatively 
activated macrophages, as well as their anti-proliferative effects, is consistent with 
their potential role as important anti-inflammatory cells. 
The identification of the suppressive cells as IL-4 dependent macrophages 
forms the basis of further molecular analysis of this cell type. (as described in chapters 
7-9). Most studies describing the properties and biological effects of macrophages 
generated under Th2 conditions (AAMD) arise from in vitro studies (Doyle et al., 
1994; King et al., 1998; McWilliam et al., 1992; Munder et al., 1998; Schebesch et al., 
1997; Stein et al., 1992), although other in vivo studies have also been described (Lee 
et al., 1999). Our ability to purify relatively large numbers of an AAM population 
that has been generated by a Th2 driving nematode parasite in vivo, puts us in a ideal 
situation to play a leading role in characterising the molecular basis of AAM. 
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Chap ter4 
WHAT IS THE MECHANISM OF SUPPRESSION? 
(Some of the experiments described in this chapter have been published in part in the 
European Journal of Immunology and were done with help from Andrew S. 
MacDonald) 
Summary 
We have previously found that the suppressive mechanism is not mediated by the 
action of soluble factors such as prostaglandins, nitric oxide, IL-10 and TGF-3 (Allen 
et al., 1996; MacDonald et al., 1998), but instead is mediated by a contact dependent 
mechanism suggesting a receptor mediated interaction (MacDonald, 1998). Here, we 
show that the proliferative block is reversible and is not a result of apoptosis. 
Suppressed cells accumulate in the GI and G2IM phase of the cell cycle. Interestingly, 
the Gi and G2IM block correlates with increased levels of Ki-67 protein, suggesting a 
mechanism that effects degradation of cell cycle proteins. We also show that, in 
addition to lymphocyte cell lines of murine origin, these suppressive cells can inhibit 
proliferation of a wide range of transformed human carcinoma lines. Apart from a 
potential role in altering host immune responses during parasitic infection, these 
macrophages and may even have the potential to reduce tumour cell growth. 
Introduction 
Understanding mechanisms that regulate cellular proliferation is a fundamental 
goal of cell biology, developmental biology, oncology, as well as immunology. In 
immunological systems, antigen-presenting cells and T cells can both adopt an 
important role in regulating or suppressing the proliferation of immune cells and 
thereby modulate immune response expansion and development. Prominent CD4 
regulatory T subsets (Groux et al., 1997; Read et al., 1998; Thornton and Shevach, 
1998) have been shown to inhibit the proliferation of other T cells via cytokines such 
as IL- 10 and TGF-. Most recently, a direct suppressive mechanism dependent on cell 
to cell contact between regulatory and responder T cells has been proposed (Read et 
al., 1998; Thornton and Shevach, 1998; Thornton and Shevach, 2000). 
Among APC, the most well characterised suppressive (or regulatory) cells are 
macrophages (M(D) 'classically activated' by Thi cytokines (such as IFN-y). By the 
release of nitric oxide (Abrahamsohn and Coffman, 1995; Channon and Kasper, 1996; 
Sternberg and Mabbott, 1996b) these cells suppress cellular proliferation by multiple 
mechanisms including the inhibition of DNA synthesis and its rate-limiting enzyme, 
ribonucleotide reductase (MacMicking et al., 1997). In addition to activation by pro- 
inflammatory cytokines, M1 can be alternatively activated by type 2 cytokines such as 
IL-4 and IL-13 (Doyle et al., 1994; Stein et al., 1992). These cells have been less well- 
characterized than classically activated M but appear to have anti-inflammatory roles 
and suppress T cell proliferation via cytokines such as TGF-0 and EL-10 (Goerdt and 
Orfanos, 1999). 
We have previously found that the suppressive peritoneal cells are induced by 
the implantation of live adult Brugia malayi (Allen et al., 1996; MacDonald et al., 
1998). As described in the previous chapter, we have now identified these suppressive 
cells as IL-4 dependent 'alternatively activated' Mb. Although alternatively activated 
M have been suggested to suppress proliferation via TGF-0 and EL-10 (Goerdt and 













reverse the proliferative inhibition exerted by B. malayi recruited cells (Allen et al., 
1996; MacDonald et 	al., 1998). Inhibitors of other mediators known to inhibit 
proliferation, such as NO, H202 , prostaglandins and IFN-y did not reverse the 
proliferative block (Allen et al., 1996). More recently, we found that instead of soluble 
cytokines, proliferative suppression occurred via cell-cell contact, suggesting a 
receptor mediated mechanism (Figure 1). This conclusion was made since the anti-
proliferative activity of parasite-recruited PEC could be reversed by transwell 
separation, while fixed PEC from implanted mice fully retained their ability to block 
proliferation (MacDonald, 1998) (Figure 1). 


































Figure 1 (courtesy of A.S. MacDonald): Proliferative inhibition is mediated by cell to 
cell contact. (A) D10.G4 and HB32 cells were either directly co-cultured with PEC or 
placed in separate transwell chambers separated by a 0.4 lam membrane. To obtain 
sufficient cell numbers, PEC from separate animals were combined, and data are shown 
as mean ± SD for six wells. Data shown are representative of three experiments. 
Although proliferation of separated HB32 cells was slightly reduced in some 
experiments (as shown), there were no significant differences in other experiments. (B) 
Control or implanted PEC were fixed with 1% paraformaldehyde before being co-
cultured with D10.G4, EL4 and HB32 cells. Proliferation was measured by [3H]TdR 
incorporation. 
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In this chapter, I describe some other unusual features regarding the 
suppressive mechanism. The data presented here, in combination with previous 
observations, suggest that alternatively activated macrophages induced by a Th2 
driving infection can regulate proliferation of a broad range of cell types via a novel 
receptor-mediated mechanism. 
Results 
Cell cycle arrest does not lead to apoptosis. 
The proliferative block of affected responder cells could be a result of 
apoptosis induced by suppressive peritoneal exudate cells (PEC) induced by B. malayi. 
We therefore assessed apoptosis in suppressed D1O.G4 cells and EL4 cells by TUNEL 
staining. Apoptosis of PEC alone was also assessed as a control for background levels 
of apoptosis. These experiments revealed that some of the parasite-recruited PEC 
undergo apoptosis after 48 hours in culture (Figure 2A). However, apoptosis of 
DlO.G4 cells and EL4 cells was not significantly increased by suppression (Figure 2B 
and 2C) when compared to the background levels of parasite recruited PEC apoptosis 
(Figure 2A). Apoptosis is therefore not the explanation for the reduction of 
proliferation. 
Cell cycle arrest is reversible 
Since the non-proliferating responder cells were not undergoing apoptosis 
when exposed to suppressive PEC, we then asked if they could recover their ability to 
proliferate after being removed from the suppressive cells. Experiments with D1O.G4 
and EL4 cells, which were removed and purified from co-culture with suppressive 
PEC after 48 hours, demonstrated that suppressed responder cells could fully recover 
their ability to proliferate (Figure 3). Indeed, thymidine incorporation of recovered 
cells was actually elevated (Figure 313), perhaps because their cell cycles had been 
synchronized after release from the cell cycle block. 
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Figure 2. Proliferative inhibition does not lead to apoptosis. Cells were TUNEL 
stained for apoptotic cells 48 hours after stimulation/co-culture with control PEC 
(black line) or implant PEC (gray line). Ml represents apoptotic cells (A) 
Implant PEC alone undergo some apoptosis, whereas control PEC do not. (B) 
EL4 and (C) Dl O.G4 cells had slightly elevated levels of apoptosis in comparison 
to imr,lant PEC alone. Data shown are reDresentative of two exneriments. 
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0 Control PEC 	• Implant PEC 
Figure 3. Proliferative suppression is reversible. (A) Proliferation of EL4, HB32 
and D1O.G4 (with 50j.tg/ml conalbumin) cells was measured by [3 H]TdR 
incorporation after 48 hours co-culture with control and implant PEC. (B) After 
48 hour exposure to PEC, non-adherent H1332, EL4 and D 1 cells were purified 
through nylon wool columns. Recounted cells were cultured for 48 hours and 
proliferation measured. Dl 0 cells were restimulated with fresh APC and antigen. 
PEC of individual animals were combined for this experiment and results shown 
are mean ± SD of quadruplicate wells. 
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Proliferation of various transformed cell lines are inhibited 
We had previously observed that proliferative suppression is very non-specific, 
acting not only on mitogen activated T cells, but also affecting transformed 
lymphocyte lines. We wanted to address how wide-ranging this anti-proliferative 
effect was by exposing a broad panel of human cancer cells to the suppressive PEC. 
Strikingly, the proliferation of many human cancer cell lines was considerably reduced 
when co-cultured with suppressive PEC, in comparison to control PEC (Table 1). This 
indicated that the suppressive mechanism was neither species specific nor cell type 
specific. However, the sensitivity of the different types of carcinoma to suppression by 
PEC did vary quite considerably. Colon carcinomas appeared to be more sensitive to 
suppression than pancreatic carcinomas, while the neuroblastoma line NGP was 
completely unaffected (Table 1). 
Effect of suppressive PEC on the cell cycle. 
In previous experiments, proliferation of cells co-cultured with adherent PEC 
was measured by [3H] thymidine incorporation after 48 hours (Allen et al., 1996; 
MacDonald et al.,1998). In order to obtain a more complete picture, we performed 
experiments to assess the effect of suppressive PEC on the cell cycle of the responder 
cells. 
Firstly, in order to determine whether the proliferative block occurred 
immediately after exposure to suppressive PEC, EL4 cells were labelled with 
proliferation marker dyes PKH26 or CFSE before co-culture with PEC. These dyes 
lose intensity as cells divide and provided the means to track cell divisions that 
occured after exposure to suppressive PEC. In these experiments, EL4 cells cultured 
with suppressive PEC completed one round of cell division after 24 hours, but failed to 
undergo a second round of cell division after 48 hours (Figure 4B). This was also 
observed when CFSE labelled D1O.G4 cells were stimulated with either control or 
parasite implanted PEC. Whereas control PEC stimulated DlO.G4 cells had undergone 
up to 3 rounds of cell division after 48 hours, suppressed D1O.G4 cells had only 
completed one round of cell division (Figure 4C). 
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Cancer type 	 - - -- - 
H358 115888 15111 87 Non-small-cell lung 
aderiocarcinoma 
HCT116 140116 19996 85.7 Colon carcinoma 
HT29 55420 12832 76.8 Colon carcinoma 
LoVo 180491 54441 69.8 Colon carcinoma 
Co1o320 251051 86639 65.4 Colon carcinoma 
H2122 148989 55024 63 Non-small cell lung carcinoma 
Capan-1 50261 25675 48.9 Pancreatic carcinoma 
COR L24 2522 1312 48 Small cell lung carcinoma 
H524 69167 42403 38.7 Small cell lung carcinoma 
Panc-1 86934 54109 37.7 Pancreatic carcinoma 
MiaPaCa-2 172272 135719 21.2 Pancreatic carcinoma 
NGP 112649 119571 -6.1 Neuroblastoma 
Table!: Effect of suppressive PEC on human tumor cell lines. 
lx iO4 cancer cells were cultured with adherent PEC (1x10 5) from control or implanted 
animals in 96 well flat bottom plates. Proliferation by [3H] thymidine incorporation 
was measured at 48h and results are shown as c.p.m. Numbers shown are the mean of 
quadruplicate wells and representative of at least 2 experiments with each cell line. 
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Figure 4. Proliferation is blocked after one cell division. EL4 cells stained with 
PKH26 were co-cultured with control PEC (A) or implant PEC (B) for 24 and 48 
hours before harvest and analysis by FACS. With each cell division fluorescence 
intensity halves. The arrow marked 0 indicates the original intensity of cells that were 
fixed immediately after staining. The arrows marked 24 and 48 indicate fluorescent 
intensity of cells harvested after 24 or 48 hours culture with PEC. This experiment 
was repeated with USE staining with identical results. (C) D1O.G4 cells stained with 
USE were stimulated (50g1m1 conalbumin) with implant PEC (thin line) or control 
PEC (broken line) for 3 days. The marked arrows indicate the number of cell divisions 
and the thick line represents the original intensity of the D1O cells. 
WHAT IS THE MECHANISM? 	 61 
Thymidme incorporation is associated with cells cycling through S phase of 
the cell cycle. To obtain additional information on the cell cycle, DlO.G4 cells and 
EL4 cells were stained with propidium iodide after co-culture with PEC for 48 hours. 
Whereas the Th2 clone DlO.G4 proliferates only in response to antigen (conalbumin) 
specific stimulation, the T cell lymphoma EL4 proliferates continuously and does not 
require antigen stimulation. The effect of co-culture with suppressive PEC on both cell 
lines (in comparison with control PEC) was to increase the percentage of cells in 
GO/Gi and G2/M, and to reduce the number of cells in S phase (Figure 5). The 
decrease in the percentage of S phase cells is consistent with the inhibition of 
thymidine incorporation in standard proliferation assays. The accumulation of 
suppressed cells at both GO/Gi as well G2/M phases suggested that there were two 
blocks on the cell cycle. 
To further distinguish between cells in CX) and Gi, cells were double stained 
with antibody against Ki-67 as well as propidium iodide. Ki-67 is expressed only in 
proliferating cells and not in quiescent GO phase cells. Surprisingly, suppressed 
DlO.G4 cells and EL4 cells had an increased level of Ki-67 protein in comparison to 
proliferating cells-cultured with control PEC (Figure 5). The accumulation of Ki-67 
was evident in GI cells (2N) as well as G2/M cells (4N). Proliferative inhibition is 
therefore not a result of entering a quiescent GO phase, but might instead be associated 
with accumulation of cell cycle proteins. 
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Figure 6. Cell cycle analysis of PEC exposed cells. (A) Histograms of D1O.G4 and EL4 cells stained with propidium ioidide (P1) 48 
hours after co-culture with either control or implant PEC. In both cell lines, implant PEC exposed cells have a decreased percentage of 
cells in S phase, and an accumulation of cells in GI and G2/M. Results shown are representative of 3 independent experiments. (B) 
FACS analysis of cells double stained with Ki-67 as well as P1 after 48 hours co-culture with PEC. Ki-67 expression is shown on the Y-
axis (FL- 1) and P1 staining is shown on X-axis (FL-2). The R2 gate represents 2N cells in G 1. The R3 gate represents 4N cells in G2/M. 
(C) Histogram analysis of Ki-67 expression in G  (R2) and G2IM (R3) cells, using gates shown in B. Implant PEC exposed cells (dotted 
lines) have increased expression of Ki-67 in both these phases of the cell cycle, compared to control (unbroken line). 
Discussion 
B. malayi induced macrophages showed several novel properties not 
previously described for anti-inflammatory macrophages. Instead of soluble cytokines, 
proliferative suppression occurred via cell-cell contact, suggesting a receptor mediated 
mechanism. Furthermore, suppressed cells were not simply blocked at the Gi/GO 
stage of the cell cycle but also at the G2/M stage. Thus, the suppressive mechanism 
has a profound but reversible effects on the GI and G2/N4 phase of the cell cycle. 
Finally, the proliferation of a wide range of transformed human cell lines was also 
inhibited by these macrophages, showing that the suppressive effect could transcend 
the species barrier. 
The identity of the cell surface molecule(s) involved in inhibiting proliferation 
remains mysterious and efforts are under way to determine it's identity (described 
further in chapter 7). The observation that the suppressive macrophages affect such a 
wide range of human tumour cells, as well transformed mouse cells, strongly suggests 
the engagement of a highly conserved receptor. Based on our findings, it is tempting to 
suggest that parasitic nematode infection could have a beneficial effect against tumour 
expansion as a by-product of recruiting macrophages that suppress proliferation. 
However, the effect of these cells is probably extremely limited because of the local 
nature of receptor mediated mechanisms. Furthermore, the reversibility of the 
proliferative block would allow any dividing cells that migrate away from the vicinity 
of the suppressor cells, to continue proliferating. Indeed, in vivo experiments described 
in chapter 6 indicate that EL4 cells that have been injected into the peritoneal cavity of 
B.malayi implanted mice can eventually evade suppression. Nonetheless, it would be 
interesting to investigate if lymphomas are less prevalent in regions endemic for 
filariasis. 
It is unusual for growth regulatory mechanisms to induce a cell cycle block in 
G2IM as well as Gi. The cell cycle machinery usually responds to external stimuli 
(such as mitogenic or anti-mitogenic factors) only during a defined window of time, 
from the beginning of GI to the restriction point (R) (Pardee, 1989; Planas-Silva and 
Weinberg, 1997; Zetterberg et al., 1995). After R, cells are relatively refractory to most 
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external stimuli, the remaining phases of the cell cycle being executed in a quasi- 
automatic fashion (Planas-Silva and Weinberg, 1997). Thus, the majority of anti- 
proliferative signals would lead to a GI arrest of the cell cycle, or entry into the 
quiescent GO state. A G2/M arrest usually occurs only as a result of interference to 
DNA replication (Elledge, 1996; Nurse, 1997). The effect on two phases of the cell 
cycle raises the possibility that more than one mechanism could be acting together to 
inhibit proliferation. Alternatively, the suppressive macrophages may be slowing 
down the cell cycle by delaying the passage through the checkpoint controls at GI and 
G2/M, while having no effect on progression through S phase. 
It was interesting that the accumulation of cells at GI and G2/M was 
associated with an increased level of Ki67 protein. Although the monoclonal antibody 
(mAb) Ki-67 has been used to identify proliferating cells since 1983 (Gerdes et al., 
1983), the function of the protein recognized by this mAb is still uncertain. Anti-sense 
oligonucleotide treatment or microinjection of antibodies into the nucleus will delay 
cell cycle progression, suggesting that Ki-67 antigen is essential for cell cycle 
progression (Schluter et al., 1993; Starborg et al., 1996). However, there are no reports 
that increased expression also leads to cell cycle arrest. Interestingly, one of the few 
factors which can lead to a G2/M as well as a Gi block is inhibition of the Proteasome 
(Machiels et al., 1997), which leads to an accumulation of ubiquitinated proteins, 
including the various cydlins necessary for cell cycle progression (King et al., 1996; 
Machiels et al., 1997). Perhaps the anti-proliferative macrophages engage receptors 
that lead to changes in protein degradation of the suppressed cells, leading to 
accumulation of cell cycle proteins such as Ki-67. We need to establish whether Ki-67 
accumulation in GI and G2/M cells is directly involved in the mechanism of 
suppression or merely an indirect consequence of cell cycle arrest. We are also 
investigating the effect of suppression on the levels of cyclins in the non-proliferating 
cells. 
In conclusion, we report the observation of a contact dependent mechanism of 
inhibiting proliferation that has profound effects on the 01 and G2/M phases of the 
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cell cycle. This novel mechanism of suppression by filarial-induced macrophages 
(which are dependent on host IL-4) can also significantly reduce the proliferation of a 
wide range of human tumour cell. Thus, the identification of the molecular players 
involved will be of interest to tumour biologists as well immunologists and 
parasitologists. 
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Chapter 5 
WHAT IS THE EFFECT OF AAM ON NAIVE T 
CELLS? 
(The experiments described in this chapter have been published in the European 
Journal of Immunology) 
Summary 
A key feature of nematode infection is a bias towards a type 2 immune response. To 
investigate the role that antigen presenting cells (APC) may play in promoting this 
bias, we used adherent peritoneal exudate cells (PEC) recruited in response to the 
filarial nematode Brugia malayi, to stimulate naïve T cells from pigeon cytochrome c 
(PCC) specific TCR iransgenic (PCC-tg) mice. Although the proliferation of PCC-tg T 
cells was inhibited by parasite-induced PEC during primary stimulation, they 
proliferated normally upon secondary stimulation and were not rendered anergic. 
However, PCC-tg T cells primed by suppressive APC differentiated into IL-4 
producing Th2 cells upon secondary stimulation instead of IFN-y producing Thi cells, 
as has been previously described. Studies with USE labeled cells indicated that Th2 
differentiation was associated with the inhibition of (or failure to stimulate) IFN-y 
production during primary stimulation. Interestingly, blocking antibodies against TGF -
0 (but not IL-b) restored the differentiation of IFN-y producing Thi cells. Identical 
results with USE labeled cells were obtained using purified F4/80 macrophages. 
These data indicate that T cells exposed to parasite-induced alternatively-activated 
macrophages are driven towards Th2 differentiation. This may be an important factor 
in the Th2 bias that accompanies nematode infection. 
Introduction 
Understanding why helminth infection induces type 2 cytokines has been a 
major goal for parasite immunologists. Since the cytokine environment is considered 
the most important factor influencing the differentiation of naïve T cells (Abbas et al., 
1996; O'garra, 1998), the source of early IL-4 production during helminth infections 
has been of particular interest (Osborne and Devaney, 1998; Sabin et al., 1996). 
However, many other factors can influence the differentiation of naïve T cells, 
including altered peptide ligands, antigen dose and costimulatoiy molecules (reviewed 
by Constant and Bottomly (Constant and Bottomly, 1997)). Most recently, it has been 
proposed that the type of APC and its previous environmental exposure could also 
play an important role in influencing T cell differentiation (Goerdt and Orfanos, 1999; 
Rissoan et al., 1999). In this chapter, we show that macrophages recruited by Brugia 
malayi can induce Tb2 differentiation in the absence of detectable levels of IL-4, via a 
mechanism that involves TGF-J3. 
Apart from a type 2 cytokine profile, another key feature of filariasis is the 
presence of hyporesponsive, or anergic, T cells in the infected host (Piessens et al., 
1980; Yazdanbakhsh et al., 1993). In the previous chapters, we have described the 
recruitment of suppressive macrophages by B. malayi, which can process and present 
antigen and stimulate antigen-specific IL4 production by the Th2 clone D10.G4 while 
actively inhibiting proliferation via a contact dependent mechanism. Based on the 
model of anergy induction proposed by Schwartz and Jenkins, linking cell division 
with clonal anergy (Beverly et al., 1992; Jenkins, 1992), we hypothesized that 
stimulation of naïve T cells by these anti-proliferative APC could lead to the 
development of anergic, or hypo-responsive cells. Additionally, to explore the 
possibility that these suppressive APC affect T cell differentiation, we investigated 
their impact on the differentiation of a clonal population of naïve CD4 lymphocytes 
from pigeon cytochrome C (PCC)-specific TCR transgenic (PCC-tg) mice. 
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Results 
Suppressive APC inhibit proliferation of naïve CD4 T cells but do not 
induce anergy 
To investigate whether stimulation of naïve T cells with anti-proliferative APC 
could induce anergy, CD4 T cells were purified from mice expressing a lransgenic 
TCR specific for the PCC peptide (88-104) with IEk.  These naïve CD4 cells were 
stimulated with either adherent PEC taken from control mice or from mice implanted 
with B. malayi. As expected CD4 T cells proliferated strongly in response to PCC 
protein (10 j.ig/ml) when presented on control PEC, but proliferated poorly in response 
to stimulation by implanted PEC (Figure 1A). IL-2 production was also severely 
abrogated on primary stimulation (Figure 1B) with suppressive PEC. In a parallel 
experiment, suppressed CD4 T cells were removed after 48 hours and rested for 72 
hours before repurification and stimulation. These cells proliferated normally in 
response to secondary stimulation with PCC and irradiated splenocytes (Figure 1A). 
IL-2 production was also fully restored (Figure 113). 
Suppressive APC induce Th2 differentiation of naïve CD4 cells 
It has been reported in several systems (Seder et al., 1992; Stockinger et al., 
1996; Takeuchi et al., 1998) that upon secondary stimulation, CD4 T cells derived 
from TCR transgenic mice will develop into Thi cells and produce high levels of JFN-
y and little IL-4, if primed in the absence of any exogenous cytokine. The addition of 
IL-4 during primary stimulation stimulates 112 differentiation leading to the 
production of high levels of IL-4 and little IFN-y (Seder et al., 1992). We observed an 
identical pattern of T cell differentiation, when irradiated splenocytes were used as 
APC to stimulate the PCC-tg I cells (Figure 2A). However, PCC-tg T cells primed by 
parasite-derived APC (in the absence of exogenous cytokines) also produced high 
levels of IL-4 upon secondary stimulation. This was in contrast to CD4 T cells primed 
with control PEC, which as expected produced high levels of IFN-y (Figure 213). The 
mechanism by which Th2 differentiation is induced in this system did not appear to be 
mediated via IL4 secretion, since IL4 produced by PEC was generally undetectable 

















(<5 pg/mi) in both control and implanted mice. Indeed, when very low levels of IL-4 
were detected, control PEC produced equal if not greater levels of IL-4 than implant 
PEC (e.g. control PEC = 27.8 ± 11.7 pg/mi, implant PEC = 16.1 ± 10.4 pg/mI). 
























Figure 1. Suppressive APC block proliferation but do not induce anergy. Purified CD4+ 
cells from splenocytes of PCC specific TCR transgenic mice were stimulated with adherent 
PEC from control or parasite-implanted animals and 10 tg/ml PCC protein. Proliferation 
(A) was measured by [3H] thymidine incorporation and IL-2 production (B) was measured 
with the NK bioassay affer 48 hours. Stimulated cells were also rested for 72 hours, 
repunfied with anti-CD4 magnetic beads and restimulated with PCC and irradiated normal 
splenocytes for another 48 hours (secondary stimulation). The addition of exogenous IL-2 
(10 Units/ml) had no effect on proliferation of restimulated cells (A). 
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Figure 2. Suppressive APC induce Th2 differentiation. (A) PCC-specific ICR transgenic 
CD4+ cells were stimulated with 10 pg/mi PCC protein and irradiated splenocytes in the 
absence or presence of IL-4 (200 pg/mi). After 5 days, primed cells were washed and 
restimulated with fresh irradiated splenocytes. 48 hours later, supernatants were 
harvested and tested for IL-4 and IFN-y production. (B) Naïve I cells were primed with 
control or parasite implanted PEC without additional cytokines (as described in Fig. 1). 5 
days later, primed cells were restimulated with PCC and fresh irradiated normal 
splenocytes. 48 hours after secondary stimulation, supernatants were harvested and 
tested for IL-4 and IFN-y production. 
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Relationship between cytokine production and proliferation 
An interesting relationship between cellular proliferation and cytokine 
production has recently been demonstrated (Bird et al., 1998; (Iett and Hodgkin, 
1998). Whereas IFN-y production can be stimulated without cell division, IL-4 
production can only be detected after at least 3 rounds of cell division (Bird et al., 
1998). We therefore investigated whether parasite-derived APC could stimulate PCC-
tg T cells to produce IL-4 in the absence of proliferation (during primary stimulation), 
by staining the I cells with the proliferation marker USE before primary stimulation 
with antigen and suppressive APC. IL-4 and IFN-y production were assessed by 
intracellular cytokine staining. 
We found that naïve T cells primed with control PEC underwent up to 9 
rounds of cell division (in 72 hours) (Figure 3A) and produced high levels of IFN-y as 
they divided (Figure 3B). In contrast, suppressive PEC-primed T cells went through 
very few rounds of cell division in the same period of time (Figure 3A). In some 
experiments, they failed to divide altogether (data not shown). Furthermore, there were 
no IFN-y producing cells among the I cells that have undergone 3-4 cell divisions 
(Figure 3B) so that suppression of IFN-y appears more profound than proliferative 
suppression. No IL-4 producing cells were observed from T cells stimulated by either 
control or implant PEC (Figure 3B). These data suggest that the shift to Th2 
differentiation we observe is more likely due to the inhibition of IFN-'y rather than the 
induction of IL-4 producing T cells during primary stimulation. 
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Figure 3. Analysis of cell division and cytokine production during primary stimulation. Naïve CD4+ I cells and the 
Th2 clone DlO.G4 were labeled with CFSE before stimulation with antigen and adherent PEC from control or parasite 
implanted mice. After 72 hours, the non-adherent T cells were harvested and stained for intracellular cytokine (IL-4 
and IFN-y). The numbers in (B) and (C) represent the percentage of cytokine positive cells. (A) Cell division of naïve 
I cells stimulated with PCC and control PEC or implant-derived PEC. (B) Intracellular IL-4 and IFN-y staining of 
dividing CD4+ transgenic T cells. (C) As a positive control for IL-4 staining, the Th2 clone DlO.G4 was also 
stimulated with conalbumin and control or implant PEC. Intracellular IL-4 and IFN-y was assessed. 
TGF-P is involved in inhibition of IFN-y producing T cells 
IL-10 and TGF-J3 are cytokines commonly associated with the capacity to 
down regulate IFN-y as well as inducing a Th2 differentiation bias (Iwasaki and 
Kelsall, 1999; King et al., 1998; Stumbles et al., 1998). In order to determine whether 
these molecules were involved in the inhibition of IFN-T production or proliferative 
suppression of naïve T cells, we used blocking antibodies to EL-10 and TGF-P to see if 
the observed phenomena could be reversed (Figure 4). Consistent with the fact that IL-
10 was undetectable in primary stimulation assays (<50pgIml), we found that blocking 
antibodies against IL- 10 did not have any significant effect on naïve T cells primed by 
parasite induced APC (Figure 4C). However, blocking antibodies against TGF-13 
doubled the number of IFN-'y positive cells stimulated by the suppressive PEC (Figure 
4D), reaching numbers which were indistinguishable from control PEC stimulated T 
cells. Upon secondary stimulation, IFN-y production by T cells primed with 
suppressive PEC and anti-TGF-0 was also indistinguishable from those primed with 
control PEC (Figure 5A), and was much enhanced compared to priming with 
suppressive PEC alone. IL-4 production was also significantly reduced as a result of 
primary stimulation with anti-TGF-P antibodies (Figure 513). This suggests that TGF-
plays a role in the induction of IL-4 production in naïve T cells stimulated by 
suppressive PEC, as well as inhibiting their production of IFN-y. 
Although these experiments suggested that TGF-P was involved in Th2 
induction by suppressive PEC, blocking antibodies against TGF-P did not reverse the 
proliferative suppression of naive T cells (Figure 4D). The observation that antibodies 
against TGF-P and IL-10 do not reverse proliferative suppression is consistent with 
our previous work using Tb2 clones and transformed cell lines (Allen et al., 1996; 
MacDonald et al., 1998). The observation that antibodies against TGF-P could reverse 
IFN-y inhibition, but not proliferative suppression, also suggests that there is no direct 
relationship between these two phenomena. 







Figure 4. TGF-3 is involved in inhibition of IFN-y by implant PEC, but not 
inhibition of proliferation. Naïve CD4+ T cells were labeled with CFSE before 
stimulation with antigen and PEC from control mice (A) or parasite implanted 
mice (B, C & D). Media (A, B), neutralizing anti-IL-10 (C) or neutralizing anti- 
TGF- (D) were added to the in vitro cultures. Blocking antibodies had no effect 
on T cells stimulated by control PEC (data not shown). After 72 hours, the naïve T 
cells were harvested and stained for intracellular IL-4 (undetectable, data not 
shown) and IFN-y. Numbers within gates represent the percentage of IFN-y 
positive cells. 
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Figure 5. TGF-13 is involved in inducing Th2 differentiation. Naïve T cells were 
primed (as described in Fig. 1 and 2) with control PEC, parasite implanted PEC 
alone and parasite implanted PEC with blocking antibodies against TGF-1i 5 days 
later, primed cells were restimulated with 10 or 50 .tg/m1 PCC and fresh irradiated 
splenocytes. 72 hours after secondary stimulation, supernatants were harvested and 
tested for IL-4 and IFN-y production. 








Effect of parasite recruited macrophages on naïve T cells 
In chapter 3 we described how F4I80 macrophages have been recently 
identified as the PEC cell type directly responsible for proliferative suppression in 
implanted mice. To examine the possibility that macrophages are responsible for the 
observed effect on naïve T cells, F4/80 cells were purified from the PEC population 
of control and parasite implanted mice, and used to stimulate CFSE stained naïve T 
cells (Figure 6). Whereas F4/80 cells from control animals stimulated cell division 
and WN-y production by naïve T cells, parasite recruited F4/80 cells suppressed 
proliferation and did not stimulate WN-y producing cells (Figure 6). This data 
demonstrates that it is the macrophage population that is responsible for the observed 
effects on IFN-y production. This suggests that alternatively-activated macrophages 
influence naïve I cell differentiation by failing to stimulate, or inhibiting, IFN-y 
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Figure 6. F4/80+ macrophages from the implant PEC population inhibit IFN-y. Naïve 
CD4+ T cells were labeled with CFSE before stimulation with antigen and F4/80+ 
purified cells from control or parasite implanted mice. After 72 hours, the naïve T cells 
were harvested and stained for intracellular IL-4 and JFN-y. Numbers in gate represents 
percentage of 1FIsT.y positive cells. 
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Discussion 
In addition to the ability to inhibit cellular proliferation, we have found that the 
macrophages recruited by B.malayi appear to drive Th2 differentiation of naïve T cells 
in vitro. The Th2 differentiation is linked with the absence of WN-y producing cells 
during the primary encounter of antigen and this effect appears to be mediated via 
TGF-13. Future efforts will be made to determine if these APC can drive Th2 responses 
in vivo as well. 
We expected the naïve T cells to be anergized by the first encounter of antigen 
in the presence of suppressive APC. The recovery of proliferative ability was 
surprising given that Schwartz and Jenkins have proposed that anergy is induced when 
signal 1 (TCR engagement of the peptide-MHC complex) is encountered in the 
absence of proliferation and IL-2 production (Beverly et al., 1992; Jenkins, 1992). 
Based on this model, Powell et al. showed that inhibiting proliferation of T cells with 
rapamycin during stimulation also leads to anergy even in the presence of co- 
stimulation (Powell et al., 1999). Our data show no induction of anergy despite 
profound inhibition of cell division and IL-2 production in naïve T cells during 
primary stimulation. Since anergy studies have primarily used established T cell 
clones (Beverly et al., 1992), our results support the observations of Hayashi et al., 
who proposed that naïve T cells are resistant to anergy induction (Hayashi et al., 
1998). 
It is significant that Th2 differentiation appeared to occur as a result of 
inhibiting differentiation of IFN-y producing T cells, instead of driving early 
differentiation of IL-4 producing cells. This supports the hypothesis that Th2 
responses might be a default pathway that occurs in the absence of a Thi driving 
factor. This is consistent with observations by Cua and Stohimans (Cua and Stohiman, 
1997), which suggest that reduced IL-12 production by a subpopulation of 
macrophages, could be associated with type 2 responses (Cua and Stohlman, 1997). 
IL-12 production by monocyte/macrophages can be down regulated by a number of 
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factors including engagement of CD47 (Armant et al., 1999) and ligation of the Fc 
gamma, complement, or scavenger receptors (Sutterwala et al., 1997). Alternatively, 
the suppressive APC may be producing down regulatory cytokines that directly inhibit 
IFN-y production (Nagelkerken et al., 1993; Tripp et al., 1995). 
Although TGF-P clearly plays an important role in the Tb2 driving effect of 
the AAM, there remain many unanswered questions about the role of TGF-13 in our 
system, especially since its role in naïve T cell differentiation is extremely complex 
with conflicting data from different experimental systems (Letterio and Roberts, 
1998). While our observations are consistent with reports that TGF-f is associated 
with the inhibition of IFN-y and Th2 development (Gorham et al., 1998; Schmitt et al., 
1994), it is in contrast with reports suggesting that TGF-3 inhibits Th2 differentiation 
(Nagelkerken et al., 1993; Sad and Mosmann, 1994; Swain et al., 1991). Thus, the 
effects of TGF-P varies depending on a variety of factors (eg. cytokine concentration 
(Lingnau et al., 1998) and genetic background (Hoehn et al., 1995)), and cannot be 
generalized beyond a particular system. Furthermore, it is uncertain in our system 
whether TGF-3 acts directly on naïve T cells or does it have an indirect effect? TGF-
production by parasite derived APC could be directly influencing IFN-y production by 
inhibiting the IL-12 responsiveness of the naïve T cells as a result of downregulating 
IL-12R expression (Gorham et al., 1998). However, TGF-P has also been shown to 
affect T cell differentiation by modulating the phenotype of APC rather than acting 
directly on T cells (Takeuchi et al., 1998; Takeuchi et al., 1997). PEC pulsed with 
TGF-[ can induce IL-4 production by D011 .TCR transgenic naïve T cells even during 
primary stimulation (Takeuchi et al., 1998; Takeuchi et al., 1997). The stimulation of 
IL-4 appeared to be a result of CD40 up-regulation, as well as inhibition of IL-12 
production (Takeuchi et al., 1998). It would be interesting to establish whether TGF-[. 
is acting directly or indirectly in our system. 
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Recent reports have described specific subsets of dendritic cells that differ in 
their capacity to stimulate the differentiation of naïve T cells (Iwasaki and Kelsall, 
1999; Rissoan et al., 1999; Stumbles et al., 1998). However, we are unaware of any 
reports suggesting that macrophages can also differ in their capacity to stimulate naïve 
T cell differentiation, although this has been proposed by Goerdt et.al . (Goerdt and 
Orfanos, 1999). Indeed, macrophages are expected to stimulate a Thl type response 
(Desmedt et al., 1998). Our observations imply that macrophages, like dendritic cells, 
might also differ in their capacity to stimulate T cell differentiation. 
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Chapter 6 
CAN THE AAM BLOCK TUMOUR 
PROLIFERATION AND PREVENT MHC 
MEDIATED REJECTION IN VIVO? 
Summary 
The ability to design new therapies to prevent the expansion of tumour cells and to 
prevent graft rejection is one of the ultimate aims of applied immunology. The 
properties of AAM that have been discussed in the previous chapters raised 
possibilities that nematode parasites might induce novel immune mechanisms that 
could be of medical significance. We found that when EL4 cells were injected (i.p.) 
into mice implanted with parasites, the proliferation of these cells was severely 
curtailed ex vivo, after 1 week of in vivo expansion in the peritoneal cavity. As 
expected, parasite implanted IL-4 deficient mice did not suppress the ex vivo 
proliferation of injected EL4 cells. However, using USE labelled EL4 cells to track 
proliferation in vivo, we found that the recruitment of suppressive AAM into the 
peritoneal cavity of parasite implanted mice could not prevent the in vivo proliferation 
of EL4 cells (i.p.). This suggests that EL4 cells can migrate away from suppressive 
AAMb in the peritoneal cavity in vivo and escape proliferative suppression, which 
they cannot do when co-cultured in vitro. We also found that USE labelled 
suppressive AAM could not prevent MI-IC restricted host rejection when transferred 
in vivo (i.p.) into allogeneic mice. However, due to a mistake in the choice of mouse 
strains, we have not been able to determine if AAMCI can prevent minor 
histocompatibility antigen mediated rejection. 
Introduction 
In the previous chapters, we have shown that suppressive macrophages can 1) 
block proliferation of tumour cells, and 2) drive differentiation of Th2 cells from naïve 
cells. These results suggested that suppressive macrophages might be able to prevent 
expansion of tumours and downmodulate the immune response. In this chapter, we 
describe experiments aimed at testing if the effects we have so far observed in vitro, 
could translate to effects in vivo. The I cell lymphoma EL4 is a very aggressive cell 
line that has been widely used in many tumour rejection studies (Stremmel et al., 
1999; Townsend et al., 1994). It's susceptibility to being suppressed by the AAM in 
vitro, as well as it's aggressive and well characterised features in vivo (Stremmel et al., 
1999; Townsend et al., 1994), encouraged us that it would make a good candidate for 
testing in vivo suppression. 
In the previous chapter, we have already described using the intracellular 
fluorescent dye 5,6-carboxyfluorescein diacetate succinimyl ester (CFSE) to 
investigate the in vitro division of naïve T cells. More recently, this technique has been 
exploited to investigate in vivo proliferation in the study of T cell homeostasis (Ernst et 
al., 1999). When analysed by flow cytometry ex vivo, each division of CFSE labelled 
cells in vivo causes a 2 fold decrease in fluorescence. We therefore decided to use this 
technique to investigate the proliferation of CFSE labelled EL4 cells when injected 
into the peritoneal cavity of mice, which have been implanted with B. inalayi. 
The ability to drive Th2 differentiation made us speculate that the suppressive 
macrophages might function as antigen presenting cells that induce the differentiation 
of T regulatory cells. T regulatory cells have been proposed to be involved in 
"infectious tolerance" and play a role in preventing graft rejection (Cobbold and 
Waldmann, 1998; Waldmann and Cobbald, 1998). In order to test the hypothesis that 
suppressive macrophages could induce T regulatory cells and prevent host rejection, 
we decided to transfer these macrophages into allogeneic mice and investigate if they 
can prevent themselves from being rejected by the host immune response. If the 
macrophages could prevent themselves from being rejected from allogeneic hosts, we 
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could then test if their presence would also prevent skin graft rejection on the 
allogeneic hosts that have received suppressive macrophages. 
Unfortunately, the experiments described in this chapter do not show a clear 
indication that the recruitment of suppressive macrophages into the peritoneal cavity 
would prevent the in vivo proliferation of EL4 cells. There was also no indication that 
suppressive macrophages can prevent themselves from being rejected when 
trasnferred into MHC mismatched hosts. 
Results 
EL4 cells are suppressed ex vivo after a week of expansion in vivo 
Since macrophages recruited into the peritoneal cavity of mice by B. inalayi 
can suppress the proliferation of tumour cells when co-cultured in vitro, we decided to 
investigate if implantation of the parasite would prevent tumour proliferation in vivo. 
We injected EL4 lymphoma cells into the peritoneal cavity of mice that have been 
implanted with parasites for 3 weeks. To control for cytotoxic effects of inflammatory 
macrophages, we injected mice with thioglycollate for 3 days before injection of EL4 
cells. After allowing the EL4 cells to expand in vivo for 7 days, we removed the PEC 
from the EL4 injected mice as well as control mice, and assessed the proliferation of 
the total PEC population ex vivo (Figure 1A). PEC from EL4 injected mice were found 
to proliferate in thioglycollate injected mice but not parasite implanted mice. PEC of 
control mice (thioglycollate injected as well as parasite implanted) not injected with 
EL4 cells, showed no signs of proliferation. (Figure 1A) 
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Figure 1: EL4 cells are suppressed ex vivo. Mice were either implanted with parasites 
for 3 weeks or injected (i.p.) with thioglycollate for 3 days, before being injected (i.p.) 
with 2x106  EL4 cells. After 7 days, PEC were removed from EL4 injected mice (+EL4) 
as well as control mice. (A) 1X105  total PEC were cultured in 96 well flat bottom plates 
for 48 hours and proliferation was measured by [3H]TdR incorporation. (B) In the same 
experiment, 1X10 5  total PEC were adhered to 96 well flat bottom plates for 2 hours, 
before removing the non-adherent cells (containing EL4 cells but not suppressive 
AAMb) to separate plates and after 48 hours, proliferation was measured by 
[3H]TdR 
incorporation. (C) In the same experiment, the adherent PEC from B were co-cultured 
with 5x10 4  fresh EL4 cells and after 48 hours, proliferation was measured by [3H]TdR 
incorporation. Data shown are the mean of quadruplicate wells for individual animals. 
Horizontal bar indicates the mean of the separate experimental groups. 
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Because the total PEC population would have both suppressive macrophages 
as well as EL4 cells, we decided to ask if the non-adherent EL4 cells would proliferate 
if separated from the adherent suppressive macrophages. In the same experiment, we 
adhered the total PEC population to flat bottom plates for 2 hours, before removing 
and assessing the proliferation of the non-adherent population of cells (Figure 1B). 
The non-adherent fraction containing EL4 cells from thioglycollate injected mice 
proliferated much more strongly and consistently than the non-adherent cells from 
PEC of implanted mice (Figure 1B), and also more consistently between animals in 
the same group in comparison to total PEC proliferation (Figure 1A). However, in 2 of 
the parasite implanted mice, there was some indication of EL4 proliferation when 
separated from the suppressive adherent cells (Figure 1B). 
Finally, we wanted to know if the adherent suppressive macrophages were 
influenced by the presence of in vivo expanding EL4 cells. By adding fresh EL4 cells 
(that were growing in vitro) to the adherent PEC population of the different 
experimental groups, we asked if the parasite implanted cells retained their 
suppressive activity in comparison to thioglycollate injected mice (Figure 1C). As 
expected, the thioglycollate injected mice that have not been injected with EL4 cells 
did not suppress proliferation of EL4 cells, whereas adherent PEC from parasite 
implanted mice (EL4) suppressed proliferation (Figure 1C). Implanted mice that had 
been injected with EL4 cells in vivo retained the presence of suppressive cells, 
whereas the majority of thioglycollate treated and EL4 injected mice did not suppress 
proliferation of fresh EL4 cells (Figure 1C). 
Since IL4 deficient( -'-) mice failed to generate suppressive macrophages, we 
decided to repeat the experiment by injecting EL4 cells (i.p.) into parasite implanted 
IL-4 mice as well as implanted wild type (WT) mice and thioglycollate injected mice 
(Figure 2). In this experiment, we also labelled the EL4 cells with CFSE so that we 
could track their proliferation in vivo as well as ex vivo (as described in the next 
section). This experiment again showed that injected EL4 cells that have expanded for 
7 days in vivo failed to proliferate ex vivo in parasite implanted mice (Figure 2). This 
was not the case for IL-4 deficient mice, whereby proliferating EL4 cells were 
observed ex vivo (Figure 2). 
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Figure 2: EL4 cells are suppressed ex vivo by parasite implanted WT PEC but 
not parasite implanted IL-4 deficient PEC. IL-4 deficient and C571BL6 mice 
were implanted with parasites for 3 weeks, and C571BL6 mice were injected 
(i.p.) with thioglycollate for 3 days, before being injected (i.p.) with 2x10 6 CFSE 
labelled EL4 cells. After 7 days, PEC were removed from EL4 injected mice 
(+EL4) as well as control mice (-E1,4). 1x10 5 total PEC were cultured in 96 well 
flat bottom plates for 48 hours and proliferation was measured by [3H]TdR 
incorporation. Data shown are the mean of quadruplicate wells for individual 
animals. Horizontal bar indicates the mean of the separate experimental groups. 
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These experiments were encouraging because they suggested that parasite 
implantation could have reduced the proliferation of EL4 cells in vivo to such an 
extent that they failed to proliferate ex vivo after 7 days. However, because the 
proliferation assay was still carried out in vitro, we could not be sure that suppression 
was really occurring in vivo as well. Furthermore, we found that the thioglycollate 
injected mice did not have as severe an inflammatory peritonitis (total PEC of between 
5-8 x 106  cell) as parasite implanted mice (1-2 x 10). Thus, when we plated out the 
same number of PEC for proliferation assays (Figure 1 & 2), there would be 
proportionally fewer injected EL4 cells in the PEC population of thioglycollate 
injected mice relative to the other PEC. However, this would not account for the 
differences observed between WT implanted mice and IL4 deficient mice, which 
have similar number of total PEC (Figure 2). 
CFSE labelled EL4 cells allow in vivo tracking of proliferation 
To assess the proliferation of EL4 cells in vivo, we decided to label these cells 
with the fluorescent dye CFSE before injecting them into the peritoneal cavity of 
experimental mice. CFSE stained cells allow us to assess proliferation in vivo in 2 
ways. First of all, we can distinguish between injected fluorescent EL4 cells with the 
rest of the peritoneal cell population. This would enable us calculate the number of 
EL4 cells recovered from individual mice. Secondly, the loss of fluorescence in CFSE 
labelled dividing cells is directly proportional to cell division. By measuring the mean 
fluorescence of recovered EL4 cells we can compare the number of cell divisions 
undergone by these cells in vivo. 
As described in the previous section, we injected CFSE labelled EL4 cells into 
parasite implanted 1L4 ' mice as well as parasite implanted WT mice and 
thioglycollate injected mice. 7 days later the total PEC population were recovered 
from these mice and assessed by flow cytometry (FACS) (Figure 3). This showed that 
the CFSE labelled EL4 cells (Figure 3, Ml) could still be distinguished from the 
unlabelled peritoneal cells of the control mice (Figure 3A). The number of EL4 cells 
recovered from each individual mouse could be calculated (Figure 4B) by multiplying 
the percentage of cells in Ml with the total number of PEC recovered from the mouse. 
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Figure 3: CFSE labelled EL4 cells can be detected by FACS. IL-4 deficient 
and C571BL6 mice were implanted with parasites for 3 weeks, and C571BL6 
mice were injected (i.p.) with thioglycollate for 3 days, before being injected 
_(i.p.) with 2x106 CFSE labelled EL4 cells. After 7 days, PEC were removed 
from EL4 injected mice (+EL4) as well as control mice (-EL4) and analysed 
by FACS. FACS histograms shown are from an individual animal 
(representative of 4-5 animals per group), gated by FSC and SSC to enrich for 
EL4 cells. Ml indicates the CFSE+ EL4 cells and provides the statistical basis 
for the analysis presented in Figure 4. Mean fluorescence gives an indication 
towards the number of cell divisions undergone since the CFSE labelled EL4 
cells lose half their fluorescence each time they divide (Figure 4A). The 
percentage of cells in Ml (of the ungated population) also allowed us to 
calculate the number of EL4 cells recovered from each individual mice (Figure 
4B). 
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Figure 4: EL4 cells are not significantly suppressed in vivo. Statistical analysis of 
CFSE labelled EL4 detected by FACS, as described in Figure 3. IL-4 deficient and 
C571BL6 mice were implanted with parasites for 3 weeks, and C571BL6 mice were 
injected (i.p.) with thioglycollate for 3 days, before being injected (i.p.) with 2x10 6 
CFSE labelled EL4 cells. After, 7 days, PEC were removed from EL4 injected mice 
(+EL4) as well as control mice (-EL4) and analysed by FACS. The numerical 
values for the CFSE+ EL4 cells that fall in Ml (Figure 3) are shown here. (A) 
Mean fluorescence gives an indication towards the number of cell divisions 
undergone since the CFSE labelled EL4 cells lose half their fluorescence each time 
they divide. EL4 cells in WT implanted mice appear to have undergone slightly less 
cell division. Although this is significantly different from IL-4 -I- implanted mice 
(p = 0.0373), it is not signifcantly different from thioglycollate injected mice (p = 
0.1895). (B) The percentage of cells in Ml (of the ungated population) also allowed 
us to calculate the number of EL4 cells recovered, by taking into account the total 
number of PEC from each individual mouse. There were no significant differences 
between the 3 groups. Horizontal bar indicates the mean of the separate 
experimental groups. 
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Proliferation of EL4 cells is not suppressed in vivo. 
There was some indication that EL4 cells in parasite implanted WT mice had 
undergone fewer rounds of cell division, since the mean fluorescence of these cells 
was slightly higher (Figure 3C & 4A). Although this difference was statistically 
significant in comparison to implanted IL-4 mice 4)=0.0373),  it fell short of being 
significant in comparison to thioglycollate injected mice (p=O.  1895). Furthermore, the 
differences in mean fluorescence was very small and would represent a difference in 
only one round of cell division. These results indicated that parasite recruited cells 
might slightly reduce the number of cell divisions of injected EL4 cells, but this was a 
qualitative reduction rather than an effective inhibition. Consequently, the number of 
EL4 cells recovered remained similar (Figure 4B) 
Data analysis of CFSE labelled EL4 cells showed that there were no significant 
differences in the number of EL4 cells recovered from WT implanted mice in 
comparison to implanted IL-4 mice and thioglycollate injected mice (Figure 413). In 
order to determine if the reduction in cell division was real, .a time course experiment 
would provide more information about the kinetic changes that occur in the peritoneal 
cavity. We carried out a time course experiment by injecting CFSE labelled EL4 cells 
into parasite implanted WT mice and thioglycollate injected mice and assayed over a 
period of 5 days. PEC for the first time point was collected 2 hours (Figure 5, Day 0) 
after injection of labelled EL4 cells to assess the recovery and fluorescence of 
undivided EL4 cells. PEC were collected subsequently 1, 3, 4 and 5 days after 
injection. FACS data was collected in 3 ways. Data for total PEC were collected 
without any gates, as well as gating for EL4 cells by FSC and SSC. We also adhered 
PEC for 2 hours and only FACS analysed the non-adherent fraction to enrich for data 
collection of EL4 cells. The two latter strategies enriched significantly for collection of 
EL4 datapoints and resulted in mean fluorescence data (as shown in Figure 5 and 
Figure 6A) that was consistent between individual mice as well as between the two 
different strategies of FACS analysis. 
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Figure 5: Parasite implantation does not prevent cell division of USE labelled EL4 cells in an in vivo time course experiment. FACS 
histograms show USE labelled EL4 cells (Ml) and the loss of fluorescence as they divide in vivo (i.p.). Mice were implanted (i.p.) with 
parasites for 3 weeks or injected with thioglycollate (i.p.) for 3 days before being injected (i.p.) with 2x10 6 USE labelled EL4 cells. PEC 
were removed from mice 2 hours later (Day 0), a day later (Day 1) and at Day 3, Day 4 and Day 5 (not shown), and analysed by FACS. 
Data shown from one of 2 mice per group. Histograms shown are enriched for EL4 cells (gated by FSC and SSC), FACS data also 
collected for ungated total PEC samples (to calculate EL4 cell recovery) and samples enriched for non-adherent EL4 cells (with similar 
results to histograms shown). Data analysis for the mean fluorescence (indicating cell division) and the percentage of cells in Ml 









• T h i o 
L-0 -- Implant 
1 

















DayO Dayl Day3 Day4 Day5 
Figure 6: Parasite implantation does not prevent cell division of CFSE labelled 
EL4 cells in an in vivo time course experiment. (A) As described in Figure 5, 
the loss of mean fluorescence of EL4 cells in Ml of the FACS analysis 
indicates cell division. Data shown are mean ± SD of 2 mice per group, over 
the different time points. (B) The percentage of cells in Ml (of the ungated 
population), indicates the number of EL4 cells recovered, by taking into 
account the total number of PEC from each individual mouse. Data shown are 
mean ± SD of 2 mice per group, over the different time points. 
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We found that EL4 cells divided at a relatively similar pace over time, in the 
peritoneal cavity of parasite implanted mice and thioglycollate treated mice, and there 
were no significant differences in the mean fluorescence of these cells over time 
(Figure 5 and Figure 6A). Furthermore, there were again no significant differences in 
the calculated number of EL4 cells recovered from the peritoneal cavity after injection 
(Figure 6B). The numbers of EL4 cells recovered increases over time as they expand 
in vivo, but quite a few cells might have migrated away from the peritoneal cavity or 
are destroyed by resident cells (Figure 6B). Considering that we injected 2x10 6 cells 
(i.p.), the numbers that we recover from the peritoneal cavity are very small (starting at 
5x104). 
These results suggest that while suppressive macrophages induced by B.malayi 
can suppress the proliferation of EL4 cells that are co-cultured in vitro very 
effectively, they are unable to prevent the in vivo expansion of these cells in the 
peritoneal cavity. 
Suppressive AAM cannot prevent MIIC mediated host rejection 
Since the suppressive macrophages induced by B. malayi exhibit properties 
that suggest immuno-modulatory function, such as the ability to block proliferation of 
T cells and induce Tb2 differentiation of naïve T cell, we decided to investigate 
whether the they could prevent MHC mediated rejection. We purified F4/80 cells 
from resident peritoneal cells from control CBAICa mice, as well as from PEC of 
parasite implanted CBAICa mice. .,F4/80+ cells were labelled with CFSE and injected 
into the peritoneal cavity of either allogeneic BALB/C mice or syngeneic CBA/Ca 
mice. Since the F4/80 maccrophages do not proliferate, they should retain their CFSE 
stain for a considerable period of time. 3 weeks later, we removed the peritoneal cavity 
cells and analysed for the presence of CFSE stained cells by FACS. In the control 
mice, where the F4/80 cells from parasite implanted CBA/Ca mice had been 
transferred back into naïve CBA/Ca mice, we could detect the presence of CFSE 
labelled cells (Figure 7A). This demonstrated that CFSE stained cells could be 
detected after 3 weeks and that at least some of the F4/80 cells remained in the 
peritoneal cavity and did not migrate away. As expected, resident F4/80 mice from 
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control CBA/Ca mice were rejected when transferred into BALB/C mice, since no 
CFSE cells were detected (Figure 7B). Unfortunately, this was also the case for 
suppressive F4/80 macrophages from parasite implanted mice (Figure 7C). This 
experiment clearly showed that the suppressive macrophages did not have the 
immuno-suppressive capabilities of preventing MHC mediated rejection. 
I 
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Figure 7:Suppressive macrophages cannot prevent MHC mediated rejection. F4/80+ 
purified macrophages from PEC of control CBA/Ca mice and parasite implanted 
CBAJCa mice were labelled with CFSE and transferred into the peritoneal cavity of 
naïve BALB/C mice (B & Q. 1x10 6  cells were transferred into each mouse. As a 
control, F4/80+ purified macrophages from PEC of parasite implanted CBA/Ca mice 
were transferred into naïve CBA/Ca mice (A). After 3 weeks, total PEC population 
of the BALB/C (B & C) and CBA/Ca (A) mice were removed and assayed by FACS 
for the presence of CFSE+ macrophages. Data shown is from one mouse of several 
in each group, as shown besides the figures, all of which gave identical results. 
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AAM and H-Y antigen mediated host rejection 
Since suppressive macrophages could not prevent MHC mediated rejection, 
we investigated whether they could prevent rejection as a result of minor 
histocompatibility antigen differences. To investigate the male HY antigen mediated 
rejection, we implanted parasites into male and female CBAICa mice and purified the 
F4/80 cells from these mice 3 weeks later. As a control, we also purified F4/80 cells 
from resident peritoneal cells from male mice. All the F4/80 cells were then labelled 
with CFSE before being transferred into recipient mice. We injected 1 x 106  F4/80 
cells from resident male peritoneal cells into the peritoneal cavity of naïve female mice 
(n = 3). We then injected I x 106  F4/80 cells from parasite implanted female mice into 
the peritoneal cavity of naive female mice (n = 5). We also injected 1 x 10 6  F4/80+  
cells from PEC of parasite implanted male mice into peritoneal cavity of naïve female 
mice (n = 5). We also decided to inject the same number of F4/80 cells from parasite 
implanted male mice into the footpads of naïve female mice (n = 5), because we hoped 
that the macrophages would migrate to the popliteal lymph nodes and have a better 
chance of encountering naïve T cells than in the peritoneal cavity. 
Almost 4 weeks later (26 days), we removed either the PEC or the popliteal 
lymph nodes from the recipient mice and analysed the cells by flow cytometry. 
Unfortunately, the popliteal lymph nodes of recipient female mice, which had received 
footpad injections of macrophages from parasite implanted male mice, did not contain 
any CFSE+  cells at all. The suppressive macrophages had clearly not migrated to the 
lymph nodes as expected. Furthermore, CFSE cells were observed in the control 
group of female mice (Figure 8a, n = 3/3), which had received resident macrophages 
from male mice, and had therefore not rejected these macrophages as a result of HY 
mismatch. Hence, it was no surprise that the suppressive macrophages from parasite 
implanted mice were also not rejected from recipient female mice (Figure 8c, n = 515 
male—*female, Figure 8b, n=5/5 female—)female). Due to the absence of rejection in 
the control group, the question of whether parasite recruited suppressive macrophages 
can prevent minor histocompatibility antigen mediated rejection remains uncertain. 
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Figure 8: HY mediated rejection does not occur in CBA/Ca mice. F4/80+ purified 
macrophages from PEC of control CBA/Ca mice and parasite implanted CBAICa mice were 
labelled with CFSE and transferred into the peritoneal cavity of male or female CBA/Ca 
mice. lx 106  cells were transferred into each mouse. After 4 weeks, total PEC population of 
the recipient mice were removed and assayed by FACS for the presence of CFSE+ 
macrophages. Data shown is from one mouse of several in each group, as shown besides the 
figures, all of which gave identical results. 
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Discussion 
We have found that the recruitment of suppressive macrophages by 
implantation of B. inalayi into the peritoneal cavity of mice does not prevent the 
proliferation of EL4 cells in vivo. However, this is not due to the differentiation of 
mutant EL4 cells that are no longer susceptible to macrophage suppression, because 
the injected EL4 cells remain suppressed when they are cultured in the presence of 
suppressive macrophages ex vivo from parasite implanted animals. There is also no 
indication that the injection of EL4 cells into the peritoneal cavity of parasite 
implanted mice will result in the loss of suppressive macrophages, since adherent PEC 
from these mice retain the ability to suppress proliferation of new EL4 cells that are 
co-cultured in vitro. It is possible that EL4 cells are simply too aggressive and the 
peritoneal cavity is too open a space for sufficient cell-cell contact to occur. 
These results suggest that suppressive macrophages can only inhibit the 
proliferation of cells that are in close contact, as would be expected from a receptor 
mediated mechanism of proliferative suppression. In the peritoneal cavity, EL4 cells 
that do not come into contact with suppressive macrophages, or migrate away from 
suppressive macrophages, would not be preventing from dividing. This is also 
consistent with the observation that suppressed cells can recover from proliferative 
inhibition after being removed from contact with suppressive macrophages. These 
results imply that suppressive macrophages would not be effective in the prevention of 
tumour proliferation, especially after metastasis. The suppressive effect is restricted to 
cells that are directly in contact with the macrophages, for example, in the context of T 
cell/APC interaction. 
- 	 It was perhaps too optimistic to predict that the suppressive macrophages could 
prevent allogeneic rejection, because approximately 2-10% of T cells are alloreactive 
(Beretta et al., 1986; Lindahi and Wilson, 1977a; Linclahi and Wilson, 1977b), 
whereas T cell frequencies specific for an infectious organisms is between 1 in l0 -
-1 0. Interestingly, it is still unclear why there is such a high frequency of alloreactive 
T cells and hence such a vigorous rejection response. Since the suppressive 
macrophages could not prevent MHC antigen mediated rejection, we decided to turn 
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to minor histocompatibiity antigens differences, which are analogous to foreign 
peptide fragments that are presented on host MIHC-molecules. The H-Y male 
transplantation antigen serves as a convenient model for our analysis (Simpson et al., 
1997). Unfortunately, due to my ignorance I did not realise that the CBAJCa strain, 
like other H-2' strains, are probably non-responders in terms of H-Y mediated 
rejection (Simpson et al., 1997). We are currently repeating these experiments using 
C57/BL6 (H2)  mice, which are well characterised in terms of being able to rapidly 
reject male skin grafts. We will also transfer PEC from EL-4 -1- parasite implanted mice 
to compare rejection rates with suppressive macrophages from WT mice. 
4/ 
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Chapter 7 
MOLECULAR CHARACTERISATION OF AAM 
AND THE IDENTIFICATION OF IL-4 DEPENDENT 
GENES? 
Summary 
In order to identify the suppressive mechanism, we decided to take a molecular 
approach towards characterising the suppressive AAM recruited by B. malayi. 
cDNA libraries were constructed from suppressive F4/80 macrophages purified from 
parasite implanted IL-Y' mice and non-suppressive macrophages from parasite 
implanted IL-4 mice. An expressed sequence tag (EST) approach was taken to 
analyse genes expressed by these 2 macrophage populations. 252 clones were 
sequenced from the suppressive macrophages and 213 clones were sequenced from the 
non-suppressive macrophages. This analysis highlighted a number of interesting genes 
that led to further analysis. Furthermore, we constructed a subtractive cDNA library 
using 2 rounds of subtraction of photo—biotinylated non-suppressive EL-4 -1- RNA from 
the WT suppressive macrophage cDNA. Between 10-20,000 primary recombinant 
were obtained. 700 clones were picked and screened for inserts. 400 clones had inserts 
greater than SOObp. 176 clones were screened for differential expression of which 22 
clones potentially showed higher expression in the WT macrophages and were 
sequenced. 5 of these clones represented transcripts of a gene that has very recently 
been described as FIZZ 1, and is an abundantly expressed protein found in the 
bronchoalveolar lavage fluid (BALF) of ova-induced asthmatic mice, which affects 
neuronal function. This gene was also identified as being potentially differentially 
expressed from the EST analysis of IL-5' and IL-4 -1- macrophages. Our gene 
expression studies suggest that IL4 dependent macrophages that have evolved to play 
a role in expulsion of nematodeparasites, could induce changes in the responsiveness 
of smooth muscle cells, whióh is an important feature of clinical asthma. These 
preliminary studies encourage a more detailed genomic characterisation of the 2 
different macrophage populations. 
Introduction 
In the previous chapters I have discussed the IL-4 dependent suppressive 
mechanism that is exerted by the macrophages induced by Brugia malayi. In order to 
identify this suppressive mechanism, as well as to describe IL-4 dependent genes that 
are expressed in these suppressive macrophages, I decided to embark on a molecular 
biology strategy. This is in part due to the close proximity to labs that have expertise in 
undertaking genomic approaches towards answering biological questions. The 
revolution in sequencing technology has made such approaches both relatively easy as 
well as cost effective. In order to be able to compare genes expressed in suppressive 
macrophages with non-suppressive IL-4 macrophages, I constructed 2 different 
cDNA libraries. I chose to construct a cDNA library of suppressive macrophages from 
parasite implanted IL-5' mice in order to reduce the possibility of contamination with 
eosinophils. I also constructed a cDNA library from non-suppressive EL-4 -/-  
macrophages. 
Since all cells within an organism contain the same genetic information, it is 
the variation in gene expression that defines the phenotypic characteristics of a 
particular cell type. This fundamental aspect of biology is a crucial factor in our 
understanding of developmental biology, oncogenesis as well as immune function. 
Thus, several techniques have been invented to identify tissue specific gene 
expression. These are "differential display" (DD), subtractive hybridisation (SD), and 
more recently, SAGE (or serial analysis of gene expression) and DNA microarrays. 
However, a direct random sequencing approach can also be very informative. 
An expressed sequence tag (EST) strategy is a very rapid and informative 
technique that is useful for analysing gene expression of specific cells or organisms 
(Adams et al., 1991). Randomly selected clones from a cDNA library are sequenced 
once only. By carrying out a non-bias survey sequencing expedition, we can identify 
abundantly expressed genes at random. This is essentially an indirect survey of a gene 
expression profile from a particular cell type or developmental stage in an organism. 
At the NCBI depository of EST sequences, they have set up a web based comparitive 
tool that is called digital differential display (DDD), which essentially relies on the 
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Fisher's exact test for a statistical comparison of the representation of genes in 
different sets of cDNA libraries (http://www.ncbi.nlm.nih.gov/CGAP/info/ddd.cgi) . 
We decided that this was a viable strategy for a rapid comparison of abundantly 
expressed genes between the 2 different macrophage populations. However, we also 
decided that one of the more directed approaches towards establishing differential 
gene expression would be a complementary strategy. Especially since a large number 
of ESTs are necessary for statistically significant conclusions. 
One of the first techniques that became widely used for this purpose was 
invented by Liang and Pardee (Liang and Pardee, 1992), and is termed "Differential 
Display" (DD). Briefly, this PCR based technique relies on 2 sets of oligonucleotide 
primer. The first set is anchored to the poly-A tail of niRNAs and the other set is short 
(10-13bp) and random in sequence. This combination amplifies a subpopulation of the 
genes expressed and can be resolved on a DNA sequencing gel. Differences in gene 
expression would be identified as differing bands resolved on the sequencing gel, 
which can be PCR amplified further for cloning purposes. The problem with this 
technique is that it is extremely labour intensive because the differentially displayed 
bands have to be cloned individually and multiple clones from each band has to 
sequenced. Furthermore, there is a high percentage of false positive bands. Cloned 
bands are also often very short (<SOObp) and are usually in the non coding region at 
the 3' end of mRNA, which makes homology searching extremely difficult. 
Nonetheless, it has been used widely and is referred to in more than 3000 papers. 
An alternative to this approach is to use "subtractive hybridization", which is 
an even older technique and was used to identify some key genes expressed on T cells 
(Chien et al., 1984; Littman et al., 1985; Maddon et al., 1985), including CD4 and 
CD8 (Littman et al., 1985; Maddon et al., 1985). As the name suggests, this technique 
involves using a 'driver' population of RNA or cDNA to subtract away common genes 
that are also expressed in the 'tester' population by hybridization. The most recent 
variations of this technique is known as subtractive suppression hybridization (SSH), 
which is based on PCR and was developed by CLONTECH (Diatchenko et al., 1996). 
This is becoming more widely used because it is of particular advantage under 
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circumstances where the amount of RNA isolated can be particularly limiting (e.g. 
from stem cells (Phillips et al., 2000)). 
More recently, a technique known as SAGE, or serial analysis of gene 
expression, was invented by Velculescu et. al. (1995). This technique works on a 
similar principle to using EST data to profile gene expression,, since the number of 
times an EST sequence is observed reflects the expression level of a corresponding 
transcript. Genes that are highly expressed would be highly represented in a cDNA 
library. Based on the principle that short sequence tags of between 10-14bp are 
sufficient to identify unique genes, special SAGE cDNA libraries are constructed by 
ligating these short sequence tags into longer serial molecules that can be cloned and 
sequenced (Velculescu et al., 1995). Thus, a sequencing reaction that produces a read 
of 5-600bp would provide information equivalent to about 50 EST sequences instead 
of just one EST read in a conventional cDNA library. Using this technique, Hashimoto 
et. al made a comprehensive comparison of the gene expression profiles, by assaying 
in excess of 50,000 tags from (1) human monocyte, (2) macrophage matured from 
monocytes with M-CSF, (3) macrophage matured from monocytes with GM-CSF and 
(4) dendritic cells matured from monocytes with GM-CSF, IL4 and TNF-a 
(Hashimoto et al., 1999a; Hashimoto et al., 1999b). 
Another recent development to analyse differential gene expression is the 
development of DNA m.icroarray technology. The concept is simple and based on the 
hybridisation properties of DNA, but has ieal1y become feasible as a result of the 
advancement in high speed robotics. Thousands of either oligonucleotides pairs (e.g. 
by Affymetrix) or PCR product (e.g. by Incyte) of known as well as unknown genes 
(i.e. EST clusters) are spotted onto a glass substrate. RNA populations of interests are 
then usually labelled with fluorescence during conversion to cDNA, before being 
hybridised to the DNA microarrays. Specialised imaging equipment that is closely 
related to a confocal microscope is used to scan for the level of fluorescence on each 
of the spots on the array. Hence, a single experiment can produce expression data on 
thousands of known, as well as unknown genes. This is by far the most rapid way of 
characterising gene expression and has already revolutionised diagnosis of cancer 
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patients (Golub et al., 1999). However, it depends on several pieces of capital 
equipment that we do not possess at the moment. Further, the disadvantage of DNA 
microarrays is that differential expression of genes can only be characterised for 
known EST clusters. However, DNA microarray technology can be used in 
combination with clones from subtractive hybridisation libraries. Interestingly, a direct 
comparison of SAGE with DNA microarray analysis indicated that these 2 methods 
correlated quite well in terms of describing differentially expressed genes, especially 
those that are quite abundantly expressed (Ishii et al., 2000). 
Because we do not have access to the technology necessary for SAGE analysis 
or DNA microarray analysis, I decided that the most cost and time efficient strategy to 
identify IL-4 dependent genes would be to use a combination of the 'Clontech' 
SMART PCR cDNA synthesis kit and the 'Invitrogen' subtractor kit to generate a 
subtractive cDNA library. This combination relies on a simple hybridization technique 
using photo-activated biotin and phenol-chloroform extraction, with the SMART 
system for generating full length, amplified, double stranded cDNA. The PCR 
amplified cDNA can then be cloned into a mammalian expression vector using the 
highly efficient new In vilrogen TOPO TA cloning system. 
Results 
EST analysis of suppressive AAM 
Live adult B.malayi parasites were implanted into IL-5 mice and the 
suppressive peritoneal cells were removed 3 weeks later. Total RNA was extracted 
from the purified F4/80+ macrophages and a unidirectional cDNA library was 
constructed directly from total RNA using a cDNA library construction kit 
(Stratagene) with the pCMV-script mammalian expression plasmid (Figure 1). This 
library contained 5 x 10 primary recombinants. 
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1) Live adult parasites are 
implanted into the 
peritoneal cavity of IL-5' 
or 1L-4 mice for 3 weeks 
2) PEC are removed from mice 
and F4/80+ cells purified 
using magnetic beads. Total 
RNA is extracted from 
purified macrophages 
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1St strand cDNA is made 
from total RNA using an 
oligo(dT) linker primer 
containing an XhoI site. 
Synthesis is performed 
with 5-methyl dCTP to 
produce hemimethylated 
cDNA with an 
unmethylated 5' end 
+ 
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3) Plasmid unidirectional 
cDNA libraries are 
constructed into pCMV-
script mammalian expression 
vector using a Stratagene kit. 
pCMV-Script 
Vector 
2nd strand cDNA is 
made with RNaseH 
and DNA 
polymerasel and 
ligated with EcoRI 
adapters. XhoI 
digestion produces 





cDNA is protected 
from being 
digesteded by XhoI. 
+ 
XL 10-Gold ultracompetent cells 
Figure 1: Protocol for the construction of cDNA libraries from parasite recruited 
macrophages 







IL-4 -I- macrophage library 









Number of EST clones 
% of libraries 
BLASTx BLASTn 	dBEST 
(BLASTn) 
Figure 2: Data analysis of the EST sequences. The sequences from the EST 
project are sent to NCBI'for 3 different blast searches; 1) Blastn against 
genbank, 2) Blastx for protein homologies and 3)Blastn search against EST 
databases (dBest). The results from the blast searches are downloaded from 
NCBI and linked to the sequence information through a WWW table, where 
all the sequence data and blast search results can be viewed and edited 
online. Redundant clones were identified by clustering the sequences with 
'Assemblyline' software. 
MOLECULAR CHARACTERISATION OF AAMD 	 106 
Expressed sequence tags (EST) of randomly selected clones provide a 
snapshot of the abundant genes that are expressed in a particular cell type (Figure 2). 
A total of 252 clones, from the cDNA library made from suppressive AAIVICI, were 
successfully sequenced from the 5' end (Fable 1). Some of the genes highly 
represented in the library such as Arginase I and a scavenger receptor (SP-a), have 
been shown to be induced by Th2 cytokines in macrophages (Goerdt and Orfanos, 
1999). We have verified that arginase I is indeed up regulated by parasite implantation 
(Figure 3). These data supported our classification of B. malayi recruited macrophages 
as AAM. 
We also observed an abundantly expressed transcript that has no homology to 
any known sequences, and has only been submitted to the NCBI databases as EST 
sequences. We had decided to temporarily call this gene Parasite induced Novel Gene 
(PNGJ). Unfortunately, it has recently been published as FIZZ 1 (Holcomb et al., 
2000) (Genbank accession number AF205951). Further description of this gene is 
described in a following section. However, the most striking finding was the extremely 
high representation of a gene known as ECF-L/Yml/ECF-L (Jin et al., 1998) in this 
library, accounting for 8.5 % of the cDNA clones. This gene has subsequently been 
identified as an eosinophil chemotactic factor (Owhathi et al., 2000). Further 
characterisation of ECF-L/Yml is the subject of the next chapter. 
1' 
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Table 1: Abundantly expressed genes in the suppressive AAM 
Gene name Number of clones Percentage of library 
YM-1 23 8.5 
PNG1IFIZZ1 8 2.9 
Serum Amyloid A (SAA) 6 2.2 
Arginase 5 1.8 
Scavenger receptor (SP-alpha) 3 1.2 
Beta actin 3 1.2 
LFA-1 3 1.2 
Ribosomal phosphoprotein (P0) 3 1.2 
ATPase6 2 0.8 
Ferritin light chain 2 0.8 
Cytochrome c oxidase 2 0.8 
Fc gamma receptor 2 0.8 
Cysteine Rich Intestinal Protein (CRIP) 2 0.8 
EST 2 0.8 
Total 252 clones 	 ribosomal RNA =6 
Figure 3: Arginase I is upregulated by parasite implantation. 
Total RNA was extracted from PEC of control animals or animals 
implanted with B. malayi and analysed by RT-PCR After 35 rounds of 
amplification the PCR reaction was run on a 1% agarose gel for 
visualisation. While arginase I was upregulated in parasite implanted 
mice, the PCR product from the arginase II primers were non-specific. 
Further studies are necessary for the verification of arginase I 
upregulation in the absence of arginase II. 
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EST analysis of non-suppressive IL-4 macrophages 
As described in the previous section, a cDNA library was constructed from 
non-suppressive IL-4 macrophages. This library was not as good quality as the 
suppressive macrophage library and only contained 1 X 105  primary recombinants. 
Using an EST approach again, a total of 213 clones were sequenced from this library, 
which revealed a higher proportion of contaminating ribosomal RNA clones in the 
library (Table 2). Interestingly, Ymi was again by far the most abundantly expressed 
transcript, representing 4.7% of the clones. This indicated that the induction of Ymi in 
macrophages recruited by B. malayi was not IL-4 dependent, unlike the suppressive 
mechanism. Interestingly, several abundantly expressed genes in the suppressive 
macrophage dataset were not equally well represented in this EST project. However, 
due to the small sample size of the 2 EST projects, it is difficult to determine 
statistically if these differences are significant. We plan to sequence a much larger 
number of EST clones from these 2 different cDNA libraries (see Discussion). 
Table 2: Abundantly expressed genes in the non-suppressive IL4' macrophages 
Gene name 	- Number of clones Percentage of library 
YM-1 10 4.7 
Thymosin beta 4 3 1.4 
Translationally regulated transcript (21 kDa 3 1.4 
(Trt) 
ClqCchain 2 0.94 
Lactate dehydrogenase 1 2 0.94 
DORA cell surface receptor 2 0.94 
Zinc finger protein 30 2 0.94 
Ribosomal protein L7a 2 0.94 
Ribosomal protein L12 2 0.94 
Calcium/calmodulin-dependent protein kinase 2 0.94 
(CAMK1) 
Ribosomal protein L35 2 0.94 
Ferritin light chain 1 2 0.94 
Total 213 clones 	 ribosomal RNA = 20 
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Construction of subtractive eDNA library (Figure 4) 
To construct a subtractive library, total RNA was extracted from F4/80 +  
purified macrophages from PEC of either WT implanted mice or 1L4' mice. ljig of 
total RNA was converted into 1" strand cDNA using the Clontech SMART system. A 
modified oligo(dT) primer (with a specific 3' PCR primer sequence) primes the 
synthesis of 1st  strand cDNA from the mRNA portion of total RNA. When the RT 
reaches the 5' end of mRNA, the enzymes terminal transferase activity adds primarily 
deoxycytidines(C) to the 3' end of the cDNA. The CLONTECH SMART oligo 
contains an oligo(G) sequence at it's 3' end, which base-pairs with the dCTP stretch 
and creates an extended template for the RT to continue replicating until it reaches the 
end of the SMART oligo. This results in full-length cDNA that contain the complete 
5' end of the mRNA as well as incorporating sequences that are complemetary to the 
SMART oligo. These sequences can be used to prime the amplification of full length 
cDNA together with the additional sequences incorporated into the oligo(dT) primer. 
Only full length transcripts that have incorporated the SMART oligo sequence will be 
amplified. This is an ideal system to amplify the rare transcripts that remain after 
subtractive hybridisation of the I st strand cDNA made from suppressive WT 
macrophages with the non-suppressive IL-4 ' macrophages. 
After the synthesis of first strand cDNA from WT macrophage, 2 rounds of 
subtractive hybridisation were undertaken with 20 times the amount of IL-4' 
macrophage RNA (20j.tg) as was used in the 1st  strand synthesis reaction of WT 
macrophage RNA. After 2 rounds of subtractive hybridisation and phenol-
choloroform extraction, the remaining single stranded cDNA was PCR amplified for 
25 cycles. The PCR products were then size separated on a GIBCO sepharose size 
selection column, which removes DNA fragments of less than 500bp. We cloned the 5 
different size selected fractions separately in order to reduce cloning bias of small 
DNA fragments. Since the subtractive template was PCR amplified with TAQ 
polymerase, which adds a single deoxyadenosine (A) to the 3' end of the product, the 
most efficient technique is to use the TOPO cloning system by Invitrogen to clone the 
subtracted/amplified cDNA. This technology relies on the ligation activity of 
topoisomerasel that is attached to the linearized "activated" TA vector, which enables 
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greater than 95% efficiency.of recombinant cloning in 5 minutes. The ligated plasmids 
were then transformed into XL-10 gold ultracompetent cells from Stratagene. Using 
this combination of kits, I managed to generate a combined subtractive cDNA library 
with between 10-20,000 primary recombinants. 
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Figure 4: Strategy for the construction of an 
IL-4 dependent subtractive cDNA library. 
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Analysis of subtractive eDNA library 
We picked 700 clones from the subtractive library and screened for inserts by 
PCR. Between 60 and 70% of the clones had inserts greater than 500bp and were 
selected for subsequent analysis. PCR products from approximately 400 clones were 
blotted onto nitrocellulose membranes to form self-made macro-arrays to analyse 
differential gene expression and to test the efficiency of the subtraction procedure. Due 
to the limitations of time, only 2 nitrocellulose membranes were analysed (Figure 5), 
representing 176 clones. Radioactively labelled ls  strand cDNA was made through a 
RT reaction with 32P-dCTP, from total RNA of PEC from WT mice and PEC from IL-
4 mice. RNA from total PEC were used instead of F4/80 purified macrophages due 
to the limitations of material, especially since this was intended to be a preliminary 
analysis. The cDNA probes were used to probe 2 duplicate nitrocellulose membranes, 
one for WT PEC and the other for IL-4 PEC. From this preliminary analysis, 22 
clones showed potential for being more highly expressed in WT PEC in comparison to 
IL-4' PEC, and the PCR products were selected for sequencing. 
It has not been technically possible to sequence PCR products through the 
poly(A) tail on the 3' end of transcripts. Since the subtractive cDNA library was not 
cloned unidirectionally into the plasmid vector (unlike the conventional cDNA 
libraries), we encountered the problem of having 50% of the transcripts cloned in the 
wrong orientation. In order to circumvent this problem, I designed a special 
sequencing primer (SMART seq primer) that incorporated the dCTP stretch resulting 
from the terminal transferase activity of RT when it reaches the end of mRNA, and 
should be restricted to only the 5' ends of all the transcripts that have been cloned. The 
3 additional base pairs of deoxycytidines (C), with an additional degenerate base, was 
sufficient to prime 5' specific sequencing reactions, thus enabling us to sequence all 
the PCR products from the 5' end of the transcript using the same primer irregardless 
of which orientation the transcript had cloned into plasmid vector. This primer (5'-
AAC GCA GAG TAC GCG GG (AGCT)-3') will be used to sequence all the 
differentially expressed clones from the subtractive library. 
MOLECULAR CHARACTERISATION OF AAMCb 	 113 
WT 
41 
Blot 1 	 Dositie  Blot 2 	 positi1e 
V 
IL-4- .f•. -.•t. 
-' 
•_:.- 
• • 4 0 I. 	• • - 
: A 41L  
Figure 5: Blots hybridised with first strand cDNA of peritoneal cells from implanted WT 
and IL-4 Brugia-implanted mice and exposed to the phosphoimager. Positive controls 
included 3-actin, YM- 1 and 02 microglobulin. * indicates clones selected for sequencing. 
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Of the 22 clones we sequenced (Table 3), 5 clones represented PNGJ/FIZZJ 
and 2 clones represented serum amyloid A3 (SAA3). Both of these genes were highly 
represented in the suppressive macrophage library (Table 1), but not found in the non-
suppressive IL-4 deficient macrophage EST project (Table 2). This result suggested 
that a combination of EST sequencing and analysis of the subtractive library would 
produce complementary data. However, from this preliminary screen of the subtractive 
library, we also picked up clones representing f-actin and 02-microglobulin, which 
should not be differentially expressed between the 2 different macrophage 
populations. This could be the result of screening with cDNA isolated from total 
peritoneal exudate cells instead of purified macrophages. It also suggested that we 
should refme our differential screening for the future. 
Table 3: Potentially differentially expressed clone from the subtractive library 
Genes potentially upregulated in AAM Frequency 
PNGJ/FIZZJ 5 
Serum amyloid A3 2 
BAC 271B7 chromosome X Gabre gene 1 
f3-Actin 1 
I2-microglobu11n 1 
Cyclin ania-6b 1 
Cysteine-rich intestinal protein 1 
Leukotriene C4 synthase 1 
Mitochondrial protein 1 
Ribosomal protein S7 1 
Ribosomal protein Si 8 1 
Failed Sequences 6 
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PNG1/FIZZ1 
PNGJ/FIZZJ (Figure 6) was highly represented in the suppressive macrophage 
library (almost 3% of the library) and represented the second most abundantly 
expressed gene after Ym1IECF-L. Furthermore, this gene was not found in the EST 
project on the non-supressive IL4 deficient macrophages. It was also highly 
represented in the subtractive cDNA library. All this evidence clearly suggests that this 
abundantly expressed gene is IL-4 dependent. Preliminary RT-PCR analysis by Meera 
Nair has confirmed that this gene is indeed upregulated in WT suppressive 
macrophages, athough it is also expressed at a basal level in resident peritoneal cells as 
well as non suppressive IL-4' macrophages. 
Since this protein did not have any clear homologues via the basic BLAST 
searches, I decided to utilise a number of Web based bioinformatic tools for protein 
property predictions to analyse the amino acid sequence of this novel EST. The amino 
acid sequence was submitted for simultaneous prediction by several servers via the 
"Predict Protein" Website (http://dodo.cpmc.columbia.edulpredictprotein ). Using the 
SignaiP WWW server (http://www.cbs.dtu.dk/services/Signalp/)  (Nielsen et al., 1997), 
a clear signal peptide was predicted with the most likely cleavage site being between 
amino acids at position 23 and 24 (VNT-DE) (Figure 7). 
A PRO SITE motif search (http://www.expasy.chlprositel) revealed potential 
protein kinase C phosphorylation sites at positions 57 (SVK) and 104 (TAR). The 
serine at position 57 was also predicted to be phosphorylated by the NetPhos server. 
Another PROSITE predicted motif is the presence of a N-myristoylation site at 
position 70 (GMTATG), with the prediction pattern being 
GEAEDRKI{PFYWI.{2}[STAGCN] ['P]. Serine residue number 47 is predicted to be 
0-glycosylated by the NetOglyc WWW server, which produces neural network 
predictions of mucin type GalNAc 0-glycosylation sites in mammalian proteins. 
FIZZ] has also been identified as a major protein band, from SDS-acrylamide 
gel analysis, of bronchoalveolar lavage fluid (BALF) from mice with experimentally 
induced asthma (via ovalbumin). Expression of this gene was confirmed to be 
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upregulated in the bronchial mucosal epithelial cells during pulmonary infammation. It 
is expressed at a low level in small clusters of epithelial cells in a control lung. The 
authors suggest that this protein could be involved in modulate neuronal function, 
because it antagonises the neurotrophic effect of NGF in vitro (Holcomb et. al., 2000). 
It is important to note that Holcomb et.al . did not find the expression of this 
protein in the alveolar macrophages of the inflammed lung. Interestingly, Lee et.al . 
have described lung interstitial F4/80+ macrophages in another experimentally 
induced asthma model, which share many similar properties to our suppressive 
macrophages. This is more evidence that AAM recruited in parasitic nematode 
infection could be very similar to the ones induced under type 2 conditions in 
pulmonary inflammation. 
10 	20 	 30 	 40 	 50 	 60 
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M K T T T C S L L 	I C 	I 	3 
	
70 	 80 	 90 	 100 	 110 	 120 
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AAG GTC AAG GAA CTT CrT 0CC AAT CCA OCr AAC TAT CCC TCC ACT GTA ACG AAG ACT CTC 
C 	K 	E 	L 	L 	A 	N 	P 	A 	N 	Y 	P 	. 	T 	I 	T 	K 	T 	I. 
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250 	 260 	 270 	 280 	 290 	 300 
ACT 000 TOT OCT TOT GGC rrr 0CC TOT GGA TCT TOG GAG ATC CAG AGT GGA OAT ACT TGC 
T 	 A C 	 A C 	c3' S 	W 	El 	Q 	S 	G 	P 	TC 
310 	 320 	 330 	- 	340 	 350 	 360 
AAC TOC CFG TOC TTA CTC GTE GAC TOG ACC ACE 0CC CGC TOC TGC CAA CTG TCC 
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370 	380 	390 	400 	410 	420 	430 	440 
TAAGAATGAAGAGGTGGAGAACCCAGCTTTGATATGATGAATCTAACAAAAACTGCAGTCTCAATTTGGAAATCTG 
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ACTCATGTGCCTTTAAATGTGTTCATATTGCCCATTTACCCTGCTTCrTGAAATGCTTCTTGAAAAATAAAGACAA 
520 	 530 	540 
ATETGCATGTGAAAAA AAAA 
Figure 6:Nucleotide and protein sequence of PNG1/FIZZJ. The protein is predicted 
to have ill amino acids, which is consistent with protein sequencing data from the 
identification of FIZZ1 protein (AF205951) as a major protein band in the 
bronchoalveolar lavage fluid in murine ova-induced asthma There are 2 other 
homologous mouse genes and two human genes have been identified (Holcomb et. 
al., 2000). 
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Figure 7: (A) PNGI /FIZZ 1 has a clear ,  signal peptide, with the most likely 
cleavage site at position 23 and 24. This signal peptide was predicted using the 
SignaiP WWW server. The signal pëptide prediction is consistent with the 
prediction of transmembrane domains (B), which was predicted using the 
"predict protein" webserver. 
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Discussion 
The primary aim of this chapter was to begin characterising the genes that are 
expressed by AAMO recruited by B.malayi. Although small, the EST data sets have 
already provided us with significant information about the biology of these 
macrophages. More importantly, it has highlighted a number of extremely interesting 
genes that could play an important role in the biological function of these 
macrophages. It led to our significant interest in the Ym1IECF-L gene, although 
unfortunately, the publication describing the characterization of this gene as a 
eosinophil chemotactic factor occurred during the midst of our experiments (Owhashi 
et al., 2000). However, this initiated a whole new set of experiments that are described 
in the next chapter. 
We are also now very interested in the expression and function of Arginase I 
(Figure 3), which appears to be one of the most robust markers for alternative 
activation. Munder et.al . found that Th2 cells induced high levels of arginase in 
macrophages that were used as APCs to present antigen. This was in contrast to Thi 
cells, which induced upregulation of NOS. Interestingly, the effects of the Th2 cells 
were much higher than individual Th2 cytokines alone, suggesting a synergistic effect 
of multiple factors produced by Th2 cells. Furthermore, it was only the hepatic 
arginase I isoform that was induced by Th2 cells, and not the extrahepatic arginase II. 
This was consistent with our findings since only arginase I is highly represented in the 
suppressive macrophage library and appears to be upregulated by parasite 
implantation. / 
From the preliminary analysis of the subtractive library, we established that 
only 10-20% of the clones are genuinely differentially expressed. Although imperfect, 
this is likely to be a substantial enrichment of differentially expressed genes. In order 
to conserve sequencing resources, we will screen the recombinant clones for 
differential expression before sequencing them individually. This is unfortunately a 
more labour intensive process than simply sequencing all the clones from the 
subtractive library. 
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The results from the subtractive library are gratifying because the data obtained 
so far from the preliminary characterisation of the subtractive library seems to be 
consistent and complementary with the EST strategy. The genomic information that 
we have obtained so far is on an extremely small scale and firm conclusions cannot yet 
be drawn from our dataset. However, the dataset as it is opens the way for a more 
detailed analysis of IL-4 dependent genes in these suppressive macrophages. Due to 
the time limitations of this PhD, this represents the final touch to a 3 year period of 
work. However, it seems more like the beginning, rather than an end of a scientific 
study. Thus, the future direction of this work will be discussed in greater detail in the 
discussion 
The original aim of this project was the identification of the suppressive 
molecule(s) that are involved in the process of proliferative suppression using a 
molecular strategy. The data presented in this chapter as well as the next chapter 
illustrates that by taking this approach we are beginning to understand a lot more about 
the biology of our suppressive macrophages than was originally intended. This has 
offset our original trepidation about whether taking a molecular approach was the most 
suitable way towards identifying the suppressive mechanism, compared to taking a 
biochemical approach. There was a substantial likelihood that the suppressive 
molecule(s) were not expressed on IL-4 -/- macrophages as a result of biochemical 
differences instead of differences in gene transcription. The molecular approach was 
chosen due to the availability of technical expertise in our surrounding environment. 
Although we might not ultimately identify the suppressive mechanism using this 
approach, at least we would have 'been able to glean some exciting information about 
alternatively activated macrophages. With the revolution in proteomics coming around 
the corner, we could be in a position where we could take advantage of this alternative, 
but equally powerful, biochemical approach towards identifying the suppressive 
molecule in the near future. 
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Chapter 8 
DOES AAM PLAY A ROLE IN EOSINOPHIL 
RECRUITMENT? 
(The work described in this chapter was the result of a close collaboration between 
Franco Falcone, Xingxing Zang and myself) 
Summary 
The recruitment of eosinopbils is a common feature of Th2 mediated inflammatory 
responses against nematode infections as well as allergic responses such as airway 
inflammatory diseases. By characterising gene expression in AAM recruited by 
Brugia malayi using an expressed sequence tag (EST) strategy, we found a dramatic 
upregulation of a novel eosinophil chemotactic factor (Yml/ECF-L), which correlates 
with the recruitment of eosinopbils by the parasite. Recently, it was found that B. 
ma!ayi secretes a homologue (Bm-MIF- 1) of the human proinflammatory cytokine 
macrophage migration inhibitory factor (M1IF). Administeration of Bm-MIF-1 on its 
own was able to reproduce the effects of live implanted adult parasites, leading both to 
a marked recruitment of eosinophils and the upregulation of Ym1IECF-L. When the 
enzymatic activity of Bm-MIF-1 was abolished by mutating the aminoterminal Proline 
to Glycine (Bm-MIF-1G), this abolished the induction of Yml/ECF-L in macrophages 
as well as the recruitment of eosionophils. This data suggests that macrophages could 
mediate the crosstalk between parasites and recruited eosinopbils. 
Introduction 
Infection with nematode parasites is associated with an immune response 
resulting in elevated IgE, systemic eosinophilia and mast cell proliferation (Maizels et 
al., 1993). These features reflect a polarized type-2 T-cell response with 
overproduction of the cytokines IL-4, IL-5 and IL-13, which is reminiscent of Th2 
mediated allergic airway inflammation (Wills-Karp, 1999). Another well established 
feature of the mammalian immune response to nematode infection is the recruitment 
of eosinophilic granulocytes to host tissues characterised by intense, focussed 
eosinophilic infiltrates often associated with extensive tissue damage. Despite the 
importance of this phenomenon, the molecular basis of eosinophil recruitment in 
helminth infection is still poorly understood (Maizels et al., 1993). It is currently 
thought that the recruitment of eosinophils to the tissues may be the result of a 
complex host-parasite interaction in which the parasite induces the production of 
chemotactic factors (such as chemokines) and cytokines by host cells and/or secretes 
products that directly target host granulocytes. 
After living for 3 weeks in the peritoneal cavity of mice, Brugia malayi 
induces an almost 10 fold increase in total cell numbers (3.1 ± 0.8 x 107  ) recruited into 
the peritoneal cavity of implanted mice, in comparison to control mice (3.8 ±1.1 x 
106). The peritoneal exudate cells from implanted mice is composed of a mixed 
population consisting mainly of macrophages (74.3 ± 3.5%) and eosinophils (11.7 ± 
0.5%) (MacDonald et al., 1998). There is a 40 fold increase in the total number of 
eosinophils in implanted mice (1.7 ± 0.8 x 106)  in comparison to control mice (4±2 x 
10). This situation is reminiscent of a condition caused by this parasite in a number of 
infected individuals known as Tropical Pulmonary Eosinophilia, which is 
characterised by a marked infiltration of eosinophils into the lung tissues (Ottesen and 
Nutman, 1992). 
In order to determine the kinetics of cell recruitment into the peritoneal cavity 
of mice, Andrew MacDonald performed a time course experiment to monitor cell 
recruitment after exposure to B. malayi for different periods of time (Figure 1A & B). 
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There was a striking neutrophilia observed immediately after implantation, which 
reduced steadily until neutrophils were no longer detectable 14 days after 
implantation. In contrast, eosinophil infiltration was observed slightly later, with 
numbers peaking at 7 days after implantation and remaining stable until the 
experiment was terminated at 21 days. The number of macrophages increased steadily 
over time to reach maximum levels after 2 to 3 weeks. 
To assess if the recruitment of eosinophils is dependent on the 112 cytokines 
IL-4 and IL-5, Andrew MacDonald implanted parasites into mice genetically deficient 
for IL-4 (Figure 1C) and IL-5 (Figure 1D) for 3 weeks before recovering the PEC. As 
expected, there was significantly fewer eosinophils recruited into the peritoneal cavity 
of 1IL4 mice. The recruitment of some eosinophils probably occurs via 
compensatory mechanisms (e.g. via IL-13). IL-5' mice failed to recruit significant 
number of eosinophils to the site of parasite implantation. This data shows that the 
recruitment of eosinophils in this nematode parasite model is partly dependent on IL-4 
and completely dependent on the presence of host IL-S. 
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Figure 1: B. malayi induces eosinophil recruitment via IL-4 and IL-5 dependent mechanisms. (A) Time course of cell 
recruitment into the peritoneal cavity after parasite implantation. (B) Cellular composition of PEC populations during a 
time course of cell recruitment. (C) Eosinophil recruitment into the peritoneal cavity of implanted 1L4-/- mice in 
comparision to WI mice. (D) Eosinophil recruitment into IL-5 -I- mice in comparison to WT mice. 
In this chapter we present evidence for a link between the recruitment and 
activation of AAM by this nematode parasite and the recruitment of eosinophils to 
the site of inflammation. Furthermore, we show that a cytokine homologue secreted by 
the nematode parasite (Bm-MIF) is directly involved in activating macrophages and 
recruiting eosinophils. 
Macrophage migration inhibitory factor (tvllF) was identified as a cytokine 
with the ability to inhibit monocyte migration in vitro. More recently, it has emerged 
as an important cytokine involved in innate immunity and the control of an 
inflammatory response. Interestingly, a homologue of this cytokine has recently been 
identified in Brugia malayi (Pastrana et al., 1998) and has been shown to be 
chemotactic for human monocyte/macrophages (Pastrana et al., 1998; Zang et al., ). 
An unusual feature of this cytokine is that both the mammalian and nematode forms 
have enzymatic activity (Zang et al., ). Although the natural substrate is not known, 
human MIF has been shown to have tautomerase activity on 2 synthetic substrates. 
The tautomerase activity of the human MIF is crucially dependent on the conserved 
proline residue at position 2 (Swope et al., 1998). Mutation of proline to glycine at this 
residue substantially reduces catalytic activity as well as neutrophil priming activity 
(Swope et at., 1998). Xingxing Zang has shown that mutation of the same proline in 
Bm-MTF-1 also abolishes exzymatic activity of this molecule (Zang et al., ). In this 
chapter, we show that the B. malayi homologue of this molecule induces eosinophil 
recruitment in vivo when injected,into the peritoneal cavity of mice and the mutation 
of the conserved proline residue to glycine eliminates this activity. We also find that 
Bm-MIF activate macrophages to produce a novel eosinophil chemotactic factor 
(ECF-L) that is also known as Ymi (Jin et al., 1998; Owhashi et at., 2000). 
Owhashi et.al . had previously shown that an eosinophil chemotactic factor was 
produced by CD8 T lymphocytes in an antigen specific manner after infection with 
Schistosoma japanicum and Toxocara canis (Owhashi et at., 1998; Owhashi and 
Nawa, 1987). This factor was biochemically purified and shown to be the same protein 
as Ymi (Owhashi et at., 2000). ECF-L/Yml was shown to be chemotactic for 
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eosinophils both in vitro as well as in vivo. Apart from eosinophils, ECF-L/Yml also 
attracted T cells and bone marrow cells in vitro (Owhashi et al., 2000). Interestingly, a 
separate group has found that eosinophilic crystals found in the lungs of viable 
motheaten mice (me'/me') were composed of Ymi protein (Guo et al., 2000). These 
crystals were found in the cytoplasm of alveolar macrophages and are thought to be 
similar to the Charcot-Leyden crystals in humans, which are also associated with 
eosinophil-rich inflammation of the lungs. In this study we show that Th2 driving 
nematodes induce the dramatic upregulation of Ym1IECF-L in macrophages and is 
associated with the recruitment of eosinopbils. All these data suggests that Yml/ECF-
L might be an important link between Th2 cytokine responses, macrophage activation 
and eosinophil chemotaxis. 
Results 
Ym1IECF-L is dramatically upregulated in macrophages exposed to B. 
malayi 
In the previous chapter, we described the characterisation of gene expression in 
AAM by an EST strategy. The most striking finding was the extremely high 
representation of a gene known as Ymi (Jin et al., 1998) in this library, accounting for 
8.5 % of the cDNA clones. This gene has subsequently been identified as a eosinophil 
chemotactic factor by Owhashi et. at. (Owhashi et al., 2000). The discovery that a 
novel eosinophil chemotactic factor accounted for a startlingly high proportion of the 
genes expressed in peritoneal macrophages of parasite-implanted mice was extremely 
provocative. Thus we decided to verify this finding by RT-PCR analysis of peritoneal 
cells from mice implanted withB. malayi (Figure 2). In resident peritoneal cells from 
control mice, Ymi was routinely detected at a low, basal level (lane 6). In comparison, 
implantation of mice with adult Brugia malayi resulted in the dramatic upregulation of 
Ymi expression in peritoneal cells (Figure 2A,lane 7). This result was observed in 
every individual mouse (n= 10) that we have analysed by RT-PCR. 
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Since eosinopbil recruitment as well as the immune response to parasitic 
nematodes is driven by Th2 cytokines, we assessed whether the implantation of 
parasites into mice deficient for IL-4 or IL-5 would have any effect on Ymi induction. 
To ensure that Ymi was expressed in macrophages we used biotin conjugated ct-F4/80 
antibodies and streptavidin conjugated microbeads to purify F4/80 macrophages for 
the RT-PCR analysis. As expected, macrophages from IL-5 mice showed the same 
induction of Ymi as wildtype mice, since the initial observation of Ymi expression 
was originally made through a cDNA library made from IL-5 -1- macrophages. IL-4 
deficient mice also showed the same dramatic upregulation of Yin  in macrophages. 
These data showed that the induction of Yin 1 in macrophages is not dependent 
on the Th2 cytokines IL-4 and IL-5. It also showed that induction of Ymi alone was 
not sufficient to recruit eosinophils to the site of inflammation since eosinophil 
recruitment is significantly reduced in IL-4 mice and completely absent in IL-5' 
mice. 
Bm-MIF-1 induces upregulation of Ym1IECF-LIECF-L 
Recently, Pastrana et al. found that Brugia malayi secretes a homologue of the 
human cytokine macrophage migration inhibitory factor (IvIIF) (Pastrana et al., 1998), 
and these parasitic products had measurable effects on human monocytes and 
macrophages. We asked whether Brugia malayi MIF (Bm-MIF-l) could be 
responsible for the induction of Ym1IECF-L seen in implanted mice. To mimic the 
long term effect of parasite secretions, we gave 9 i.p. injections of lj.Lg recombinant, 
endotoxin-free Bm-MTF- 1 over a period of three weeks (Figure 3). As a control for the 
experimental procedure, we treated the control group with a corresponding volume of 
sterile PBS. Three days after the last injection, the animals were sacrificed and the 
cells recruited to or resident in the peritoneal cavity were analysed by RT-PCR. 
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Injected with 1 .ig: 
Bm-MIF-1, Bm-MIF-1G, 
LPS, PBS, Hu-MIF 






Figure 3: Experimental procedure to assess the in vivo effects of Bm-MIF- 1. 1 .Lg of 
BmMIF-1, BmIvllF-1G and human MTF were injected i.p. into BALB/C mice 3 times a week 
for 3 weeks (9 injections), after which the mice were killed by cardiac puncture and PEC 
were harvested for Cytospin and RT-PCR analysis. Sera were collected from treated mice for 
analysis of antibodies. 
/ 
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Figure 4 shows the RT-PCR analysis performed with RNA isolated from 
F4/80+ macrophages purified from the peritoneal cells of mice after treatment. Bm-
MIF-1 effectively induced Yml/ECF-L, whereas Ym1IECF-L was only detected at a 
low basal level in the PBS-treated mice. Since mammalian vflF share an enzymatic 
activity with the parasitic MIF (Pastrana et al., 1998; Zang et al., ), which can be 
effectively destroyed by mutating the N-terminal Pro to Gly, we treated mice with the 
recombinant mutant Bm-MIF- 1 G with an identical protocol. Interestingly, Bm-MTF-
1G did not induce YM1/ECF-L, indicating that enzymatic activity, (or alternatively, 
the presence of an intact N-terminal Pro) is a prerequisite for effective induction of 
Ym1JECF-L. We do not think that the dramatic difference between the two 
recombinant forms could be due to an artefact such as a different folding pattern of the 
mutated recombinant protein, but truly reflects the effects of the enzymatically active 
cytokine homologue which is secreted by live Brugia malayi parasites. 
Before treatment of the animals, the native and the mutated recombinant forms 
of Bm-MTF were removed of endotoxin contaminants (below the detection limit of the 
Limulus assay). However, in order to rule out an effect of LPS contamination in 
inducing Ymi, we also treated a group of mice with LPS. As shown in Figure 4B, LPS 
was not effective at inducing Ymi in the treated mice. 
We next examined whether the three-week treatment course with rBm-MIF-1 
is necessary for effective induction of YM1IECF-LIECF-L and/or eosinopbilia (Figure 
5). Therefore, we treated mice with one single dose (10 jig) or three doses of 1 jig each 
spread over one week. The single fmjection of a high dose of rBm-MIF-1 had no effect 
(data not shown), whereas the fhree consecutive injections effectively induced Ymi 
(Figure 5). Again, neither PBS nor Bm-MIF-1G induced Yml/ECF-L (Figure 5). A 
high dose of LPS (I Ogg) also did not induce Ymi (data not shown). 
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A 
B Bm-MI17-1 Bm-IvllF-1G PBS 	- LPS 
no. Yin I+ /total no. 14/19 2/11 2/9 115 
Figure 4: RT-PCR analysis of Ymi expression from i.p. injected mice. After 35 rounds of 
amplification the PCR reaction was run on a 1% agarose gel for visualisation. 
F4/80 macrohages were purified from the PEC of mice that have been injected with 
Bm-MIF-1(a) or Bm-MIF-1G(b), and gene expression was analysed by RT-PCR. 
Macrophages from Bm-MIF-1 injected mice show a significant upregulation of Ymi as well 
as arginase I (but not arginase II), in comparison to Bm-MIF-1G injected mice. 
PEC from i.p. injected mice were analysed individually by RT-PCR. Yml+ mice are 
defined as having Ymi PCR products that were greater than 50% the intensity of actin PCR 
products by densitometry. 
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Figure 5: 1 week treatment of Bm-MIF-1 induced Ymi expression but not eosinopbil 
recruitment. (A) PEC from mice injected i.p. with 3 doses of Bm-MIF-1, Bm-MIF-1G or 
PBS over a 1 week period was analysed by RT-PCR for Ymi expression and (B) by 
cytospin analysis for eosinophii recruitment. Each lane represents an individual 
experimental animal. 
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Bm-MIF-1 induces recruitment of eosinophils 
The dramatic increase in Yin  transcription should correspond to a significant 
rise in the production of Yml/ECF-L protein. Since Ym1IECF-L recruits eosinophils 
in vitro as well as in vivo (Owhashi et al., 2000), we asked if there was any 
relationship between recruitment of eosinophils to the peritoneal cavity and the 
induction of Ymi gene expression. If there was an increase in eosinophil recruitment, 
we wanted to know if this was dependent on the enzymatic activity of Bm-MIF. 
Hence, we examined stained cytospins of cells derived from the peritoneal cavity of 
mice treated with either PBS, Bm-MIF-1 or Bm-MIF-1G and assessed the percentage 
of eosinophil granulocytes. Figure 6 shows that the 3-wk treatment of mice with rBm-
MIF-1 leads to an average of about 3 fold increase of peritoneal cosinophils compared 
with PBS or rBm-MTF-1G treated mice (p0.0001). Interestingly, although the 1-wk 
treatment with rBm-MIF-1 effectively induced YM1IECF-L, these mice did not 
display any increased eosinophil recruitment (Figure 5). This result points to a more 
complex relationship between in vivo induction of Ymi and the recruitment of 
eosinophils to the tissues. 
/ 
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Eosinophil recruitment 
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Figure 6: Bm-MIF-1 (but not Bm-IVIIF-1G) induces eosinophil recruitment into the 
peritoneal cavity. The cell composition of PEC (from mice injected i.p. over a 3 week 
period) was determined by microscopy of cyto-centrifuge preparations stained with Diff 
Quik (A). about 500 cells were 'counted from randomly selected fields per cyto-centrifuge 
preparation. Data presented is ppoled from several independent experiments. Each data point 
represents an individual animal, with the horizontal bar representing the mean of the group. - 
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Discussion 
Our results suggest that a parasite homologue of MIF could activate 
macrophages to recruit eosinophils at the local site of inflammation. Mammalian MIF 
has not been reported to have eosinophil recruitment activity (whether directly or 
indirectly), although it is produced by human eosinophils (Rossi et al., 1998). We are 
currently investigating whether this is a yet undiscovered function for MIF, which we 
have identified by studying the parasite homologue. Our preliminary studies suggests 
that human MIF does not induce eosinophil recruitment or induction of ECF-LIYm- 1 
expression (Figure 6). However, we are not confident of a positive biological effect of 
our purchased batch of human MIF. Nonetheles, these data suggests that macrophages 
could provide a crucial link between parasitic infections and eosinophil chemotaxis. 
Since the production of MIF-like enzymatic activity has been demonstrated in a 
variety of parasites (Pennock et al., 1998), ECF-L/Ym-1 induction by parasites could 
be a wide spread mechanism that results in tissue eosinophilia. 
It is interesting to note the homology of ECF-L/Ym1IECF-L with bacterial, 
plant and mammalian chitniases (Owhashi et al., 2000). Guo et al. found a 3- to 5-fold 
increase in chitinase activity in the broncho-alveolar lavage fluids from me"Ime" mice,  
which correlated with the Ym1IECF-L protein band in native electrophoresis gels 
(Guo et al., 2000). On the other hand, the sequence of ECF-L/Ym1IECF-L suggests 
that it may not possess chitinase activity due to the replacement of two residues (Glu 
and Asp by Gin and Asn), which are perfet.tly conserved in active chitinases and are 
I 
considered essential for chitinase (Owhashi et al., 2000). The biological relevance of 
this chitinase homology and/or activity remains unclear. 
Since the role of eosinophils in the host response against filarial parasites is 
unclear, it is not known whether this effect represents an immune evasion strategy of 
the parasite, or is a byproduct of an alternative effect. We have also not established 
whether there is a direct or indirect relationship between the action of BmMJF- 1, the 
activation of macrophages to produce ECF-L/Ym-1 and the recruitment of 
eosinophuls. Our results suggest more complex relationship between ECF-L/Ym-1 
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induction and eosinophil recruitment since the induction of ECF-LIYm-1 alone is not 
sufficient to recruit eosinopbils. Eosinophil recruitment only occurs after a long term 
treatment with Bm-MIF- 1 and does not occur in IL-5 4 mice, whereas ECF-L/Ym- 1 
can be induced after 1 week and is also induced in IL-5 -1- mice. Further, we also found 
induction of ECF-LIYm-1 in thioglycolate-injected animals (data not shown), which 
do not recruit eosinophils. 
In this chapter, we have shown how the characterisation of gene expression in 
macrophages recruited by B. malayi using a genomic strategy via an expressed 
sequence tag (EST) analysis has serendipitously led to the identification of a novel 
relationship between macrophage activation by MIF, and the recruitment of 
eosinophils by macrophage derived Ym1IECF-L. This illustrates the advantages of 
working in a functional post genomic era of biology. EST analysis was introduced for 
the purpose of gene discovery on a large scale. However, by doing a small EST 
analysis of a relatively uncharacterised cell type, we have identified an interesting 
relationship between a parasite gene product (also identified as part of the much larger 
filarial genome EST project), host derived macrophages and eosinophils recruitment. 
BM-MIF-J, YMI/ECF-L & EOSINOPHIL RECRUITMENT 	 136 
Chapter 9 
DISCUSSION 
Macrophages are key effector cells in many bacterial, protozoan and viral 
infections. Indeed one of the most critical functions of a type 1 immune response is the 
activation of macrophages by IFN-y. This activation is required for disease resolution 
following infection with a large number of intracellular pathogens, most clearly 
illustrated in murine models of leishmaniasis (Reiner and Locksley, 1995). The 
functional importance of macrophages in helminth infection in general and lymphatic 
filariasis in particular is far less apparent. However, the presence of large numbers of 
macrophages at the site of infection in experimental models of lymphatic filariasis has 
long implicated macrophages as important cells in the killing of parasites, the 
pathology associated with dying worms and quite possibly the immune hypo-
responsiveness associated with infection. The work described in this thesis, as well as 
previous work, has led us to believe that macrophages may be critical mediators of 
immune regulation in lymphatic filariasis. 
Using a mouse model, we have established that the filarial parasite Brugia 
malayi can recruit suppressive macrophages that are dependent on IL4 in vivo. This 
has strongly suggested that they represent an in vivo manifestation of the recently 
defined category of alternatively activated macrophages (AAM). Molecular 
characterisation of genes expressed in parasite induced macrophages supports this 
classification since many genes known to be upregulated by IL4 were expressed in 
these macrophages. Furthermore, we have shown for the first time that these AAM 
can drive Th2 cell differentiation, consistent with suggestions that they play an 
important role in the regulation of the immune response. In this discussion, we would 
like to put our findings into the general context regarding what is known about 
macrophages in filarial infection. We would like to hypothesise that while dead or 
dying worms induce the "classical" activation of macrophages and a subsequent pro-
inflammatory response, live and healthy worms secrete products that induces type 2 
cytokines and induces the differentiation of "alternatively" activated macrophages that 
down-regulate an inflammatory response. Thus, the balance between the 'classical' 
and 'alternative' activation pathways of macrophages could be an important factor in 
inflammatory pathology associated with filariasis. In this discussion, I will review all 
the work we have done and also the filarial literature that has led to this hypothesis. I 
will also present a strategy for the future in terms of characterising the AAMI) that we 
have found. 
Macrophages as effector cells in filarial infection 
Considerable in vitro evidence exists to suggest that macrophages are effective 
at killing the larval stages of filarial parasites. For example, resident macrophages 
from the peritoneal cavity of rats have been shown to kill A. viteae microfilaria in the 
presence of immune sera (Haque et a., 1980). The same result is seen with Brugia 
pahangi in jirds and mice where adherent macrophages are able to kill MCI in the 
presence of anti-microfilarial sera (Karavodin and Ash, 1982; Oxenham et al., 1984). 
One mechanism by which macrophages are able to damage an organism that they 
cannot engulf appears to be through the release of reactive oxygen species and nitric 
oxide derivatives. Two separate groups have shown that B. malayi MCI) can be killed in 
vitro by IFN-y activated macrophages and this appears to be mediated least in part by 
nitric oxide (NO) (Taylor et al., 1996b; Thomas et al., 1997). In contrast, H202 
appears to have little effect on Brugia although it does affect Onchocerca MCI (Ou et 
al., 1995; Taylor et al., 1996a). Despite the ability of activated macrophages to kill 
these parasites in vitro, filarial nematodes are remarkably resistant to a lethal hit and 
killing required sustained exposure to NO (Thomas et al., 1997). Adult parasites 
appear to be even more resistant to macrophage mediated damage than the larval 
stages (Thomas et al., 1997) perhaps due to the production of antioxidant enzymes (Ou 
et al., 1995). The evidence that filarial parasites have evolved numerous strategies to 
counter oxidative attack highlights the importance of reactive oxygen species as a 
means of immune attack (Selkirk et al., 1998). 
In vivo, B. pahangi L3 induce activation of macrophages in the peritoneal 
cavity of jirds. These macrophages have significant increases in phagocytic and 
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microbicidal activity (Jeffers et al., 1984). Further, in both the lymphatics and the 
peritoneal cavity of jirds macrophages are the dominant cell type associated with 
granulomatous lesion that forms around the adult parasites and microfilaria. The 
macrophages are observed to be adherent to the parasite surface (Jeffers et al., 1984). 
More direct evidence in vivo for a role of macrophages in resistance to infection is 
found with studies that demonstrate that age and sex-related differences mice 
susceptibility are abolished when macrophage activity is blocked by carbon particle 
injection. (Nakanishi et al., 1989). There is considerable cumulative evidence that 
macrophages together with granulocytes are important in parasite destruction. 
However, there is little information about the factors in vivo that activate macrophages 
to kill these large extracellular pathogens and despite the evidence that NO producing 
IFN-'y activated-macrophages can kill parasites in vitro, their importance in vivo 
remains unresolved. 
These studies suggest that macrophages can be activated to kill filarial 
parasites but as is so often the case, the line between protection and pathology is barely 
distinguishable. The same evidence that suggests macrophages can be activated to kill 
parasites suggests that these cells may be responsible for some of the pathology 
associated with filariasis. Inflammatory lesions in the lymphatic vessels of individuals 
infected with filarial parasites are commonly observed in both human and animal 
studies (Rao et al., 1996). The pathological granulomatous lesions that develop around 
dying parasites are predominantly comprised of eosinophils and macrophages 
(Vickery et al., 1991) suggesting'that macrophages activated by parasite infection may 
damage host tissue. 	I 
More recently, Taylor et.al . produced an important study to show that the 
intracellular bacteria (Wolbachia) present in Brugia could play an important role in 
inflammatory pathology (Taylor et al., 2000). They found that soluble worm debris 
from Brugia malayi could stimulate macrophages to produce pro-inflammatory 
cytokines such as TNF, IL-1 and NO in an in vitro assay. Using a macrophage cell line 
that was defective in binding LPS due to the lack of surface CD14, and also a mouse 
strain that had a mutation in the Toll-like receptor 4 (another LPS receptor), they 
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elegantly demonstrated that the proinflammatory stimulus was due to the presence of 
LPS. Taylor et al. hypothesize that dying (but not live worms) release LPS. This could 
account for pathology that accompanies chemotherapy as well as the fever-like 
symptoms associated with acute filarial disease (Taylor et al., 2000). 
Further evidence for macrophages as important players in the control of filarial 
infection come from studies using xid mice. CBA/N mice have a defect in the 
Bruton's tyrosine kinase (Btk) gene and a number of studies have shown that they 
have a reduced ability to clear MI as compared to wild-type CBAIJ (A1-Qaoud et al., 
1998; Mukhopadhyay et al., 1999). The assumption has generally been that the 
phenotype observed is due to defects in B cell signalling and development. However, 
Btk is expressed in both B cells and APCs of myeloid origin. Mukhopadhyay et al. 
(Mukhopadhyay et al., 1999) have demonstrated that CBA/N mice have significant 
alterations in macrophage function that could play an important role in filarial 
infection. Macrophages from CBAIN mice have a reduced capacity to produce nitric 
oxide but an enhancement of IL-12 production perhaps due to the down regulatory 
effects of NO on IL-12 induction. (Mukhopadhyay et al., 1999). Further, T cell 
responses to MI antigen in CBAIN mice are skewed toward a more type 1 immune 
response and Mukhopadhyay et al. have shown by adoptive transfer experiments that 
these alterations in cytokine responses are due to macrophages rather than B cells. So 
the long held view that the inability of xid mice to rapidly clear their microfilaria is 
due to defective antibody production may need to be reconsidered and the contribution 
of macrophages reevaluated. 
Macrophages as suppressor cells in filarial infection 
One of the most consistent findings in both human (Maizels and Lawrence, 
1991; Ottesen et al., 1977; Piessens et al., 1980) and animal (Baize et al., 1997; 
Lamniie and Katz, 1984; Miller et al., 1991; Prier and Lammie, 1988; Rao et al., 1996) 
studies is that individuals infected with filarial parasite exhibit profound defects in 
cellular proliferation. In humans, this is primarily an antigen-specific defect. However, 
in animal studies both antigen-specific and non-specific components have been 
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identified in the proliferative suppression observed following infection. Several studies 
in the experimental jird model (Lammie and Katz, 1984; Prier and Lammie, 1988) 
demonstrated that removal of plastic-adherent cell populations was able to reverse the 
proliferative defect. Similar findings have been described for human peripheral blood 
in which an adherent phagocytic mononuclear cell mediated proliferative suppression 
(Piessens et al., 1980). Although not directly demonstrated to be macrophages, the 
cells described in these studies are likely to be either macrophages or monocytes and 
strongly implicated a role for macrophages in the immune suppression observed over 
the course of filarial infection. Using an intraperitoneal (i.p.) infection model in jirds, 
C. Nasarre found that chronic infection with B. pahangi led to the deactivation of 
macrophages, as measured by their ability to kill Toxoplasma and produce TNF-a 
(Nasarre et al., 1998). The emergence of deactivated macrophages correlates with a 
reduction in the systemic granulomatous inflammatory response that they observe in 
the jird. This data suggests that the recruitment of anti-inflammatory macrophages 
could down modulate immuno-pathology. 
IL-10 is a downregulatory cytokine produced by macrophages as well as 
lymphocytes that can directly counter the pro-inflammatory effects of IFN-y. IL-10 
produced by blood monoculear cells has been implicated in the down-regulation of T 
cell responses observed during human filarial infection (Mahanty and Nutman, 1995) 
and the spontaneous release of high levels of IL-10 by adherent mononuclear cells has 
been associated with the hypo-responsive state. Osborne and Devaney (Osborne and 
Devaney, 1999) have further demonstrated that EL-10 produced by an adherent 
splenocyte population can suppress I cell proliferative responses in B. pahangi 
infected mice. Taken together, these results suggest that IL-10, potentially produced 
by monocyte/macrophages, may regulate the immune response during filarial 
infection. 
Several years ago, my supervisor, Dr. Judith Allen set out to determine 
whether exposure to filarial parasites caused an alteration in antigen presenting cell 
(APC) function that could lead to the defect in antigen-specific T cell proliferation 
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associated with infection(Allen et al., 1996). There wasn't a direct effect of parasites 
on APC in vitro. However, she found that when adult or larval stages of the parasite 
were implanted in the peritoneal cavity of mice, a population of adherent cells were 
recruited in vivo that when used as APC in vitro prevented the proliferation of a T cell 
clone. Interestingly, despite the profound effect on cell division, T cells were able to 
produce normal or elevated levels of antigen-specific cytokine. Further, using a range 
of lymphocyte cell lines she found that the anti-proliferative effect was remarkably 
non-specific and that cell division was blocked in a broad range of target cells whether 
stimulated with antigen or mitogen (Allen et al., 1996). Anti-proliferative cell could 
not be generated when animals were exposed to McI)  alone. As MI induces IFN-'y 
while L3 and adult stages induce high levels of early IL-4 (Lawrence et al., 1994; 
Osborne and Devaney, 1998) the induction of suppressor cells may require IL-4. 
Subsequently, a PhD student Andrew S. MacDonald, used neutralizing 
antibodies to IL-4 and mice genetically deficient in IL-4, to establish that recruitment 
and/or development of these anti-proliferative cells required host IL-4 (MacDonald et 
al., 1998). Interestingly, IL-10 had no effect in these studies as full suppression was 
observed in IL- 10 deficient mice. Further, studies with neutralizing antibodies to IL- 10 
and TGF-0 or inhibitors of nitric oxide, H202 or prostaglandins also were unable to 
reverse the proliferative defect (Allen et at., 1996). 
In this thesis, I have been able to demonstrate that the cell type responsible for 
these suppressive effects is indeed'a macrophage. Purification of cells using antibodies 
to the macrophage marker F4/80 is able to replicate the results with whole peritoneal 
cell populations. Although IL-4 deficient mice recruit slightly fewer macrophages than 
wild type mice, this does not account for the failure of IL-4' PEC to block 
proliferation, since purified macrophages from IL-4 deficient mice are still non-
suppressive. -• 
The combination of in vitro studies, animal models and field studies strongly 
suggests that macrophages associated with Th2 cytokines could play a vital role in the 
proliferative defect that is associated with filarial infection. The recognition that anti- 
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inflammatory macrophages are often associated with Th2 cytokines is an emerging 
concept in macrophage biology. The phenotypic differences between such 
"alternatively activated" macrophages from "classically activated" macrophages could 
account for the different roles that macrophages seem to play in filarial infection. 
Thus, the relationship between parasite clearance/coexistence, immune 
pathology/suppression with the balance of Thi and Th2 cytokines could reflect the 
type of macrophages that is induced by infection. 
A balance of cytokines and macrophages 
Whereas the Thl11'h2 paradigm has been well accepted as playing a central 
role in our interpretation of immune responses, the concept that these opposing 
cytokine responses might act on macrophages in different ways has only recently 
attracted the attention of a wider audience. While macrophages activated by 
interferon-y play a critical role in destroying intracellular pathogens (Kaufmann, 
1993), macrophages can also be activated by type 2 cytokines(particularly IL-4 and 
IL- 13) to develop a phenotype quite distinct from that of IFN-y activated macrophages 
(Doyle et al., 1994; Gordon, 1999; Stein et al., 1992). These cells have been termed 
"alternatively activated macrophages" (AAM) to distinguish them from classically 
activated macrophages (CAMb) (Stein et al., 1992). This alternative activation 
pathway is not simply a down-regulation of the IFN-T mediated effects but a 
developmental pathway in its own right (Gordon, 1999). Thus, it is apparent that 
macrophages, like T cells and dendritic cells (Rissoan et al., 1999), represent a 
heterogeneous population of cells with distinct biological roles. As with other cells of 
the immune system, this heterogeneity in function and developmental pathway is 
dependent on the cytokine microenvironment. We believe that this duality (or 
plurality) of macrophage function also exists within the context of lymphatic filariasis 
and could play a key role in the balance between parasite clearance and immuno-
pathology. 
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Since the evidence for macrophages as effector cells in filiariasis is correlated 
with such inflammatory factors as NO, we think that these fall into the category of 
CAM. The suppressive AAMD observed in our mouse model do not produce NO. 
Consistent with NO being a key effector molecule in macrophage function, probably 
the clearest distinction between the 2 categories of macrophages is the different 
metabolic pathways for L-arginine (Modolell et al., 1995). Under type 1 conditions, 
inflammatory macrophages produce NO as a result of upregulating inducible NO 
synthase (iNOS), which catalyzes the L-arginine substrate (MacMicking et al., 1997). 
Under type 2 cytokine conditions, arginase is upregulated instead of iNOS (Munder et 
al., 1998; Munder et al., 1999). The induction of arginase leads to the catalysis of L-
arginine into L-omithine and urea. The induction of either iNOS or arginase is usually 
associated with the suppression of the opposing enzyme, indicating a competitive 
nature in these alternative states of macrophage metabolism. 
Recent in vitro studies on the alternative arginase pathway showed that Th2 T 
cell clones were considerably more powerful at inducing arginase activity than the 
addition of Th2 cytokines alone (Munder et al., 1998). A different group has shown 
that peritoneal macrophages from strains of mice that were more inclined to mount a 
Thi (C57/BL6, B10.1)2) response, preferentially produce NO, whereas macrophages 
from strains that were biased towards Th2 responses appeared to inhibit NO 
production via TGF-. Consistent with. this arginase/iNOS paradigm, the EST project 
(chapter 7) showed that the AAM that are recruited by live adult B.malayi 
implantation have highly .upreg(ilated expression of hepatic arginase I, but not 
extrahepatic arginase H. This 'is was consistent with studies using bone marrow 
derived macrophages, which respond to Th2 stimuli by specifically inducing arginase 
I, but not affecting the constitutive expression of arginase II (Munder et al., 1999). 
Both CAM and AAM have been shown to suppress proliferation of 
lymphocytes. It is important to recognise that although NO is a clear indicator of 
classical activation, it is also involved in the inhibition of T cell proliferation. In the 
presence of inhibitors of NO synthesis, or in the absence of INOS, proliferation of T 
cells and production of inflammatory cytokines can be enhanced significantly 
DISCUSSION 	 144 
(MacMicking et al., 1997). Infection of mice with the protozoan,, Trypanosoma brucei 
also leads to generation of suppressive macrophages that act via NO and 
prostaglandins (Mabbott et al., 1995; Schleifer and Mansfield, 1993b; Sternberg and 
Mabbott, 1996a). 
Although CAM have some down-regulatory capacity, their prime function is 
microbial destruction. In contrast, the primary function of AAMb may be the 
dampening down or regulation of immune responses. Goerdt and Orfanos suggest that 
the production of anti-inflammatory cytokines is a key feature of APC activated under 
type 2 conditions (Goerdt and Orfanos, 1999). Immuno-suppressive macrophages 
induced under Th2 conditions have been described both in vitro as well as in vivo. 
Human monocyte/macrophages co-cultured in the presence of IL-4 and 
glucocorticoids in vitro, suppress proliferation of T cells (Schebesch et al., 1997). 
Alveolar and placental macrophages which have known suppressive effects exist 
under type 2 conditions and are likely to represent in vivo examples of AAM (Goerdt 
and Orfanos, 1999). In the context of helminth infection, macrophages which actively 
down-regulate granulomatous lesions surrounding schistosome eggs have been very 
well characterised (Stadecker, 1999). The formation of granulomas around 
schistosome eggs is dependent on CD4 T cells. The initial response to the egg is a 
type 1 pro-inflammatory response with the induction a large poorly circumscribed 
granuloma. Macrophages with an alternatively-activated phenotype appear to then 
rapidly down-regulate the inflammatory response and promote a switch to a type 2 
response. This is mediated primarily by IL-10. The subsequent granulomotous lesion 
is smaller in size and more compact, causing reduced damage to host tissue 
(Stadecker, 1999). 
Although IL-10 and TGF—P are supposed to be involved in AAM mediated 
suppression (Goerdt and Orfanos, 1999), there is clearly an alternative mechanism by 
which AAM are able to suppress cellular proliferation that is not understood. Studies 
of human AAM induced in vitro in the presence of IL-4 and glucocorticoids 
demonstrated the suppression was independent of IL- 10, NO or prostaglandins 
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(Schebesch et al., 1997). This was highly consistent with our previous work on 
suppressive macrophages induced by filarial infection that had also ruled out these 
potential mediators (Allen et al., 1996). Andrew MacDonald had also found that 
suppression required cell-to-cell contact and does not occur across a membrane. He 
also showed that AAM are capable of blocking cellular proliferation when fixed 
with paraformaldehye demonstrating that a soluble mediator is not responsible. 
Furthermore, I described in chapter 5 how we had found that the macrophages induced 
by filarial infection not only suppressed lymphocyte proliferation but suppressed the 
proliferation of a large number of human tumour cell lines. 
Our findings bear a remarkable similarity to the macrophages described by Lee 
et al. using an aerosol challenge transgënic mice system (Lee et al., 1999). Lee et.al . 
showed that lung parenchymal T cells failed to proliferate ex vivo, but retained their 
ability to produce ThlfTb2 cytokines. Interstitial F4/80 macrophages were 
responsible for this proliferative suppression since the depletion of F4/80 
macrophages restored the proliferation of T cells ex vivo. Further, this suppression 
could not occur across a lranswell membrane suggesting that these macrophages also 
act in a contact dependent manner. As with our peritoneal cells these macrophages are 
associated with eosinophilia suggesting a type 2 cytokine environment. These 
macrophages also seemed to augment IL4 and IL-5 production of Th2 cells, while 
suppressing the proliferation of both Thi and Th2 cells. 
The combination of evidences suggests that Th2 responses can drive the 
activation/differentiation of a macrophage population that inhibits proliferation of cells 
in the local vicinity via a novel receptor mediated mechanism. The ability of these 
macrophages to block cellular proliferation over a broad range of cell types and 
strongly suggests the engagement of a highly conserved receptor. A key direction of 
future studies on AAM4 will be the identification of this anti-proliferative 
mechanism. 
Apart from a role in immune suppression, Geordt et. al. also proposed that 
AAMcD, like DC2, could induce naïve T cells to differentiate in Th2 cells. CAM that 
are typically associated with cellular immunity have been shown to promote Thi cell 
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differention (Desmedt et al., 1998). However, the production of TGF—P and EL- 10 by 
AAM would suggest that these cells in contrast might help to promote Th2 
responses, either directly or by the inhibition of type 1 responses. In chapter 6, I 
described how we have found that the AAMCI that are induced by live adult Brugia 
malayi can indeed drive Tb2 differentiation of naïve T cells from pigeon cytochrome c 
(PCC) specific TCR transgenic (PCC-tg) mice. This observation showed that 
macrophages can be both the targets of T cell cytokines as well as regulators of T cell 
differentiation. While there have been reports describing dendritic cell subsets that 
differ in their capacity to stimulate the differentiation of naïve T cells (Iwasaki and 
Kelsall, 1999; Rissoan et al., 1999; Stumbles et al., 1998), this was one of the first 
studies to show that macrophages can also stimulate Th2 differentiation. Although it is 
still unclear how filarial parasites initiate a Th2 response, it is unlikely that AAM 
play an early role in this process. Since AAM are only induced under existing Th2 
response, it probably plays a more downstream role of suppressing Thi cells and thus 
stabilising the Th2 response. 
Future work 
Generation of a AAM gene expression database 
The definition of AAMID has been based on the expression of a number of 
molecules that appear to be upregulated in the presence of IL4 and/or IL- 13 (Doyle et 
al., 1994; Goerdt and Orfanos, 1999; Munder et al., 1998; Munder et al., 1999; Stein et 
al., 1992). These include the marophage mannose receptor, arginase and the CIO 
chemokine. Since AAMD are considered to be important in down-modulating certain 
pathogenic immune responses, further clarification of their cellular and molecular 
repertoires may help in developing novel immuno-therapeutic strategies. The ability to 
generate large numbers of these cells with B. malayi in vivo provides us with sufficient 
material to enable a detailed characterisation of the genes that are expressed by these 
cells. One of the main aims of the future is to identify the molecules that are involved 
in suppressing proliferation of other cells, as well as driving Th2 differentiation of 
naïve T cells. 
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I would like to take advantage of the recent explosion in genomic technology 
and use several complementary approaches to advance our understanding of AAM. 
First, we could survey genes from a recently constructed subtractive cDNA library to 
identify genes in AAM regulated by IL-4. Secondly, we could use DNA microarray 
technology to analyse expression of genes in AAM, complementing the 
identification of potentially novel genes in the subtractive library. Thirdly, we would 
like to expand expressed sequence tag (EST) projects from IL-4 and IL-4 AAM 
that would provide meaningful comparisons with other EST datasets, including the 
EST data from the subtractive library. The data generated from this type of study will 
define for the first time, in vivo IL4 dependent genes that are uniquely expressed or 
highly up-regulated by parasite induced macrophages. It will also provide a thorough 
survey of gene expression of AAM(D generated in vivo and thus greatly enhance our 
knowledge of macrophage biology. Finally, it may reveal the receptor that is involved 
in macrophage mediated proliferative inhibition. 
In chapter 7 we have described the construction of a subtractive library by 
using 'driver' RNA from non-suppressive IL-4 deficient PEC to subtract away 'tester' 
RNA from suppressive AAMCI. This yielded a population of 10-20,000 recombinants 
enriched in putative suppression generating transcripts. A preliminary assay of 160 
randomly selected clones from this library has revealed that between 10-20% of the 
recombinants are differentially expressed between the 2 macrophage populations. I 
would like to identify and sequence more clones (around 1000) from this library in 
order to generate a detailed profile 'of IL-4 dependent genes that are expressed in 
AAM that are induced by B. rnalayi in vivo. 
With modem high speed robotics, we could plate out the subtractive library 
and pick the colonies into 384 well plates with a robotic picker. These clones could 
then be gridded onto nylon membranes, which now represent a clone macroarray. This 
can be probed with radioactively labelled cDNA made from either suppressive AAM 
RNA or non-suppressive IL-4 deficient AAM in order to identify the genuinely 
differentially expressed clones. These can then be sequenced rapidly from the PCR 
product. Alternatively, we are exploring the possibility of constructing a DNA 
microarray from the subtractive library. This would save considerable amounts of time 
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for the identification of differentially expressed clones. Since a DNA microarray 
maker has just become available in Edinburgh, we could be able to exploit this facility. 
At the same time, I would like to expand our existing EST datasets (described 
in chapter 7). Because highly expressed genes appear more frequently in non-
normalised cDNA libraries, valuable expression pattern information can be obtained 
from comparisons of datasets from different libraries. This is the basis of Digital 
Differential Display (DDD) analysis currently available on NCBI'. DDD is a 
computational method for comparing sequence-based gene representation profiles 
among individual cDNA libraries or pools of libraries. The accuracy of such 
comparisons is dependent on the number of available EST from the different libraries. 
I would like to sequence at least another 1000 clones from our suppressive 
AAM(D cDNA library and another 1000 clones from non-suppressive macrophages. 
This will allow the identification of important new genes as well as a comparison of 
gene expression patterns between macrophages activated in the presence or absence of 
IL-4 in vivo. In addition we can compare our dataset to the currently available dataset 
of 5534 ESTs from the macrophage cell line WEHI-3. Fortunately, we have just 
received a grant in order to carry out this sequencing project. 
I would also like to exploit the recent availability of DNA microarray analysis. 
Gene microarray analysis is the most time efficient way to characterise expression of 
known genes or ESTs from our different populations of macrophages. I will compare 
1) suppressive parasite induced AAMD vs non-suppressive IL-4 deficient AAM in 
order to identify IL-4 dependent genes that are expressed by AAM(D and 2) 
suppressive parasite induced A&Mb vs resident macrophages in order to identify 
which genes are upregulated as a result of parasite induction of AAM. Because most 
DNA arrays contains previously uncharacterised murine ESTs, it may also allow us to 
identify new genes involved in suppression of cellular proliferation. 
In the future, all the sequences produced from the conventional and subtractive 
cDNA libraries will be submitted to dbest division of GenBank. The AAM EST 
I (http.//www.ncbinlm.nih.gov/UniGene/ddd.cgi?ORG=Mm)  
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sequences will be compared to each other and to other relevant datasets to defme 
'clusters' of ESTs deriving from single genes. The clustering information, associated 
expression profiles, and consensus sequences will be collated in a relational database 
in FileMaker Pro. This will then become available on our website for access to the 
scientific community. 
The data generated from these studies will have an immediate impact on our 
understanding of macrophage activation in a T12 environment. It will also provide the 
foundation for future work in this area and provide an outstanding resource for other 
investigators working in the field of macrophage biology. 
Characterisation of genes expressed by AAM 
Apart from molecules that are involved in proliferative suppression as well as 
Th2 differentiation, we are interested in other IL-4 dependent genes that might be 
important in the function of AAM. We will begin to characterise these genes using a 
combination of molecular, cellular and immunological strategies. The nature of future 
investigations will be subject to the kinds of genes that we identify. Since the cDNA 
libraries were constructed into a mammalian expression vectors (pCMV-Script & 
pcDNA3. 1), interesting genes can immediately be expressed by Iransfection into 
mammalian cells. 2 particularly interesting genes that deserve attention are described 
below. 
PNG11FIZZ1 is extremely interesting because of its abundant expression as 
well as its IL-4 dependent induction pattern. Recently, this gene has been described as 
a major secreted protein found in the lungs of OVA-induced asthmatic mice (Holcomb 
et al., 2000). We were going to begin by charaàterising it's expression in different 
tissue types by probing mouse tissue specific Northern blots, however, the recent 
publication of this data has changed our analysis strategy. We will use our light cycler 
quantitative PCR machine (Roche) to verify the differential expression of this gene in 
different immunological cell types, eg. Thi vs Th2 cells, B cells, bone marrow cells, 
thymocytes, splenocytes and etc., because the published study has not characterised it's 
expression in immune cells. We will then make a Ig-fusion protein, which can be used 
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for flow cytometry to establish the cell types that have a receptor for this molecule. An 
Ig-fusion protein would also enable us to inimuno-precipitate the receptor for 
biochemical characterisation as well as for peptide sequencing and cDNA cloning. 
Blocking studies can also be carried out with Ig-fusion proteins. We have already 
designed primers to express this small molecule in E. Co/i using the pET29 vector. 
Expressed protein can be used to generate polyclonal antibodies that will be useful for 
western blots, flow cytometly and immunocytochemistiy. Future studies, based on the 
interests of the results we receive from these experiments could include the generation 
of genetically deficient mice. 
We are especially interested in any IL-4 dependent transcription factors (eg. 
CRIP). The identification of transcription factors that could drive the differentiation of 
AAM and not the maturation of CAMO would be a significant discovery. We can 
use the strategy of transferring retroviral infected bone marrow cells into lethally 
irradiated syngeneic mice. This strategy has been used to study the differentiation of 
stem cells (Chen et al., 1998a; Pui et al., 1999) as well as the transformation activity of 
certain proto-oncogenes (Pear et al., 1996). We can make retroviral expression 
constructs expressing candidate transcription factors, which will be transfected into 
retroviral packaging cell lines and high titre retroviral supernatants can be used to 
infect bone marrow cells, which will then be transferred into lethally irradiated 
syngeneic host. 
The original purpose of our molecular characterisation strategy for these 
suppressive macrophages was the 4dentification of the suppressive molecule. Our aims 
and intentions have changed cbnsiderably since the determination of this original 
objective. The data we obtained with respect to the relationship between Yml/ECF-L, 
eosinophils and Bm-MIF-1, fundamentally changed my perspective regarding the 
most suitable direction to proceed, which broadened from a more focused and direct 
goal of identifying the suppressive molecule towards a broader aim of understanding 
the biology of these suppressive macrophages by analysing gene expression. 
Using a molecular strategy would not guarantee the identification of the 
suppressive molecule(s), which could have involved post-translational modifications, 
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glycosylations and other properties that could not have been identified by differential 
gene expression. We have not lost sight of this original objective and are considering 
other non-molecular strategies for identifying the suppressive mechanism. Proteomics 
for example is in the process of undergoing the same revolution as we have observed 
in molecular biology over the last few years. Since we already know that the 
suppressive molecule is likely to be a cell surface molecule, we could biotinylate all 
the cell surface proteins of suppressive macrophages and non suppressive 1L-4 6 
macrophages. Biotinylated proteins can then be extracted with streptavidin and run on 
2D gels for MALDI analysis. This approach would provide us with information about 
variations in other cell surface molecules as well as the potential suppressive 
molecules. Perhaps we might even identify unique cell surface markers that are 
distinct for suppressive macrophages. This approach would be complementary to our 
molecular approach, since peptide sequences of unknown proteins could well 
correspond to novel genes that we would identify through our molecular strategies. 
7 
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Future goals and opinions 
Immunologists today, who are in possession of sophisticated genetic tools to 
study experimental antigens (e.g. ovalbumin, haptens, KLH, HEL PCC and etc..), 
often overlook the fact that our immune response evolved primarily for the protection 
against infectious diseases. From this perspective, my opinions are in agreement with 
Zinkernagel, in that to understand the process of immunity we must take an 
evolutionary perspective with emphasis on how protection against infection is 
achieved (Zinkernagel, 2000). The increasingly sophisticated and complicated 
transgenic mice, which are mostly specific to experimental antigens instead of 
infectious organisms, are useful in revealing the extreme limits of the immune system, 
but might not reflect the general physiology of the immune system. To understand 
physiological processes in vivo, we should perhaps turn to infectious organisms again 
for guidance. Unfortunately, these experimental models tend to produce messy rather 
than clean data due to the complex nature of 2 organisms interacting (rather than a one 
sided interaction with an inanimate, antigen), which is probably why they were 
abandoned by the majority of basic immunologists. 
Although Matzinger argues that we must "understand what the immune system 
does (i.e. transplantation, tumour immunity, autoimmunity), not only what it may have 
evolved to do (i.e. combat infection)" (Matzinger, 1998), it seems to me that a 
disproportionate amount of resources is directed towards understanding relatively low 
level effects, in comparison to understanding what may be more physiologically as 
well as evolutionarily relevant and affecting a much wider proportion of the worlds 
population. My research aims in- the future will be to work with experimental systems 
that bear closer resemblance to real life immune responses against infections. 
Hopefully the immunological tools from basic immunological research will begin to 
trickle down to fill the voids in infection orientated immunology, especially in the 
field of parasite immunology. 
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APPENDIX: PUBLISHED PAPERS 
Loke P, MacDonald AS, Robb AO, Maizels RM, Allen JE European 
Journal of Immunology 2000 Sep;30(9):2669-78 Alternatively activated 
macrophages induced by nematode infection inhibit proliferation via cell to cell 
contact. 
Loke P, MacDonald AS, Allen JE European Journal of Immunology 2000 
Apr;30(4):1127-35 Antigen-presenting cells recruited by Brugia malayi induce Th2 
differentiation of naive CD4(+) T cells. 
Le Goff L, Loke P, Ali HF, Taylor DW, Allen JE Infection & Immunity 2000 
May;68(5):2513-7 Interleukin-5 is essential for vaccine-mediated immunity but not 
innate resistance to a filarial parasite. 
MacDonald AS, Loke P, Allen JE Pathobiology 1999;67(5-6):265-8 
Suppressive antigen-presenting cells in Helminth infection. 
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